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 Summary 
Transparent and standardized reporting in clinical research is a prerequisite for 
optimal healthcare decision-making. This applies to any clinical discipline, but may be 
specifically challenging, when complex surgical interventions are involved. There, the 
impact of surgeons’ experience on the size of treatment effects, standardization of 
interventions and of outcome assessment need to be specifically addressed. 
In a previous investigation on selective outcome reporting in surgical trials (Rosenthal 
and Dwan 2013), we found a remarkably high percentage of unexplained 
discrepancies between registry entries and final reports of randomized controlled 
trials (RCTs) that were published in high-impact surgical journals. In order to address 
problems of reporting in surgical research more in depth, I decided to dedicate my 
PhD to this topic. Thus, the overall aim of my PhD research is to investigate and 
promote transparent and standardized reporting in surgical research. As follows, I 
outline the different aspects I specifically addressed. 
Project 1: How to write a surgical clinical research protocol: literature review 
and practical guide 
Any clinical research starts with asking a research question. The question shall be 
embedded in the existing body of evidence. If the study question and hypothesis is 
not precise and the study is not designed in a sound manner, this will impact on 
reporting and overall study conclusions. The core document of the design phase is 
the study protocol. Our first project was thus to develop a straightforward 10-step 
practice guideline on how to develop a surgical clinical trial protocol with a focus on 
methodological aspects. Our project and initiative was highly welcomed by the journal 
reviewer of the American Journal of Surgery, where the study was published 
(Rosenthal et al. 2014) and is reflected in his reviewer comment “This is a valuable 
report that describes the steps necessary to optimize the design of clinical research 
studies. This information is important and the article should be required reading for all 
surgeons who are embarking on a research career.” 
Project 2: The use of systematic reviews when designing and reporting 
surgical trials  
A systematic review (SR) on the existing literature should be part of any clinical 
research project to justify the planned research from a scientific, ethical and 
economic point of view as well as to inform the trial design and, finally to sum up the 
results within the existing body of evidence. In a meta-epidemiological research 
project we investigated to what extend investigators systematically searched the 
literature in the context of their project and whether this information was provided in 
the final publication (Rosenthal et al. 2015a). Of 596 studies, 51 RCTs published in 3 
high-impact general surgical journals were identified. SRs were referenced in 65%, 
either to summarize evidence concerning a related topic (43%) or the study topic 
(excluding first-in-area RCTs: introduction 24%, discussion 26%). No SRs were used 
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 to inform trial design and no trial updated a SR for the integration of the new results. 
In conclusion, in the surgical literature SR are rarely used to inform trial design, justify 
the research and synthesize knowledge for informed decision making.  
Project 3: Completion and publication rates of surgical randomized controlled 
trials – an empirical study 
In a next step, we addressed important issues when conducting and reporting results 
of clinical trials in surgery. We investigated to what extent surgical trials were 
discontinued early and/or not published. For this purpose, all RCT protocols 
approved from 2000 to 2003 by six ethics committees in Canada, Germany and 
Switzerland were screened. We explored risk factors for early trial discontinuation 
due to slow recruitment and compared surgical to medical trials. Early trial 
discontinuation due to slow recruitment has an impact on reporting: first, overall trial 
conclusions due to limited power may be biased if the targeted sample size has not 
been reached and second early discontinuation may increase the risk of publication 
bias if results typically derived from underpowered studies are not published.   
In total, 863 RCT protocols involving adult patients were identified; 127 in surgery 
(15%) and 736 in medicine (85%). Surgical trials were discontinued for any reason 
more often than medical trials (43% versus 27%, risk difference 16% (95% 
confidence interval [CI] 5%, 26%); p=0.001) and were also more often discontinued 
for slow recruitment (18% versus 11%, risk difference 8% (95% CI 0.1%, 16%); 
p=0.020). The percentage of trials not published as full journal article was similar in 
surgical and medical trials (44% versus 40%, risk difference 4% (95% CI -5%, 14%); 
p=0.373). Discontinuation of surgical trials was a strong risk factor for non-publication 
(odds ratio 4.18, 95% CI 1.45, 12.06; p=0.008) (Rosenthal et al. 2015b). 
Project 4: Reporting of adverse events in surgical trials: critical appraisal of 
current practice  
Reporting of surgical outcomes should include detailed reporting of harm. The 
information needs to be generated according to uniform and reproducible standards 
that allow for the comparison of results, techniques, centres or surgeons. For 
postoperative complications, several classifications have been proposed and 
validated; however, there exists no recognised classification system for intraoperative 
complications. Therefore, we aimed at assessing the current practice of reporting 
intra- and postoperative complications in surgical trials that were published in 2010 in 
three major surgical journals (Rosenthal et al. 2015c). We identified 46 trials that 
reported intra- and postoperative complications. These complications were reported 
separately in 42% and pooled in 15%. In 37% intraoperative, in 2% postoperative, 
and in 4% both intra- and postoperative complications were not reported at all. Exact 
definitions were provided in 13% for intraoperative and in 50% for postoperative 
complications. A classification was used in 9% for intra- and in 54% for postoperative 
complications, most frequently according to severity. As further research, we thus 
plan to develop and validate a classification of intraoperative complications in order to 
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 facilitate the evaluation of safety and the continuous quality control of surgical 
interventions with the ultimate goal to contribute to patient safety.  
Project 5: Definition and Classification of Intraoperative Complications 
(CLASSIC): Delphi Study and pilot evaluation  
Our abovementioned investigation (Project 4) of reporting of harm clearly showed the 
urgent need for a classification of intraoperative complications. We therefore 
conducted a two-stage Delphi study among experts in surgical practice and trial 
methodology to develop a definition and classification of intraoperative complications 
(Rosenthal et al. 2015d). 
In the Delphi study, a total of 40 out of 52 experts (77% return rate) from 14 countries 
took part in both rounds. It resulted in a comprehensive definition of intraoperative 
complications and a straightforward classification. We then conducted a pilot study 
reviewing 60 records involving surgical interventions of variable complexity by two 
independent reviewers. It showed good practicability (6 on a 7-point scale) and an 
87% agreement with a weighted kappa of 0.83 (95% CI 0.73, 0.94) and an intraclass 
correlation coefficient of 0.83 (95% CI 0.73, 0.90).  
Project 6: How to report multiple outcome metrics in virtual reality simulation 
Virtual reality (VR) simulation is increasingly being used for assessment and training 
purposes in various surgical disciplines. However, there is no consensus on how to 
report outcomes derived from simulators. VR simulators objectively measure multiple 
outcomes, which is frequently handled by selective reporting or multiple testing. This 
compromises comparison between different VR studies and introduces a risk of bias. 
Thus, suitable methods are needed to either address multiplicity issues or combine 
evidence from multiple possibly related outcomes into a lower dimensional outcome. 
We developed an algorithm for summarizing multiple VR outcome metrics into a total 
score and illustrate the approach with two real data examples (Rosenthal et al. 
2015e). Given the increasing number of articles in the field, a standardized and 
transparent approach for analyzing and reporting VR outcome data is of utmost 
importance to enhance the validity of VR derived surgical reports. 
Project 7 (ongoing): Disregarding paired data in surgical research – evaluation 
of current practice and estimation of implications on study results 
In surgical practice and research, patients may be affected by a pathology and 
treated on both sides of their body, e.g. in extremity surgery. As a consequence, 
paired data are generated. In the context of our consultancy service for surgeons we 
were faced with studies that did not account for the paired design in the statistical 
analysis. We therefore decided to carry out a systematic literature review based on 
the example of inguinal hernia repair, one of the most frequently conducted surgical 
interventions (ongoing). The aim of this project is to first evaluate to what extent 
paired data are accounted for in the statistical analysis and second to estimate the 
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 impact on overall study conclusions if this specific design issue is not correctly 
considered in the statistical analysis.   
Conclusion 
In conclusion, with the present work the reporting of surgical trials is addressed from 
two points of view: i) evaluation of current practice and ii) proposal for procedures to 
address identified challenges in reporting. Since any study report depends on the 
study conception and conduct, these two phases are included in the evaluation. 
Figure 1 gives an overview of the projects within this framework.  
 
Figure 1: Framework of projects evaluating reporting in surgical research 
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 Zusammenfassung 
Eine transparente, reproduzierbare und standardisierte Darstellung von klinischen 
Forschungsergebnissen ist eine Grundvoraussetzung, damit wissenschaftliche 
Erkenntnisse kritisch evaluiert und – falls valide und relevant - in die Praxis 
umgesetzt werden können. Sie ist somit eine Grundvoraussetzung für die 
evidenzbasierte Medizin und für eine optimale Entscheidungsfindung im 
Gesundheitswesen. Dies gilt für jede klinische Disziplin, ist aber eine besondere 
Herausforderung, wenn es um komplexe chirurgische Interventionen geht. Dort muss 
speziellen Gegebenheiten Rechnung getragen werden, wie der Bedeutung der 
Erfahrung des Chirurgen und deren Einfluss oder Ausmass auf den 
Behandlungseffekt, der Standardisierung von Interventionen und der 
Endpunkterfassung.  
In einer früheren Untersuchung über die selektive Darstellung  von 
Studienendpunkten (Outcomes) in chirurgischen randomisiert kontrollierten Studien 
(RCT) (Rosenthal & Dwan 2013) fanden wir einen recht hohen Anteil an unerklärten 
Diskrepanzen zwischen Ergebnisendpunkten in Studienregistern und den 
entsprechenden Publikationen von RCTs, welche in allgemeinchirurgischen 
Zeitschriften mit hohem Impaktfaktor publiziert wurden. Um mich noch weiteren 
Aspekten dieses Themas zu widmen, entschloss ich mich, meine Doktorarbeit (PhD) 
diesem Gebiet zu widmen. Daher ist das übergeordnete Ziel meiner Forschung im 
Rahmen der Doktorarbeit, die transparente und standardisierte Darstellung und das 
Berichten von Studienergebnissenn in der chirurgischen Forschung zu untersuchen 
und zu fördern. Nachfolgend fasse ich die spezifischen Fragestellungen, die ich 
untersucht habe, zusammen.   
Projekt 1: Wie man ein chirurgisches klinisches Studienprotokoll abfasst: 
Literaturreview und Leitfaden 
Jede klinische Forschung beginnt mit einer Forschungsfrage. Diese sollte in die 
bereits bestehende Evidenz eingebettet sein und das adäquate Studiendesign muss 
dafür gewählt werden. Wenn eine Studie nicht fundiert geplant wird, hat dies 
schlussendlich Auswirkungen auf die gesamten Schlussfolgerungen der Studie. Das 
zentrale Dokument in der Studienplanungs- und Durchführungsphase ist das 
Studienprotokoll. Unser erstes Projekt ist daher die Entwicklung eines 10-Punkte 
Leitfadens zum Thema „Wie entwickle ich ein Studienprotokoll für eine klinische 
chirurgische Studie“ mit Fokus auf methodologische Aspekte. Diese Arbeit wurde im 
American Journal of Surgery publiziert (Rosenthal et al. 2014) und ein Reviewer der 
Zeitschrift hat die Bedeutung unserer Arbeit wie folgt kommentiert (Zitat übersetzt) 
„Dies ist ein wertvoller Bericht, der die notwendigen Schritte beschreibt, um die 
Planung klinischer Studien optimal zu gestalten. Diese Information ist wichtig und der 
Artikel sollte eine Pflichtlektüre für alle Chirurgen sein, die eine Forscherkarriere 
planen.“ 
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 Projekt 2: Die Verwendung von systematischen Reviewarbeiten für die Planung 
und das Berichten von Ergebnissen in chirurgischen randomisierten 
kontrollierten Studien 
Als nächstes untersuchten wir, inwiefern Information aus systematischen 
Reviewarbeiten (SR) verwendet wird, um die geplante Studie aus wissenschaftlicher, 
ethischer und ökonomischer Sicht zu rechtfertigen sowie um das Studiendesign zu 
planen. Zudem evaluierten wir, inwiefern am Ende die Resultate in bestehende 
Information im Sinne einer Synthese integrieren werden (Rosenthal et al. 2015a). 
Von 596 Studien, welche in allgemeinchirurgischen Zeitschriften mit hohem 
Impaktfaktor publiziert wurden, konnten 51 RCTs identifiziert werden. SR wurden in 
65% verwendet, entweder um Evidenz zu einem verwandten Thema 
zusammenzufassen (43%) oder zum Studienthema (unter Ausschluss der RCTs, die 
eine neue Fragestellung untersuchen: Einleitung 24%, Diskussion 26%).  In keinem 
einzigen Fall wurden SR zum Entwickeln des Studiendesigns verwendet und keine 
RCT hat eine SR aktualisiert unter Integration der neuen Studienresultate. 
Zusammenfassend lässt sich festhalten, dass SR selten zur Studienplanung, 
Studienrechtfertigung und Informationssynthese verwendet werden. Dies 
beeinträchtigt die Beurteilung der Ergebnisse und deren Interpretation im 
wissenschaftlichen Kontext. 
Projekt 3: Studienabschluss –und Publikationsraten bei chirurgischen 
randomisiert kontrollierten Studien – eine empirische Untersuchung 
In diesem Projekt konzentrierten wir uns auf die Aspekte  der Studiendurchführung 
und der Darstellung sowie des Berichtens von Studienresultaten. Der Fokus der 
Studie lag auf der Untersuchung des Anteils an nicht abgeschlossenen und nicht 
publizierten Studien. Dafür evaluierten wir alle Studienprotokolle von RCTs, welche 
zwischen 2000 und 2003 von sechs Ethikkommissionen in Kanada, Deutschland und 
der Schweiz bewilligt wurden. Wir untersuchten Risikofaktoren für den frühzeitigen 
Studienabbruch wegen Rekrutierungsproblemen und verglichen chirurgische mit 
medizinischen Studien. Vorzeitiger Studienabbruch wegen Rekrutierungsproblemen 
hat einen wichtigen Einfluss auf das Berichten der Resultate: erstens können die 
Studienresultate wegen der nicht erreichten Fallzahl verzerrt sein, da die statistische 
Kraft zum Belegen der Studienhypothese fehlen kann und zweitens hat ein 
frühzeitiger Studienabschluss einen Einfluss darauf, ob die Resultate überhaupt 
publiziert werden. Studien mit negativen oder unschlüssigen Ergebnissen werden 
erfahrungsgemäss weniger häufig publiziert.  
Insgesamt fanden wir 863 RCT Protokolle von Studien an erwachsenen Patienten, 
127 aus der Chirurgie (15%) und 736 aus der Medizin (85%). Chirurgische RCTs 
wurden insgesamt häufiger vorzeitig abgebrochen als medizinische RCTs (43% 
versus 27%, Risikodifferenz 16% (95% Vertrauensintervall [CI] 5%, 26%); p=0.001) 
als auch  häufiger wegen Rekrutierungsproblemen abgebrochen (18% versus 11%, 
Risikodifferenz 8% (95% CI 0.1%, 16%); p=0.020). Der Prozentsatz an RCTs, welche 
nicht als volle Zeitschriftenartikel publiziert wurden, war zwischen chirurgischen und 
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 medizinischen RCTs vergleichbar (44% versus 40%, Risikodifferenz 4% (95% CI -
5%, 14%); p=0.373). Vorzeitiger Studienabbruch chirurgischer RCTs war ein starker 
unabhängiger Risikofaktor, dass keine Publikation erfolgte (Odds-Ratio 4.18, 95% CI 
1.45, 12.06; p=0.008) (Rosenthal et al. 2015b). 
Projekt 4: In der Literatur gebräuchliches Berichten von intra- und 
postoperativen Komplikationen  
Die Darstellung und das Berichten von Ergebnissen chirurgischer Studien sollten  
Komplikationen einschliessen. Es gibt mehrere publizierte und validierte 
Klassifikationen für postoperative Komplikationen, nicht jedoch für intraoperative 
Komplikationen. Das Ziel der vorliegenden Untersuchung ist deshalb, das aktuell 
gebräuchliche Berichten von intra- und postoperativen Komplikationen in 
chirurgischen RCT zu untersuchen (Rosenthal et al. 2015c). Die Untersuchung von 
45 RCTs, welche im Jahr 2002 in den drei höchst zitierten chirurgischen Zeitschriften 
publiziert wurden, zeigte, dass über intra- und postoperative Komplikationen in 42% 
separat und in 15% zusammen berichtet wurde. Über intraoperative Komplikationen 
wurde in 37%, über postoperative in 2% und über intra- und postoperative in 4% 
überhaupt nicht berichtet. Exakte Definitionen wurden in 13% für intraoperative und 
in 50% für postoperative Komplikationen angegeben, meist klassifiziert nach 
Schweregrad der Komplikation. Daher planten wir als nächsten Schritt die 
Entwicklung und Validierung einer Klassifikation intraoperativer Komplikationen. Ein 
einheitliches Klassifikationssystem  erleichtert die Überprüfung von Sicherheit im 
Sinne der Qualitätskontrolle chirurgischer Interventionen und leistet schlussendlich 
einen Beitrag zur Patientensicherheit.  
Projekt 5: Definition und Klassifikation intraoperativer Komplikationen 
(CLASSIC): Delphi Studie und Pilotstudie  
Die obengenannte Untersuchung (Projekt 4) zur Darstellung und zum Berichten von 
Komplikationen zeigt den dringenden Handlungsbedarf und die Notwendigkeit der 
Entwicklung  einer Klassifikation für intraoperative Komplikationen. Wir führten 
deshalb eine Delphi Studie mit zweimaliger Befragung von Experten in Chirurgie und 
Studienmethodologie durch zur Entwicklung einer Definition und Klassifikation von 
intraoperativen Komplikationen (Rosenthal et al. 2015d). Insgesamt 40 von 52 
Experten (77% Rücklaufquote) aus 14 Ländern nahmen an beiden 
Befragungsrunden der Delphi Studie teil. Die Studie führte zu einer umfassenden 
Definition intraoperativer Komplikationen sowie zu einer überschaubaren 
Klassifikation. Zwei unabhängige Begutachter wandten  dann in einer Pilotstudie mit 
60 chirurgischen Eingriffen unterschiedlicher Komplexität die Klassifikation an. Es  
zeigte sich eine gute Praktikabilität (6 von 7 möglichen Punkten) sowie eine 87-
prozentige Übereinstimmung mit einem gewichteten Kappa von 0.83 (95% CI 0.73, 
0.94) und einem Intraklasse-Korrelationskoeffizienten von 0.83 (95% CI 0.73, 0.90).  
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 Projekt 6: Wie man multiple unterschiedliche Endpunkte (Outcomes) bei der 
Simulation mit Virtueller Realität berichtet 
Virtuelle Realität (VR) wird zunehmend für die Evaluation und das Training in 
diversen chirurgischen Disziplinen verwendet. Es gibt allerdings keinen Konsensus, 
wie man Ergebnisse von Simulatordaten berichten soll. VR Simulatoren messen 
objektiv eine Vielzahl von Endpunkten (Outcomes), was oft entweder zu selektivem 
Berichten von Ergebnissen  führt oder zum Durchführen multipler statistischer Tests. 
Dies schränkt die Vergleichbarkeit zwischen Simulatorstudien ein und erhöht das 
Risiko für eine verzerrte Darstellung der Ergebnisse (Bias). Daher sollten geeignete 
Methoden zur Verfügung stehen, um die Multiplizität anzugehen oder um Evidenz 
aus multiplen zum Teil zueinander in Beziehung stehenden Outcomes in einem 
niedriger dimensionalen Outcome zusammenzufassen. Wir entwickelten einen 
Algorithmus um multiple VR Outcomeparameter in einen totalen Score 
zusammenzufassen und wandten diesen an zwei Datensätzen an (Rosenthal et al. 
2015e). Im Hinblick auf die steigende Anzahl an Publikationen auf diesem Gebiet ist 
ein standardisiertes und transparentes Vorgehen bei der Analyse und dem Berichten 
von VR Outcomes extrem wichtig, um die Validität von VR Berichten zu stärken.  
Projekt 7 (laufend): Vorliegen gepaarter Daten in der chirurgischen Forschung - 
Evaluation der in der Literatur verwandten Verfahren und Bedeutung für 
Studienresultate  
Im chirurgischen Alltag und der chirurgischen Forschung können Patienten von einer 
Erkrankung und Behandlung auf beiden Körperseiten betroffen sein, z.B. in der 
Extremitätenchirurgie. Demzufolge werden bei zweiseitiger Operation gepaarte 
Daten generiert. Da wir im Rahmen unserer Beratungstätigkeit mehrere Studien 
fanden, welche das gepaarte Design in der Analyse nicht berücksichtigten, 
entschlossen wir uns zu einer systematischen Evaluation von Studien im Bereiche 
der Leistenhernienchirurgie (laufendes Projekt). Das Ziel ist in einem ersten Schritt 
zu evaluieren, inwiefern dem gepaarten Design in den untersuchten Studien in der 
statistischen Analyse gerecht wird und in einem zweiten Schritt dann zu untersuchen, 
inwiefern die fehlende Berücksichtigung der gepaarten Datennatur mit nicht 
unabhängigen Ergebnissen bei doppelseitigen Eingriffen einen Einfluss auf die 
Gesamtschlussfolgerungen der Studien hat.  
Schlussfolgerung 
Zusammenfassend gehen wir mit der vorliegenden Arbeit das Berichtswesen 
(Reporting) chirurgischer RCTs von zwei Blickrichtungen an: Wir zeigen die aktuelle 
Praxis des Publikationswesens in der Chirurgie mit ihren Unzulänglichkeiten und 
Inkonsistenzen und präsentieren Vorschläge für Massnahmen, um die 
Herausforderung bei der Darstellung und dem Berichten von Studienergebnissen 
anzugehen. Da das Berichten von Studienresultaten immer auch von der 
Studienkonzeption und praktischen Durchführung abhängt, haben wir diese beiden 
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 Phasen in unsere Beurteilung integriert. In Abbildung 1 (Figure 1) ist die 
Projektübersicht in diesem Rahmen grafisch dargestellt.  
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1. Introduction   
         
1.1. Background 
 
Transparent, standardized and accurate reporting in clinical research is of utmost 
importance for decision making in healthcare. Reporting should follow 
standardized guidelines as proposed by CONSORT (Consolidated Standards of 
Reporting Trials Statement) (Schulz et al. 2010). Of specific interest to surgery are 
the CONSORT extensions for nonpharmacologic treatment (Boutron et al. 2008). 
There, challenges to surgical trials such as blinding, experience of and clustering 
by care providers and centers and standardization of interventions are accounted 
for.  
 
In order to be able to accurately report study results, the study needs to be well-
designed and well-conducted. Thus, for reporting in clinical research, all three 
phases are relevant: the study design, study conduct and study report phase.  
In the study design phase, numerous methodological issues need to be 
considered and finally included in a detailed study protocol. Importantly, to be able 
to justify a planned research from a scientific, ethical and economic point of view, 
the current research question should be set in context with the existing body of 
evidence. Information from previous trials and systematic reviews may be used to 
inform trial design.  
In the study conduct phase, the developed protocol should be strictly followed. 
Additionally, threats to completing an ongoing trial, such as early discontinuation 
for slow recruitment, should be monitored and anticipated.  
Finally, in the study report phase, great care should be given to standardized and 
transparent reporting, relying on clear definitions and validated classifications. This 
is a pre-requisite for comparison of study results and healthcare decision making. 
It applies both to safety and efficacy outcomes. Whereas for postoperative 
complications several classification systems have been proposed (Clavien et al. 
1992;Clavien et al. 2009;Dindo et al. 2004;Pillai et al. 1999;Pomposelli et al. 
1997;Strasberg et al. 2009), we are unaware of a validated definition and 
classification strictly applying to intraoperative complications. An example of 
efficacy outcomes that should be transparently reported are performance 
measurements generated by virtual reality (VR) simulators. VR simulators 
measure multiple outcomes on different scales. Therefore, suitable methods are 
needed to either address multiplicity issues or combine evidence into a lower 
dimensional outcome. Additionally, in any type of outcome, the statistical analysis 
and the report should account for paired data, resulting from several interventions 
per patient. If not accounted for, effects may be overestimated. 
 
There are two areas to be addressed when further evaluating reporting in surgical 
research: 1) the evaluation of current practice and 2) the development of 
guidelines to optimize specific reporting challenges. Based on current literature in 
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the field, we have thus identified seven research projects addressing study design, 
conduct and reporting from a perspective of current practice evaluation or 
guideline development (Figure 1).  
 
1.2. Aims and objectives 
The overall aim of the present research is the evaluation and optimization of 
reporting in surgical research, thus facilitating informed healthcare decision 
making. 
Within seven projects, we specifically address the following objectives:  
1. To develop a practice guide outlining key methodological issues important 
when planning an ethically and scientifically sound research project involving 
surgical interventions. 
2. To evaluate to what extent systematic reviews are used in surgical RCTs to 
inform trial design and to integrate trial results in the overall body of evidence. 
3. To determine the proportion of discontinued surgical trials and the reasons for 
discontinuation, differences in discontinuation between medical and surgical 
trials and risk factors for non-publication of surgical trials.  
4. To systematically assess the current practice of reporting intra- and 
postoperative adverse events in RCTs published during one year in three 
major general surgery journals.  
5. To develop a definition and classification for intraoperative complications 
within a Delphi study and to conduct a pilot study evaluating practicability and 
interrater agreement. 
6. To present an algorithm for summarizing multiple VR outcomes of different 
dimensions and weighing them within a total score.  
7. To analyze in RCTs of patients undergoing hernia repair without exclusion of 
bilateral surgery i) to what extent the presence of clustered data has been 
accounted for in the study design and statistical analysis and ii) to estimate the 
effect of disregarding clustered data on the overall results (ongoing).  
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Abstract  
Background: The study protocol is the core document of every clinical research 
project. Clinical research in studies involving surgical interventions presents some 
specific challenges, which need to be accounted for and described in the study 
protocol. The aim of this review is to provide a practical guide for developing a 
clinical study protocol for surgical interventions with a focus on methodological 
issues. 
Data sources: Based on an in-depth literature search of methodological literature 
and on some cardinal published surgical trials and observational studies, this 
paper provides a 10-step guide for developing a clinical study protocol in surgery.  
Conclusions: This practical guide outlines key methodological issues important 
when planning an ethically- and scientifically sound research project involving 
surgical interventions, with the ultimate goal to provide high level evidence 
relevant for healthcare decision-making in surgery.  
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2.1. Introduction 
The study protocol as a core document in clinical research 
The study protocol is the central document of a clinical research project and takes 
into account scientific, ethical and regulatory considerations. It provides detailed 
information on all aspects of the planning and conduct of the research project and 
is the main document for evaluation of the planned research, e.g. by an 
independent ethics committee and regulatory authorities. It guides study 
investigators to conduct the study according to standardized criteria and it allows 
replication in subsequent studies. The protocol includes the justification for the 
planned research, the objectives, details on the intervention and the study 
population, information on data management, quality assurance, statistical 
analyses and ethical considerations. Importantly, the protocol should be developed 
in an interdisciplinary setting, including clinicians, scientists, statisticians and other 
involved parties. Study protocols need to be approved by an independent ethics 
committee (IEC) and by the regulatory authorities according to local guidelines.  
Types and phases of surgical research 
Surgical clinical research may involve pharmaceuticals, medical devices, surgical 
procedures and other interventions concerning prevention, diagnostics, treatment 
and rehabilitation. In drug development, the phases of investigation have been 
well-defined and most typically range from human pharmacology studies (phase I) 
through therapeutic exploratory (phase II) to therapeutic confirmatory studies 
(phase III), followed by post-marketing studies (phase IV) (The International 
Conference on Harmonisation of Technical Requirements for Registration of 
Pharmaceuticals for HumanUse (ICH) 2014). Similar phases ranging from pilot, 
pivotal through to post-marketing surveillance have been described for medical 
devices, for which requirements for demonstrating safety and efficacy depend on 
the risk associated with the device (Kaplan et al. 2004). In the example of research 
involving surgical interventions, the IDEAL framework has been proposed, the 
acronym standing for the stages (1) idea including proof of concept, (2a) 
development, (2b) exploration, (3) assessment and (4) long-term study (Heikens 
et al. 2013;McCulloch et al. 2009). An overview of the IDEAL framework with 
examples is provided in table 1. 
In this review article, we focus on surgical interventions; however some of the 
concepts may be extrapolated to other interventions.   
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Table 1: Stages of Surgical Innovation (adapted from McCulloch and colleagues (McCulloch, Altman, Campbell, Flum, Glasziou, Marshall, Nicholl, 
Aronson, Barkun, Blazeby, Boutron, Campbell, Clavien, Cook, Ergina, Feldman, Flum, Maddern, Nicholl, Reeves, Seiler, Strasberg, Meakins, Ashby, 
Black, Bunker, Burton, Campbell, Chalkidou, Chalmers, de, Deeks, Ergina, Grant, Gray, Greenhalgh, Jenicek, Kehoe, Lilford, Littlejohns, Loke, 
Madhock, McPherson, Meakins, Rothwell, Summerskill, Taggart, Tekkis, Thompson, Treasure, Trohler, & Vandenbroucke 2009)) 
IDEAL stage Purpose Study design Example  
Ileo neorectal anastomosis (INRA) after ulcerative 
colitis and familial adenomatous polyposis (Heikens, 
Gooszen, Rovers, & van Laarhoven 2013)  
1 Idea Proof of 
Concept 
· Case report/Case series Based on animal experiments (pig model), pilot 
study in 11 patients  
2a Development Development · Prospective cohort Confirmation of pilot study findings and refining of 
technique in 26 patients 
2b Exploration Learning · Research database (Prospective cohort) 
· Feasibility/explanatory RCT1 
Prospective cohort with extended inclusion criteria 
3 Assessment Assessment · RCT 
· Alternative designs if RCT not applicable 
o Matched case-control study 
o Interrupted time series (multiple 
observations over time, interrupted by 
intervention) 
o Controlled before-after study 
(observation before and after 
intervention in intervention and control 
group) 
o Step-wedged design (random order of 
introduction of intervention in a 
prospective cohort) 
Matched case-control study (INRA versus IPAA 
(ileal pouch anal anastomosis as gold standard) with 
long-term results showing comparable morbidity and 
functional results, no advantage from the patients’ 
point of view, and a disadvantage from the 
surgeons’ point of view (technically demanding and 
long surgery) 
® decision not to offer INRA anymore, use of IPAA 
as standard 
4 Long-term 
study 
Surveillance · Routine database/registry (prospective 
cohort) 
· Case report (rare events) 
 
1 RCT=randomized controlled trial 
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Challenges in clinical research of surgical interventions 
When planning surgical research involving surgical interventions, some specific 
challenges need to be addressed (for an overview, possible solutions and 
examples refer to table 2) (Bonenkamp et al. 1999;Boutron, Moher, Altman, 
Schulz, & Ravaud 2008;Clavien, Barkun, de Oliveira, Vauthey, Dindo, Schulick, 
de, Pekolj, Slankamenac, Bassi, Graf, Vonlanthen, Padbury, Cameron, & 
Makuuchi 2009;Clinical Outcomes of Surgical Therapy Study Group. 2004;Dindo, 
Demartines, & Clavien 2004;Finkemeier et al. 2000;Mangram et al. 
1999a;Moseley et al. 2002;Tincello et al. 2009).  
First, as compared to pharmacological trials, surgical interventions are more 
complex and may thus be more difficult to standardize. Standardization may be 
enhanced and controlled by specific surgeon selection (i.e. minimum training 
requirements) and training, direct and video-recorded supervision as well as by 
anatomo-pathological quality control, as for instance in the Dutch gastric cancer 
D1 versus D2 lymphadenectomy trial (Bonenkamp, Hermans, Sasako, van de 
Velde, Welvaart, Songun, Meyer, Plukker, Van, Obertop, Gouma, van Lanschot, 
Taat, de Graaf, von Meyenfeldt, & Tilanus 1999) and the COST laparoscopic 
versus open colectomy colon cancer trial (Clinical Outcomes of Surgical Therapy 
Study Group. 2004). If applicable, details should be provided in the protocol how 
interventions are tailored to individual patients (Boutron, Moher, Altman, Schulz, & 
Ravaud 2008). 
Second, the surgeons’ expertise or hospital standards may have an impact on the 
clinical outcome, respectively treatment effect, which needs to be accounted for in 
the design and analysis phase of the study (Boutron, Moher, Altman, Schulz, & 
Ravaud 2008;Devereaux et al. 2005). This may, for instance, be addressed by 
defining eligibility criteria to participate as a care provider and center in a trial, and 
further be enhanced by foreseeing baseline data on the care providers’ and 
centers case volume, expertise and qualifications as well as by taking into account 
the clustering effect of care providers and centers in sample size calculation, 
statistical analysis and reporting (Boutron, Moher, Altman, Schulz, & Ravaud 
2008). However, surgeons may tend to be most experienced in one surgical 
approach, which potentially leads to differential expertise bias, even if they meet 
minimum criteria for participation in a trial (Devereaux, Bhandari, Clarke, Montori, 
Cook, Yusuf, Sackett, Cina, Walter, Haynes, Schunemann, Norman, & Guyatt 
2005). This problem may be addressed by surgical expertise based randomized 
controlled trials, in which patients are randomized to different surgeons who are 
experts in the respective treatment arm (Devereaux, Bhandari, Clarke, Montori, 
Cook, Yusuf, Sackett, Cina, Walter, Haynes, Schunemann, Norman, & Guyatt 
2005). This concept has, for instance, been applied for a trial comparing tibial shaft 
fracture treatment with intramedullary nails, with versus without reaming 
(Finkemeier, Schmidt, Kyle, Templeman, & Varecka 2000).  
Third, due to the nature of surgical interventions, blinding may be difficult to 
achieve. If those administering the intervention cannot be blinded, blinding of 
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outcome assessors and/or patients may still be achieved. In a trial investigating 
the effect of arthroscopy in patients with knee osteoarthritis, placebo surgery was 
carried out using skin incisions accompanied with operation room acoustics, 
comparable to real arthroscopy (Moseley, O'Malley, Petersen, Menke, Brody, 
Kuykendall, Hollingsworth, Ashton, & Wray 2002). However, such measures to 
reduce bias need to undergo careful ethical considerations.  
Fourth, reporting of adverse events needs to be standardized in order to be 
comparable between studies (Martin et al. 2002a). Therefore, clear definitions of 
intra- and postoperative complications in the study protocol are mandatory, 
including their grading of severity and specification of foreseen follow-up. Surgical 
site infections for instance may be defined according to the Centers of Disease 
Control and Prevention and graded in superficial incisional, deep incisional and 
organ/space (Mangram, Horan, Pearson, Silver, & Jarvis 1999a). A widely used 
classification of postoperative complications according to severity has been 
proposed by Clavien and Dindo (Clavien, Barkun, de Oliveira, Vauthey, Dindo, 
Schulick, de, Pekolj, Slankamenac, Bassi, Graf, Vonlanthen, Padbury, Cameron, & 
Makuuchi 2009;Dindo, Demartines, & Clavien 2004). 
Last, there are some ethical considerations. Whereas equipoise refers to the 
uncertainty within the scientific community whether one treatment is superior to the 
other and is an ethical pre-requisite for conducting a randomized controlled trial, 
patients may not be willing to be randomized to either arm, such as when 
comparing surgery to medical treatment, potentially leading to selection bias and 
slow recruitment with early trial termination (McCulloch et al. 2002). A pilot study 
may be helpful in investigating the informed consent and recruitment process 
(Lancaster et al. 2004). Additionally, surgeons should be well aware of their 
potentially conflicting role as clinician versus investigator. Even if clinical equipoise 
is established within the expert clinical community, an individual surgeon may still 
have a preference for one treatment. This dilemma may be addressed by 
recognizing that the overall body of evidence does not suggest any treatment to be 
superior (McDonald et al. 2010). Moreover, sometimes regular practice, surgical 
innovation and surgical research may be difficult to discriminate. In such 
circumstances, ethics committees should be liberally consulted (McDonald, 
Kulkarni, Farrokhyar, & Bhandari 2010). 
The purpose of this paper is to provide a guide for developing a study protocol 
while focussing on the key methodological issues to consider when investigating a 
surgical intervention, be it in an observational or interventional setting. 
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Table 2: Challenges in Surgical Research 
 
Challenge Meaning Possible solution Examples 
Standardization Surgical interventions are 
complex and difficult to 
standardize 
ü Minimum training requirements 
ü Direct/video supervision 
ü Anatomo-pathological quality control  
Dutch gastric cancer D1 versus D2 
lymphadenectomy trial (Supervision; 
Monitoring pathological results) 
(Bonenkamp, Hermans, Sasako, van de 
Velde, Welvaart, Songun, Meyer, 
Plukker, Van, Obertop, Gouma, van 
Lanschot, Taat, de Graaf, von 
Meyenfeldt, & Tilanus 1999) 
 
COST laparoscopic versus open 
colectomy colon cancer trial (Minimum 
training requirement) (Clinical Outcomes 
of Surgical Therapy Study Group. 2004)  
Expertise Surgeons’ and hospitals’ 
expertise have an impact 
on the outcome 
ü Eligibility criteria to participate as care 
provider 
ü Collect baseline characteristics on 
expertise 
ü Account for clustering effect in design and 
analysis 
ü Expertise-based randomized controlled trial 
Tibial shaft fracture treatment with 
intramedullary nails, with versus without 
reaming (Expertise based randomized 
controlled trial) (Finkemeier, Schmidt, 
Kyle, Templeman, & Varecka 2000) 
Blinding Blinding not always 
possible 
ü Blinded outcome assessors 
ü Placebo surgery (caveat: ethical 
considerations) 
Randomized controlled trial with sham 
surgery to evaluate effect of arthroscopy 
in patients with knee osteoarthritis  
(Moseley, O'Malley, Petersen, Menke, 
Brody, Kuykendall, Hollingsworth, 
Ashton, & Wray 2002) 
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Table 2: Challenges in Surgical Research (continued)  
 
Challenge Meaning Possible solution Examples 
Adverse events reporting Standardization of 
adverse event reporting 
not always considered 
ü Clear definitions of intra- and postoperative 
complications 
ü Reproducible grading of complications 
Surgical site infections defined 
according to the Centers of Disease 
Control and Prevention (Mangram, 
Horan, Pearson, Silver, & Jarvis 1999a) 
 
Classification of postoperative 
complications according to severity  
(Clavien, Barkun, de Oliveira, Vauthey, 
Dindo, Schulick, de, Pekolj, 
Slankamenac, Bassi, Graf, Vonlanthen, 
Padbury, Cameron, & Makuuchi 
2009;Dindo, Demartines, & Clavien 
2004) 
Ethical considerations Patient may not be willing 
to be randomized to 
surgical interventions 
 
Equipoise versus 
surgeons’ preference 
 
Surgical innovation versus 
surgical research  
ü Pilot study  
 
 
 
ü Consider overall body of evidence 
 
 
ü Ethics committee clearance 
Pilot randomized patient-preference 
study comparing colposuspension with 
tension-free vaginal tape plus anterior 
repair in women with incontinence and 
prolapse (Tincello, Kenyon, Slack, 
Toozs-Hobson, Mayne, Jones, & Taylor 
2009) 
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2.2. Guide for developing a clinical study protocol for surgical interventions  
This paper provides a 10-step practical guide for developing a clinical study 
protocol investigating a surgical intervention using observational or interventional 
data. It focuses on methodological issues and may be used as adjunct to existing 
international guidelines (The International Conference on Harmonisation of 
Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH) 
2014), local regulations, and the recommendations of the SPIRIT (Standard 
Protocol Items: Recommendations for Interventional Trials) initiative (Chan et al. 
2013a;Chan et al. 2013b). The informed consent process is beyond the scope of 
this article.  
Step 1: Defining the research question 
The heart of every protocol is the research question. It defines the knowledge gap 
which shall be filled with the planned research. Characteristics of a good research 
question are easily described by the mnemonic „FINER“, as proposed by 
Cummings and colleagues, standing for Feasible in terms of scope, expertise, 
resources and recruitment, Interesting to the investigator and the scientific 
community, Novel, targeting new findings or the extension, confirmation or 
rejection of previous findings, Ethical with a fair subject selection and a favourable 
risk-benefit ratio, and Relevant to scientific knowledge, daily practice, health policy 
and future research (Cummings et al. 2007). It is crucial to precisely formulate the 
research question. This allows to develop a statistical analysis plan and to 
determine the sample size necessary to attain a targeted power. When formulating 
a research question, the PICO acronym (Richardson et al. 1995) may be helpful 
for phrasing testable questions. PICO stands for the Patient/problem, the 
Intervention or exposure, the Comparison and the Outcome. Some add a “T” 
(PICOT) as a fifth element, which stands for Time (time frame of outcome 
assessment) (Haynes 2014), whereas in review questions it may stand for study 
Type (e.g. randomized controlled trial, cohort study etc.). The relevant points to 
consider when formulating the research question and examples are presented in 
table 3.  
There may be several research questions, however in general the most important 
one should be labelled as the primary research question, the other(s) as 
secondary research question(s). For each research question, a hypothesis should 
be formulated to pre-specify what results are expected. Since the sample size 
calculation is based on the primary outcome, secondary research questions may 
not necessarily be answered with sufficient power. They are thus often more 
exploratory in nature. In an inguinal hernia trial comparing two surgical techniques, 
a secondary research question could be, for instance, to compare the 
postoperative quality of life between the two techniques, whereas the primary 
research question may be the comparison of recurrence rates.  
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It is important to define these research questions and outcomes in advance. Post 
hoc specification with the risk of data-driven selection may firstly introduce 
considerable outcome reporting bias, i.e. significant results being more likely to be 
reported than negative results, and secondly lead to the error prone acceptance of 
an association based on multiple posthoc testing (Chan et al. 2004). Trial 
registries have been introduced to enhance transparency and to address the 
problem of publication bias and outcome reporting bias (Zarin et al. 2007). Trial 
registration includes information on the choice of primary and secondary outcomes 
(World Health Organization 2013). The International Committee of Medical Journal 
Editors (ICMJE) (De et al. 2004) and subsequently the Surgical Journal Editors 
Group (SJEG) (Surgical Journal Editors Group 2007) have published guidelines 
for mandatory trial registration for all trials as a prerequisite for considering a 
scientific paper for publication in the respective member journals. 
Step 2: Justification of the planned research 
It is important for the reader to understand why this research is planned. This 
involves an overview of the current knowledge in the field («What has been 
done?») and a presentation of the knowledge gap which will be addressed with the 
planned research («What needs to be done?»). The ultimate purpose is to justify 
from a scientific, ethical and economic point of view the conduct of this research. 
The presentation of the current state of the art and knowledge in the field implies a 
systematic review of the literature, including published literature, grey literature 
and consulting trial registries to get information about ongoing trials or past 
unpublished trials. The presented literature should be critically commented and 
indicate eventual discrepancies in study results or limitations of study design, 
methodological quality components such as blinding or extent of follow-up, and the 
number of included participants. The key information of the cited studies may be 
presented within a table. This part of the protocol directly leads the reader to the 
aim of the planned research, which represents the logical consequence of the lack 
of knowledge previously described.  
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Table 3: Phrasing testable questions (adapted from Richardson and colleagues (Richardson, Wilson, Nishikawa, & Hayward 1995) and Haynes 
(Haynes 2014) 
PICO(T) Meaning  Consider Example Research 
question/Hypothesis 
Patient/problem What patient or 
problem are you 
planning to address? 
ü Age 
ü Gender 
ü Pathology 
ü In-/outpatients 
ü Emergency/elective 
ü Vulnerable population, e.g. children, 
cognitively impaired 
All patients aged ³18 
years with primary 
unilateral inguinal 
hernia 
 
 
 
Research question: 
What is the 5-year 
recurrence rate in adult 
patients with primary 
unilateral inguinal hernia 
undergoing total 
extraperitoneal versus 
Lichtenstein hernia repair? 
 
 
 
Hypothesis:  
The 5-year recurrence rate 
in adult patients with 
primary unilateral inguinal 
hernia is lower after total 
extraperitoneal hernia repair 
than after Lichtenstein 
hernia repair. 
Intervention/ 
exposure 
What is the planned 
intervention? 
ü Surgical intervention 
ü Pharmaceutical treatment 
ü Diagnostic procedure 
ü Prophylactic procedure 
ü Management process 
Total extraperitoneal 
hernia repair 
Comparison  What is your 
intervention 
compared to? 
ü Other intervention 
ü Standard intervention 
ü No intervention 
ü Placebo 
Lichtenstein (open) 
hernia repair 
Outcome What will be affected 
by the intervention? 
ü Efficacy, e.g. recurrence rate  
ü Safety, e.g. complication rate 
ü Mortality rate 
ü Length of hospital stay 
ü Patient-reported outcomes, e.g. pain, 
quality of life 
Hernia recurrence 
(Time) When will you assess 
the effect of your 
intervention?  
ü At one time point 
ü At several time points 
ü Continuously over a certain period  
ü Is time until reaching the endpoint 
important? 
5 years 
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Step 3: Deciding on outcomes and confounders 
Variables may be divided into i) outcome/dependent variables, such as the 
recurrence rate in a study comparing two different surgical techniques for hernia 
repair, and ii) independent variables or exposure of interest, in this example 
surgical technique for hernia repair, and iii) confounders, such as age or ASA 
(American Society of Anaesthesiologists) classification. 
Outcomes 
Every outcome (or endpoint) needs to be clearly defined in order to standardize 
outcome measures. For this purpose, the time point of assessment and unit of the 
outcome measure should be noted and references to definitions and validations 
should be included such as the “rate of surgical site infections, defined according 
to the Centers for Disease Control and Prevention (Mangram, Horan, Pearson, 
Silver, & Jarvis 1999a)” or “Quality of life, measured using the 36-item short-form 
health survey (SF-36) (Ware, Jr. and Sherbourne 1992)”. Efficacy and safety 
outcomes should be labelled as such and standard procedures for reporting and 
patient follow-up of adverse events need to be described. 
When choosing outcomes it is important to be aware of several points that affect 
the statistical analysis plan and sample size calculation: i) The type of variables 
that are collected (Whitley and Ball 2002) (e.g. categorical, metric, time-to-event 
data), ii) in the case of continuous variables, whether they can be expected to be 
normally distributed or not, and iii) if paired or unpaired data are collected. 
Categorical (binary in case of two categories) or qualitative variables have no units 
and may be divided into nominal variables in the case of unordered categories 
(e.g. blood group) and ordinal variables in the case of ordered categories (e.g. 
American Society of Anesthesiologists (ASA) classification system). They are most 
often displayed in frequency tables and bar charts. Metric or quantitative variables 
are either referred to as discrete variables with integer values and counted units 
(e.g. number of episodes of angina pectoris per week) or continuous variables with 
stepless values and measured units (e.g. blood pressure). They are typically 
displayed reporting their central value and variation, i.e. mean and standard 
deviation in case of normal distribution, else median and range or interquartile 
range. In graphs, box plots and histograms are used for displaying metric 
variables. Typical examples of time-to-event data are overall or progression-free 
survival. Categorization of continuous variables should be avoided, since this is 
associated with a loss of information and therefore a loss of power and precision. 
Right-skewed data (i.e. the mass of the data is concentrated on the left with 
relatively few high values) are relatively frequent; examples are many laboratory 
findings, or duration of surgery or of hospitalization. Skewed data may be 
transformed for statistical analysis to achieve better approximation to normality by, 
for example, logarithmic transformation. Paired or clustered data are generated if 
the same measurement is repeated in the same patient over time (e.g. repeated 
measurements of pain in the same patient after hernia repair) or twice in the same 
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patient at one point in time, such as evaluation of hernia recurrence on the right 
and the left side after bilateral inguinal hernia repair. Paired and clustered data will 
have an impact on the choice of methods for statistical analysis, since the 
variability of several measurements within one patient is smaller than the variability 
of measurements between several independent patients.  
For some outcome variables and settings it is a prerequisite to get baseline 
information, such as evaluating the quality of life before and after hernia repair.  
Outcomes may be objective, such as mortality or subjective, such as pain. In any 
case, patient-important outcomes should be considered. For subjective outcomes, 
blinding is especially relevant.  
In the case of rare events with insufficient power to evaluate multiple single 
outcomes, or when no single outcome optimally represents the outcome of 
interest, a composite endpoint may be chosen (Mascha and Sessler 2011). In 
order to enhance feasibility and comparability of RCTs (randomized controlled 
trials), this has for instance been proposed for liver surgery with a composite 
endpoint involving «ascites, postresectional liver failure, bile leakage, intra-
abdominal haemorrhage, intra-abdominal abscess and operative mortality» (van 
den Broek et al. 2011). Hereby the individual components of the composite 
endpoint should be of similar importance to patients, they should occur with similar 
frequency, and similar treatment effects (e.g. relative risk reductions) should be 
expected (Montori et al. 2005b). whereas components which are redundant or 
marginally related to the intervention should be avoided (Mascha & Sessler 2011). 
Surrogate endpoints and surrogate biomarkers are frequently used, since they 
may be easier and faster to assess as compared to the patient-important outcome 
(Buyse 2009). An example is the surrogate endpoint lipid profile instead of major 
cardiovascular events. A surrogate endpoint can be defined as “a laboratory 
measurement or a physical sign used as a substitute for a clinically meaningful 
endpoint that measures directly how a patient feels, functions or survives” (Temple 
2014). The effect of the intervention on the surrogate endpoint should predict the 
effect on the clinically relevant outcome (Fleming and DeMets 1996). Thus, the 
use of surrogate endpoints needs to be carefully evaluated (Bucher et al. 
1999;Riggs et al. 1990).  
Independent and confounding variables 
In a randomized controlled trial (RCT), confounders should be equally distributed 
in the different treatment arms through the process of randomization, if 
randomization has been correctly conducted and if the number of randomized 
individuals is sufficiently large. This is not the case in observational data. In a 
cohort study including patients having undergone laparoscopic or open left 
colectomy for example, not only the surgical technique, but also age or ASA 
classification may have an impact on the length of hospital stay and will probably 
not be equally distributed between groups. To be regarded as a confounder, these 
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factors need to have an impact not only on the outcome, but also on the choice of 
intervention (i.e. independent variable), meaning an older patient may be more 
likely to be assigned to one treatment option than to the other. Which factors 
qualify to be a confounder, i.e. are associated with the outcome as well as with the 
exposure of interest, should be pre-specified in the study protocol according to 
expert opinion and information gathered accordingly (Babyak 2004). 
Confounding may be controlled for in the design as well as in the analysis of a 
study. In the design, randomization should lead to equally distributed known and 
unknown confounders in the groups. Stratification with/without randomization aims 
at balancing the groups for specific prognostic patient characteristics (Altman and 
Bland 1999). In the COST trial comparing laparoscopically-assisted to open 
colectomy for colon cancer, randomization stratified for the site of primary tumour, 
ASA classification and surgeon was undertaken (Clinical Outcomes of Surgical 
Therapy Study Group. 2004). If a randomized study is not possible, matching may 
be a strategy to reduce confounding. In the statistical analysis, potential 
confounding may be addressed by adjusting for these variables using multivariable 
regression analysis. Other ways to control for confounding are using propensity 
scores (probability of an individual to be treated with an intervention given all 
available baseline information on the patient) or inverse probability weighting 
(reciprocal of an individual’s probability of receiving the treatment that they actually 
received) (D'Agostino, Jr. 1998;Hernan and Robins 2006). 
Superiority/Equivalence/Non-Inferiority 
An a priori statement of the overall goal of comparison needs to be provided in the 
protocol. The reader should know whether the goal is to show that treatment A is 
superior to treatment B, equivalent, or non-inferior. From a superiority study with 
non-significant results, one may not conclude that the interventions are equivalent 
(Alderson 2004). In an equivalence (two-sided hypothesis) or non-inferiority (one-
sided hypothesis) setting, the margin of non-inferiority, respectively the two 
margins of equivalence, need to be pre-specified, i.e. the largest, respectively the 
largest and smallest value representing a clinically irrelevant difference, need to be 
defined in advance. A help when defining the margin(s) is the question whether 
the investigational intervention is equivalent if its efficacy or safety outcome is 
within the chosen boundaries. This margin has implications on the sample size, 
i.e. the smaller the margin, the larger the sample size. As a rule of thumb, the 
required sample size is higher with equivalence/non-inferiority designs than in 
superiority trials. Examples of non-inferiority trials are trials in surgical oncology 
with the ultimate goal to assess whether a new intervention with potential benefits 
such as lower invasiveness, lower toxicity or reduced cost is equivalent or not 
inferior to an established therapy concerning efficacy, i.e. cancer control 
(Fueglistaler et al. 2007). Examples are the above mentioned gastric 
lymphadenectomy trial (Bonenkamp, Hermans, Sasako, van de Velde, Welvaart, 
Songun, Meyer, Plukker, Van, Obertop, Gouma, van Lanschot, Taat, de Graaf, 
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von Meyenfeldt, & Tilanus 1999) or the COST trial (Clinical Outcomes of Surgical 
Therapy Study Group. 2004). 
Multiple comparisons, multiple testing and interim analyses 
Multiple comparisons between different groups need to be carefully justified; the 
same is true for multiple testing due to multiple outcomes or multiple time points in 
the case of interim analyses.  
If there is a possibility that the treatment effect might be different in different 
subgroups of patients, this should be examined through an additional interaction 
term in the regression model (Assmann et al. 2000), rather than multiple testing of 
each subgroup (Schulz and Grimes 2005). To give an example, in a long-term 
comparison of endovascular versus open aortic aneurysm repair, a significant 
interaction between age and type of treatment was found with a better survival in 
patients younger than 70 years after endovascular repair versus a borderline 
better survival in patients 70 years of age or older after open repair (Lederle et al. 
2012). Subgroups should be pre-specified in the study protocol; post-hoc 
subgroup analyses should be declared as such and thus are more explorative in 
nature. All subgroup analyses should be reported to avoid the risk of selective 
data-driven reporting (Schulz & Grimes 2005). In case of a continuous covariate 
which may influence response to treatment, advanced methods to modelling 
treatment-covariate interactions by fractional polynomials should be considered 
(Royston and Sauerbrei 2004). 
Since multiple comparisons and multiple testing increase the chance of committing 
an a-error (type I error, i.e. concluding that there is a difference when in fact there 
is no difference), this needs to be accounted for with a more stringent p-value 
considered as significant. To give an example, if 20 independent outcomes are 
compared between 2 groups using hypothesis tests, the global type I error rate will 
increase to 64%. Various procedures have been described to control for the 
multiple type I error rate out of which the Bonferroni (a divided by the number of 
tests) and Bonferroni-Holm procedures are quite common as they strictly control 
the multiple type I error rate (Neuhauser 2006). Thus, in the case of 20 outcomes, 
in order to be statistically significant the p-value needs to be below 0.0025 
(0.05/20) after correction for multiple testing according to the Bonferroni 
procedure.  
In an interim analysis, trial data are analyzed by treatment group for study 
monitoring purposes before the final analysis. Reasons may be monitoring for 
superiority, harm or futility. Based on the results of interim analyses, trials may be 
stopped early, typically as evaluated by an independent data safety and 
monitoring board (DSMB). The number of interim analyses and definition of 
stopping rules accounting for multiple testing (e.g. according to O’Brien-Fleming, 
Peto or Pocock) needs to be pre-specified in the study protocol (Schulz & Grimes 
2005). These rules define p-values for considering stopping a trial early depending 
17 
 
   
 
on the overall number of planned interim analyses and preserving the overall type 
I error rate (Schulz & Grimes 2005). In a trial with two interim analyses and one 
final analysis for instance, the p-value for the interim stopping level would be for 
the first interim, second interim and the final analysis 0.0005, 0.014 and 0.045 
according to the rule of O’Brien-Fleming and 0.001, 0.001 and 0.05 according to 
the rule of Peto, the latter applying constant stopping levels until the final analysis 
(Schulz & Grimes 2005). To give an example, a study investigating surgery 
followed by radiotherapy versus radiotherapy alone for metastatic cancer spinal 
cord compression was stopped early by the DSMB at a planned interim analysis 
after recruitment of half of the foreseen patients for superiority of the surgical 
intervention arm at a p-value of 0.001 according to the rule of O’Brien-Fleming 
(Patchell et al. 2005). Stopping a trial early for superiority or futility needs however 
to be carefully evaluated. Empirical evidence indicates that trials having been 
stopped early for benefit tend to overestimate the underlying true treatment effect. 
Therefore, interim analysis should be well justified and if possible not be 
conducted for detecting an early benefit (Bassler et al. 2010).  
Step 4: Choosing the appropriate design  
Types of study design and potential biases 
Depending on the research question, the appropriate study design needs to be 
chosen and described in the protocol. An overview of study designs (Guralnik 
2014) with examples (Champagne et al. 2012;Emami et al. 2011;Law et al. 
2010;Lu et al. 2013;Marks et al. 2011;Patel et al. 2012) is provided in table 4. A 
more detailed description of the pros and cons of different study designs is beyond 
the scope of the present article. 
Bias, i.e. a systematic error, jeopardizes the internal (reliability and accuracy) and 
external validity (generalizability) of studies. Therefore, methods to minimize the 
risk of bias need to be outlined in the protocol (Montori, Permanyer-Miralda, 
Ferreira-Gonzalez, Busse, Pacheco-Huergo, Bryant, Alonso, Akl, Domingo-
Salvany, Mills, Wu, Schunemann, Jaeschke, & Guyatt 2005b;van den Broek, van 
Dam, van Breukelen, Bemelmans, Oussoultzoglou, Pessaux, Dejong, Freemantle, 
& Olde Damink 2011). Many different types of biases have been described and 
they may be classified in different ways, such as by the direction of resulting 
change in the estimate or by the stage of research, in which they occur (Delgado-
Rodriguez and Llorca 2004).  Examples are randomization or matched pairs to 
address selection bias, blinding to address performance and detection bias, and 
measures to reduce loss to follow-up to address attrition bias. An outline of biases 
and possible solutions to address them is provided in table 5 (Akobeng 
2008;Bornhoft et al. 2006).  
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Table 4: Design types (adapted from Guralnik and Manolio (Guralnik 2014) 
Study type Descriptive Analytical 
Population Individual Observational Interventional 
(Experimental) 
Ecological 
(correlational) study 
Case Report/  
case series 
Cross–sectional 
(prevalence) 
study 
Cohort study  
(retro-/prospective) 
Case-control study 
(retro-/prospective) 
(Non-) 
Randomized 
controlled trial 
Exposure/ 
Outcome 
  Observation: 
Exposure and 
outcome 
simultaneously 
Observation: 
Exposure®Outcome 
Observation:  
Exposure¬Outcome 
Assignment:  
Exposure  
Example Population level 
correlation between 
use of non-steroidal 
anti-inflammatory 
drugs and proton 
pump inhibitors and 
peptic ulcer bleeding 
(Lu, Sverden, Ljung, 
Soderlund, & 
Lagergren 2013) 
Early experience of 
single-incision 
laparoscopic 
colectomy (Law, 
Fan, & Poon 2010) 
Assessment of 
adoption of 
laparoscopic colon 
resection (Patel, 
Patel, Mahanti, 
Ortega, Ault, 
Kaiser, & 
Senagore 2012) 
Single-incision versus 
standard laparoscopic 
cholecystectomy 
(retrospective cohort 
with historical control) 
in children (Emami, 
Garrett, Anselmo, 
Torres, & Nguyen 
2011) 
Matched case-control 
study of single-incision 
versus standard 
multiport 
laparoscopic 
colectomy 
(Champagne, 
Papaconstantinou, 
Parmar, Nagle, 
Young-Fadok, Lee, & 
Delaney 2012) 
Randomized 
controlled trial of 
single incision 
versus standard 
laparoscopic 
cholecystectomy 
(Marks, Tacchino, 
Roberts, Onders, 
DeNoto, Paraskeva, 
Rivas, Soper, 
Rosemurgy, & Shah 
2011) 
Caveats ü Ecological 
fallacy (group 
level 
association¹ 
individual level 
association) 
ü Low level of 
evidence 
ü Lacking 
generalizabili-
ty 
ü Not suitable 
for rare/short 
duration 
diseases 
ü Confounding 
ü Choice of control 
group 
ü Only one 
exposure studied 
ü Confounding 
ü Choice of control 
group 
ü Recall bias 
ü Overmatching 
ü Equipoise 
required 
ü Ethics 
ü Resources 
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Table 5: Bias types (adapted from Akobeng (Akobeng 2008) and Bornhöft and colleagues (Bornhoft, Maxion-Bergemann, Wolf, Kienle, Michalsen, 
Vollmar, Gilbertson, & Matthiessen 2006) 
Bias Meaning Example Possible solutions 
Selection bias Intervention group differs from control group 
regarding baseline characteristics  
Difference in age, severity of illness ü Randomization 
ü Stratified randomization 
ü Matched pairs 
Performance bias Apart from investigated intervention, the 
intervention group is treated differently than 
the control group 
When comparing two types of surgery for 
fracture treatment one group is followed 
more intensively by physiotherapist 
ü Blinding 
ü Documentation of concomitant 
interventions  
Detection bias The outcomes are assessed differently in 
the intervention than in the control group  
 
A small postoperative hematoma is 
regarded as complication in the control 
group, but not in the intervention group 
ü Blinding 
ü Blinded outcome assessors 
ü Several outcome assessors 
ü Objective criteria 
Attrition bias The loss of participants from the study (i.e. 
drop-out, withdrawal for example because of 
deviation from the protocol) is different in 
the intervention and control group  
A higher drop-out rate in the intervention 
group than in the control group may 
underestimate hernia recurrences in a trial 
comparing two hernia repair techniques 
ü Measures to reduce drop-outs 
ü Documentation of patient flow 
including drop-outs 
ü Intention-to-treat analysis 
ü Declaration of strategies to deal 
with missing data (e.g. last 
observed value carried forward, 
best/worst case scenario 
assumption) 
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Randomization 
The process of randomization comprises the allocation sequence generation, 
allocation concealment, i.e. neither the participant nor the investigators are able to 
predict the group assignment, and allocation sequence implementation (Akobeng 
2008).  
The protocol needs to specify how the randomization sequence is generated, 
examples are variable block size randomization, stratified randomization, or cluster 
randomization. Pseudo- or quasi-randomization (e.g. according to the date of birth, 
date of entry, patient ID, alternating) should be avoided, since allocation will be 
easily predictable. 
Additionally, the method of information transfer needs to be described, e.g. central 
web-based randomization, central telephone randomization, or serially numbered 
opaque sealed envelopes. Central randomization is preferred because it is more 
reliable to ensure allocation concealment.  
Since the surgeons’ and institutions’ expertise may have an impact on the clinical 
outcome respectively treatment effect (i.e. performance bias), an expertise-based 
design may be appropriate in certain circumstances (Devereaux, Bhandari, Clarke, 
Montori, Cook, Yusuf, Sackett, Cina, Walter, Haynes, Schunemann, Norman, & 
Guyatt 2005). 
Blinding 
Whenever possible, blinding should be considered and outlined in the study 
protocol. Studies may be unblinded (open-label), single-blind (i.e. patient-blind) or 
double-blind (patient and caregiver-blinded) (Day and Altman 2000). Other terms 
have been used such as triple-blind, referring to the patient, caregiver and 
assessor. Since there are other persons involved in a trial (data collector, outcome 
adjudicator, data analyst), it is best to describe in detail who is blinded and for 
what.  
In surgery, blinding may be a challenge. To limit detection bias it is advisable to 
use blinded outcome assessment, e.g. through a separate team of assessors not 
involved in surgery. Sham or placebo surgery has been previously conducted 
(Moseley, O'Malley, Petersen, Menke, Brody, Kuykendall, Hollingsworth, Ashton, 
& Wray 2002), needs however special ethical justification.  
Step 5: Description of the study procedures  
A detailed description of all study procedures should be provided. Importantly, it 
should become clear, what is part of clinical routine and what is study-specific. 
Since surgical interventions are complex, they need to be standardized as outlined 
above in order to be able to draw generalizable conclusions from the study. 
Moreover, the surgeons’ expertise or specific hospital standards may have an 
impact on the outcome, which needs to be accounted for (Boutron, Moher, Altman, 
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Schulz, & Ravaud 2008). If applicable, measures to assure compliance should be 
described.  
An activity plan in the format of a table describing all activities during the study 
periods enrolment, allocation, postallocation and closeout such as screening 
procedures, intervention, and different types of outcome assessments with 
corresponding timelines and allowed deviance from the foreseen date could be 
helpful to provide an overview of all involved procedures (Cummings, Browner, & 
Hulley 2007). Discontinuation criteria for either study participants, parts of the trial, 
or the trial as a whole, should be described as well.   
Step 6: Description of the study population 
There are medical, methodological and ethical criteria to define a study population. 
The choice of participant inclusion and exclusion criteria will have an impact on the 
internal (reliability and accuracy) and external validity (generalizability) of a study 
(Akobeng 2008;Bornhoft, Maxion-Bergemann, Wolf, Kienle, Michalsen, Vollmar, 
Gilbertson, & Matthiessen 2006) and depends on the goal of the study, i.e. an 
explanatory trial testing efficacy with rigorous control of internal validity versus a 
pragmatic trial evaluating effectiveness under clinical real-life conditions (Godwin 
et al. 2003).  
The inclusion of a vulnerable population, such as minor children or cognitively 
impaired adults, e.g. in emergency settings, needs special justification and 
measures of participant protection (Brody et al. 2005). 
Step 7: Development of a statistical analysis plan 
The goal of a quantitative assessment entails that the scientific research question 
is translated into a statistical problem. In the respective protocol section, the 
statistical methods should be described in sufficient detail including the statistical 
software to be used, the analysis population (e.g. intention-to-treat (ITT) or per 
protocol (PP)), descriptive/exploratory statistics, hypothesis-testing indicating the 
level of significance and taking into account the type of outcome, effect measures 
(with confidence intervals), type of sample (paired versus unpaired), assumption of 
data distribution (normally versus not normally distributed data) and modelling if 
applicable. Table 6 summarizes the most common hypothesis tests and examples 
of regression models depending on the type of outcome variable (Kirkwood and 
Sterne).  
Confidence intervals are preferred over p-values, since they provide information 
not only regarding statistical significance, but also about the smallest and largest 
plausible value of the effect measure of interest. Importantly, “absence of 
evidence” commonly does not equal “evidence of absence”, and statistical 
significance is not to be considered equivalent to clinical relevance (Alderson 
2004).  
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According to the design, the analysis population (ITT versus PP) needs to be pre-
specified. ITT refers to the population as randomized, regardless of factors such 
as compliance, crossover, or loss to follow-up, whereas PP refers to the patients 
actually treated and followed as foreseen in the protocol. In a superiority trial, the 
ITT analysis is preferred. It is conservative, since non-compliers generally reduce 
the treatment effect. In contrast, in an equivalence/non-inferiority design, due to 
the potentially reduced treatment effect, ITT is no longer conservative. Therefore, 
the PP analysis is the conservative and preferred primary analysis in the non-
inferiority setting, complemented by an ITT analysis (Matilde and Chen 2006).  
Procedures of handling missing data (e.g. last observation carried forward, best or 
worst case scenario imputation, multiple imputation, censoring) should be outlined 
as well as any planned interim analyses indicating the number, time point, and 
definition of stopping rule as outlined above. Subgroup investigations/interaction 
analyses should be determined in advance.    
Step 8: Sample size calculation 
The sample size is chosen to assure that the study will have sufficient power to 
allow conclusive inferences regarding the primary outcome, given the assumptions 
for the sample size calculation happen to be realistic. In a superiority trial, a 
sample size statement should include the a-level, power (equals 1-β or type II 
error), the event rate or value in the control group, the expected (or clinically 
relevant) effect in the experimental group, one- versus two-sided testing and the 
expected rate of loss to follow-up. In case of binary outcomes, the effects are 
estimated in proportions and in case of continuous normally distributed outcome 
measures, in means and standard deviations (SDs), the latter as a measure of 
variability in the two groups. Table 7 summarizes the assumptions required for 
sample size calculation depending on the type of outcome variable. The source of 
information for the assumed treatment effects (e.g. literature, pilot study) should be 
indicated. 
In equivalence and non-inferiority trials, the boundaries of equivalence and the 
non-inferiority margin respectively need to be pre-specified instead of the expected 
effect in the experimental group.  
In case of non-normally distributed data, as a rule of thumb, the sample size may 
be computed for a two-sample t-test and then inflated by 15% (Lehmann 2014). 
Alternatively, the sample size may be determined using computer simulations or in 
case of availability of pilot or historical data, using bootstrap methods (Collings and 
Hamilton 1988). 
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Table 6: Hypothesis tests and multivariable analysis (adapted from Kirkwood and Sterne 
(Kirkwood & Sterne)) 
Outcome  Parametric Non-
parametric 
Multivariable 
analysis 
(Examples) 
Continuous Unpaired 
measurements 
(comparison of 
two groups) 
Unpaired t-test Wilcoxon rank 
sum test 
(Mann-
Whitney-U test) 
Continuous:  
Linear 
regression 
 
Discrete: 
Poisson 
regression 
 Paired 
measurements 
(comparison of 
two groups) 
Paired t-test Wilcoxon 
signed rank 
test, Sign test  
 Comparison of 
more than two 
groups 
ANOVA 
(Analysis of 
Variance) 
Kruskall-Wallis 
test 
Categorical Unpaired 
measurements 
Chi-squared 
test  
Fisher’s exact 
test1 
Binary: 
Logistic 
regression  Paired 
measurements 
McNemar’s 
chi-squared 
test 
Methods based 
on exact 
probabilities 
Time-to-event  Log-rank test   Regression 
analysis of 
survival/time-
to-event data 
(e.g. Cox or 
Poisson 
regression or 
parametric 
models) 
 
 
1 Applicable if the expected value (under the null) of any of the cells in the table <5 
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Table 7: Sample size calculation 
 
Univariable/ 
Multi-
variable 
Assumptions/Sample size Consider Example binary 
outcome variable: 
Complication yes/no 
Example quasi-continuous 
outcome variable (normally 
distributed): 
Quality of life score 
Univariable Assump-
tions 
Significance level ® type I 
error (Study erroneously 
rejects the null, i.e. claims a 
difference although there is 
none) 
Most typically  
ü  0.05 
ü  0.01 
0.05 0.05 
Power ® type II error  
(Study erroneously accepts the 
null, i.e. finds no difference 
although there is one) 
Most typically  
ü  80% 
ü  90% 
80% 90% 
Effect control group ü  Literature 
ü  Pilot study 
10% mean 35.5  
Effect intervention group ü  Clinically relevant 
difference 
5% mean 45.5   
Standard deviation/variance ü  Assume equal SD1 in 
intervention/control group 
Not necessary, will be 
derived from the 
chosen effects 
SD 9.0 in control and 
intervention group 
One-/two sided ü  Superiority design 
most typically two-sided 
Two-sided Two-sided 
1 SD= Standard deviation 
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Table 7: Sample size calculation (continued) 
Univariable/
Multi-
variable 
Assumptions/Sample size Consider Example binary outcome 
variable: Complication 
yes/no 
Example quasi-continuous 
outcome variable (normally 
distributed):Quality of life 
score 
Univariable Sample 
size 
Calculated sample 
size1 
Lack of normality for continuous 
outcome®  
ü  Inflate sample size by 15% 
(Lehmann 2014) 
 Estimate sample size with 
simulation (Collings & Hamilton 
1988) 
434 per group or  
868 in total 
 
18 per group or 
36 in total 
Final sample size 
accounting for drop-
outs 
ü  Literature 
 Pilot study 
10% drop out, resulting in 
478 per group or 956 in 
total 
20% drop out, resulting in  
22 per group or 44 in total 
Sample size 
statement 
 Assuming a 10% drop-out 
rate, a sample size of 478 
per group is necessary to 
have a 80% chance of 
detecting, as significant at 
the 5% level, a decrease in 
complication rate from 10% 
in the control group to 5% 
in the intervention group. 
Assuming a drop-out rate of 
20%, 44 patients are 
required to have a 90% 
chance of detecting, as 
significant at the 5% level, an 
increase in the primary 
outcome measure from 35.5 
(SD 9.0) in the control group 
to 45.5 (SD 9.0) in the 
experimental group.  
 
  
1 Using R version 2.14.2 (R Foundation for Statistical Computing, Vienna, Austria) 
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Table 7: Sample size calculation (continued)  
Univariable/
Multi-
variable 
Assumptions/Sample size Consider Example binary outcome 
variable:Complication 
yes/no 
Example quasi-continuous 
outcome variable (normally 
distributed):Quality of life 
score 
Multivariable 
 
Rule of 
thumb 
 
ü  binary 
outcome: 10 
events per variable 
(Peduzzi et al. 
1996) 
ü  continuous 
outcome: 10-15 
observations per 
variable (Babyak 
2004) 
ü Avoid overfitting (do not include 
too many variables) 
To adjust for age, surgeon 
experience (high vs1 low) 
and ASA (³3 vs <3) (i.e. 1 
independent variable & 3 
confounders), a minimum 
of 40 patients with/without 
complication (whichever is 
the smaller percentage) 
need to be observed.  
To adjust for age, gender 
and ASA (³3 versus <3) (i.e. 
1 independent variable & 3 
confounders), a minimum of 
40 patients need to be 
observed. 
  
1 vs= versus 
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In multivariable analysis, particularly relevant when analyzing observational data, 
as a rule of thumb a minimum of 10 to 15 events, respectively non-events, per 
variable in the model are necessary in order to achieve reliable estimates from 
logistic regression (binary outcome) (Peduzzi, Concato, Kemper, Holford, & 
Feinstein 1996) and 10 to 15 observations in multiple linear regression (continuous 
outcome) (Babyak 2004). For example in a study evaluating risk factors to develop 
a surgical site infection after hernia repair, a minimum of 10 surgical site infections 
and of 10 non-surgical site infections are necessary to evaluate one candidate risk 
factor, whereas to evaluate predictors of length of hospital stay, 10 patients per 
predictor should be included (table 7).   
In retrospective studies and pilot studies, there is generally no formal sample size 
calculation, but a plausible rationale for the choice of sample size should be 
provided.  
Step 9: Description of data management and quality assurance   
The process of data entry, data management, monitoring, quality control and 
quality assurance should be described. A statement of permitting access to source 
data for the purpose of audits and inspections by the IEC and regulatory 
authorities should be included. The process of privacy protection (e.g. reversible 
anonymization) and the duration of data storage should be described. A detailed 
description of data management and quality assurance options is beyond the 
scope of this article.    
Step 10: Ethical considerations 
Under ethical considerations, a risk-benefit assessment should be presented. 
Potential benefits, risks, but also inconveniences should be mentioned. These 
should refer to the individual study participant, may however also include potential 
benefits for future patients. The inclusion of a vulnerable population should be 
further elaborated and justified in this section. Other ethical aspects should be 
mentioned here, such as participation being entirely voluntary and withdrawal 
being possible at any time without giving any reason and without any impact on 
patient management. The handling of incidental findings and genetic information 
as well as the justification of placebo procedures, if applicable, should be included. 
Additionally, a statement that the study will be conducted according to the study 
protocol and Good Clinical Practice (GCP) should be included as well as that the 
study protocol and any potential amendments will be submitted to an IEC and 
potential regulatory authorities. A funding statement, a description of any potential 
conflicts of interest, and insurance issues should be provided. Any clinical study 
with ethical approval should disseminate its results through publication; the agreed 
publication policy can complete this section.  
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2.3. Conclusion 
The study protocol is the core document when planning and conducting clinical 
research. It should be created in an interdisciplinary setting, approved and strictly 
followed. Any changes require an amendment approved by an IEC and the 
regulatory authorities. The ultimate goal of the protocol is to support the conduct of 
scientifically and ethically sound research providing high-level evidence relevant 
for healthcare decision-making.  
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Abstract 
Background: When planning clinical trials, previous trials in the field should be 
considered to inform trial design. Likewise, the findings of any trial should be set in 
context with the overall body of evidence. We aim to investigate to what extent 
information from systematic reviews (SR) is used to inform trial design and report 
trial results in general surgical journals.  
Methods: All randomized controlled trials (RCTs) published in 2010 in the Annals 
of Surgery, JAMA Surgery and the British Journal of Surgery were considered.  
Results: Of 596 studies, 51 RCTs were identified. SRs were referenced in 65%, 
either to summarize evidence concerning a related topic (43%) or the study topic 
(excluding first-in-area RCTs: introduction 24%, discussion 26%).  No SRs were 
used to inform trial design and no trial updated a SR integrating the new results.  
Conclusions: SR are rarely used to inform trial design and synthesize knowledge 
for informed decision-making. 
  
31 
 
   
 
3.1. Introduction 
Clinical research projects typically target new research questions or the extension, 
confirmation, or rejection of previous findings. Therefore, a prerequisite for any 
clinical research project is an extensive literature review. This is especially of 
importance when planning clinical trials. Evidence from systematic reviews (SR) 
and when applicable meta-analyses should be considered to inform the design of 
clinical trials (Thompson et al. 2013).  Moreover, when reporting trial results, these 
should be used to update previous SR, as recommended for the discussion 
section by the CONSORT group (“Ideally, we recommend a systematic review and 
indication of the potential limitation of the discussion if this cannot be completed”) 
(Altman et al. 2001).  
The use of SRs to inform the design of new trials is important from an ethical, 
scientific, but also economic point of view. Some funding agencies ask for 
knowledge synthesis in grant applications. The Canadian Institutes of Health 
Research, requires grant applicants planning a randomized controlled trial (RCT) 
to include in their application a SR (Graham 2012). Similarly, for the National 
Institute for Health Research  (NIHR) Research for Patient Benefit Programme,  
“all proposals must show evidence from systematic reviews to ensure patient 
safety and value for money” (National Institute for Health Research 2013).  
However, knowledge synthesis prior to conducting an RCT is not uniformly 
applied. An investigation of RCTs funded by the National Institute for Health 
Research Health Technology Assessment (NIHR HTA) between 2006 and 2008 
including data from 48 trials found 77.1% of the trials referencing a SR (Jones et 
al. 2013). However, only 41.7% of the trials informed the design of the proposed 
RCT using information from a SR. SRs were used to define the primary outcome 
and description of adverse events, as well as for sample size calculation and 
determination of duration of follow-up. A repeated investigation of RCTs published 
in the May issue of the Annals of Internal Medicine, BMJ, JAMA, Lancet and New 
England Journal of Medicine in 1997 (Clarke and Chalmers 1998), 2001 (Clarke et 
al. 2002), 2005 (Clarke et al. 2007), 2009 (Clarke et al. 2010), and 2012 (Clarke 
and Hopewell 2013), evaluated whether the trial reports referred to the existing 
body of evidence in the discussion section and, since 2005, if SRs were used in 
the introduction section. The results suggest that the proportion of trials 
synthesising new findings with previous findings is low (39% in 2012 excluding 
trials that were the first addressing the question) without an apparent progress 
over the years (Clarke & Hopewell 2013).  
To the best of our knowledge, the use of SR to justify the planned research, inform 
the design and finally to be updated integrating the new results has not previously 
been investigated in surgical trials. The aim of the current research is to 
investigate to what extent information from SR is used 1) to justify and 2) design 
trials, as well as 3) to synthesize results, evaluating all RCTs published in 2010 in 
the Annals of Surgery, JAMA Surgery and the British Journal of Surgery.  
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3.2. Methods 
Here we present a secondary analysis of a review investigating discrepancies 
between registry entries and final reports of RCTs published in 2010 in the Annals 
of Surgery, JAMA Surgery and the British Journal of Surgery (Rosenthal & Dwan 
2013).  
The three Journals were screened for RCTs and study characteristics were 
extracted as previously described (Rosenthal & Dwan 2013). For the present 
investigation, two reviewers (RR and KD) independently extracted information 
concerning the use of SRs in the introduction section (justification of the research) 
and discussion section (synthesis of results), adapted from the extraction forms 
previously described for five reviews of major medical journals conducted between 
1997 and 2012 (Clarke & Chalmers 1998) (Clarke, Alderson, & Chalmers 2002) 
(Clarke, Hopewell, & Chalmers 2007) (Clarke, Hopewell, & Chalmers 2010) (Clarke 
& Hopewell 2013). Additionally, the methods sections were screened for 
statements that the trial design had been informed by a SR, adapting the 
extracting scheme applied to evaluate the use of systematic reviews to inform the 
study design in grant applications to the NIHR HTA (Jones, Conroy, Williamson, 
Clarke, & Gamble 2013). Discrepancies between the two reviewers were resolved 
by discussion and agreement. For data extraction, an Excel spreadsheet 
(Microsoft Office XP, Microsoft Corporation, Redmond, WA, USA) was used. 
Descriptive statistics were conducted using Intercooled Stata Version 12.1; 
StataCorp LP, College Station, Texas, USA. 
 
3.3. Results 
 
The flow of included studies and individual study details were published previously 
(Rosenthal & Dwan 2013).In brief, out of 596 studies identified through the search 
of the three journals, 51 RCTs fulfilled criteria for data extraction. Main baseline 
characteristics are presented in Table 8.  
Overall, out of the 51 RCTs, one or several SRs were referenced anywhere in the 
final report in 33 studies (65%), in 22 studies (43%) to summarize evidence 
concerning a different topic (example: RCT investigating early versus late drain 
removal after pancreatectomy cites a SR about drain versus no drain after 
colorectal surgery). None of the RCTs mentioned in the introduction or methods 
section that a SR was used to inform the trial design and no RCT contained an 
updated SR in the discussion section integrating the new results. Details on the 
findings of knowledge synthesis in the design and reporting phase, respectively, 
are presented in Table 9.  
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Table 8: Baseline characteristics of the included studies (n=51) 
Characteristic Item Summary measure 
Study intervention, n 
(%)  
Surgery 16 (31%) 
Invasive intervention1 4 (8%) 
Both surgery and invasive 
intervention  
4 (8%) 
The intervention is neither 
surgery nor an invasive 
intervention, but surgery is 
part of the study2  
22 (43%) 
Conservative treatment 3 (6%) 
Informed consent process 2 (4%) 
Primary outcome is 
safety, n (%)  
No 39 (76%) 
Yes 12 (24%) 
Sample size3, median 
(IQR) 
 122 (70, 206) 
Funding, n (%) Trial receiving any support 
from industry4 
19 (37%) 
Trial not receiving any 
support from industry 
22 (43%) 
Missing/insufficient 
information 
10 (20%) 
  
  
Seventeen RCTs claimed to be the first RCTs in the topic area, two stated this 
explicitly (i.e. “this is the first trial…”) and 15 implicitly (i.e. “previously no trial 
investigated…”) and were excluded from further analysis. Out of the remaining 34 
trials, eight (24%) RCTs discussed a SR in the topic area in the introduction 
section without mentioning that it was used to inform the trial design and nine 
(26%) discussed a previous SR in the discussion section without attempting to 
integrate the new results and in no trials were findings used to update a SR. 
  
1 Interventions requiring either percutaneous access (such as radiofrequency ablation of liver metastases) or access 
through natural orifices (such as endoscopic retrograde cholangio-pancreatography, but not natural orifice transluminal 
endoscopic surgery) 
2 Surgery was part of the study, but the intervention in itself was not, such as peri- or intraoperative administration of a drug, 
nutrition, bowel preparation, or transplant organ preparation 
3 total number of randomized patients 
4 be it by funding the entire trial, part of the trial, or any other support (e.g, support of investigators) 
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Table 9: Use of systematic reviews to inform trial design by publication section 
Characteristic Item N(%) 
Introduction  Claims to be the first RCT1 addressing the question2 17 (33%) 
Contains an updated SR3, which was used to design the new trial 0 (0%) 
Contains an updated SR, not mentioning that it was used to design the new trial 0 (0%) 
Discusses a previous SR in the topic area4 of the trial, which was used to design 
the new trial 
0 (0%) 
Discusses a previous SR in the topic area of the trial, not mentioning that it was 
used to design the new trial 
8 (16%) 
Does not contain a reference to a SR, but contains references to (an) other 
RCT(s) addressing the topic area 
20 (39%) 
Does not contain a reference to a SR, does not contain references to (an) other 
RCT(s) addressing the topic area, and does not claim to be the first RCT 
6 (12%) 
Methods Claims in the methods section to be the first RCT addressing the question  0 (0%) 
Refers to a previous or updated SR, which was used to design the new trial  0 (0%) 
Does not contain reference to a previous or updated SR, which was used to 
design the new trial and does not claim in the methods section to be the first trial 
51 (100%) 
                 
 
  
1 RCT=randomized controlled trial 
2 Explicitly stated to be the first or derived from statements that no such study has previously been conducted  
3 SR=systematic review 
4 Topic area= same or similar intervention and condition 
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Table 9 (continued) 
Characteristic Item N(%) 
Discussion Contains an updated SR1 integrating the new results 0 (0%) 
Discusses a previous SR in the topic area2 of the new trial, but did not attempt to 
integrate their results 
9 (18%) 
No apparent systematic attempt to set the results in the context of other trials 20 (39%) 
Claims in the discussion section to be the first RCT3 addressing the question4 8 (15%) 
Claims in another section than the discussion section to be the first RCT 
addressing the question2 
9 (18%) 
Claims in any section to be the first RCT with exactly the same population, 
intervention, control and outcome (but not necessarily the first RCT in the topic 
area) 
5 (10%)  
 
1 SR=systematic review 
2 Topic area=same or similar intervention and condition 
3 RCT=randomized controlled trial 
4 Explicitly stated to be the first or derived from statements that no such study has previously been conducted  
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3.4. Discussion 
Our results show that two-thirds of the RCTs referenced a SR, however none 
mentioned the use of a SR to inform the trial design and none of the RCTs 
presented an updated existing SR integrating the new results. Additionally, we 
found only two RCTs to include explicit statements on whether the trial was the 
first RCT in the field. Our findings suggest that SRs are considered rather to 
summarize findings than to inform trial design or for knowledge synthesis after trial 
conduct. This is in line with previous findings (Clarke & Chalmers 1998),(Clarke, 
Alderson, & Chalmers 2002),(Clarke, Hopewell, & Chalmers 2007),(Clarke, 
Hopewell, & Chalmers 2010),(Clarke & Hopewell 2013), although even more 
marked. However, it is not possible to identify circumstances when a SR may have 
been used to inform trial design without explicit statements.  
In practice, the following four-step framework has been suggested for the use of 
SR to inform the design of new trials: In step one, the research question of the 
proposed trial is formulated focussing on definition of the populations, 
interventions, comparators, outcomes, timing and setting (PICOTS) (Thompson, 
Tiwari, Fu, Moe, & Buckley 2013). In step two, an up-to-date relevant and valid SR 
is identified or conducted, and in step three the SR is used to inform the planned 
trial. If there are several RCTs, but no SR in the field, we propose to first 
synthesize the body of evidence within a SR and if appropriate conduct a meta-
analysis. Finally, in step four the implications for the proposed trial are 
summarised. This procedure is important to justify any research from a scientific, 
ethical and economic point of view. Similarly, we propose that trialists attempt to 
report their results in the context of other trials in the field, whenever possible 
integrating the new findings by updating a SR. Only when evaluating study results 
within the overall body of evidence, well-informed decisions in health care are 
possible.    
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Abstract 
 
Objective: To investigate the prevalence of discontinuation and non-publication of 
surgical versus medical randomized controlled trials (RCTs) and to explore risk 
factors for discontinuation and non-publication of surgical RCTs.  
 
Summary background data: Trial discontinuation has significant scientific, 
ethical, and economic implications. To date, the prevalence of discontinuation of 
surgical RCTs is unknown.  
 
Methods: All RCT protocols approved 2000-2003 by six ethics committees in 
Canada, Germany and Switzerland were screened. Baseline characteristics were 
collected and, if published, full reports retrieved. Risk factors for early 
discontinuation for slow recruitment and non-publication were explored using 
multivariable logistic regression analyses.  
 
Results: In total, 863 RCT protocols involving adult patients were identified, 127 in 
surgery (15%) and 736 in medicine (85%). Surgical trials were discontinued for 
any reason more often than medical trials (43% versus 27%, risk difference 16% 
(95% confidence interval [CI] 5%, 26%); p=0.001) and more often discontinued for 
slow recruitment (18% versus 11%, risk difference 8% (95% CI 0.1%, 16%); 
p=0.020). The percentage of trials not published as full journal article was similar 
in surgical and medical trials (44% versus 40%, risk difference 4% (95% CI -5%, 
14%); p=0.373). Discontinuation of surgical trials was a strong risk factor for non-
publication (odds ratio 4.18, 95% CI 1.45, 12.06; p=0.008).  
 
Conclusions: Discontinuation and non-publication rates were substantial in 
surgical RCTs and trial discontinuation was strongly associated with non-
publication. These findings need to be taken into account when interpreting 
surgical literature. Surgical trialists should consider feasibility studies before 
embarking on full-scale trials.  
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4.1. Introduction 
Randomized controlled trials (RCTs) can provide high-level evidence about safety 
and efficacy of interventions. Conducting RCTs involving surgical interventions 
presents challenges distinct from RCTs investigating pharmacological 
interventions. Examples are standardization of operative and peri-operative 
interventions, surgeon and team experience, blinding of study personnel and 
participants and recruitment (e.g. due to patient preference) (Boutron, Moher, 
Altman, Schulz, & Ravaud 2008;Devereaux, Bhandari, Clarke, Montori, Cook, 
Yusuf, Sackett, Cina, Walter, Haynes, Schunemann, Norman, & Guyatt 
2005;Solomon and McLeod 1995).  
Trials may be discontinued earlier than planned for various reasons, including 
compelling evidence of treatment benefit or harm, futility, slow recruitment, 
commercial reasons or the emergence of new evidence from other trials that 
negates the need for another study (Goodman 2009;Iltis 2005). When there is no 
early evidence of harm or irrefutable benefit, trial discontinuation has a significant 
scientific, ethical and economic impact. The involvement of steering committees 
and Data and Safety Monitoring Boards with members independent of the sponsor 
is of utmost importance when deciding to stop a trial early. Moreover, reasons for 
early trial termination should be transparently communicated. To the best of our 
knowledge, discontinuation of surgical trials as well as the associated risk-factors 
has not yet been investigated.  
We determined the prevalence of, and reasons for, discontinuation of surgical 
trials. We further explored differences in the prevalence of discontinuation 
between medical and surgical trials and risk factors for non-publication of surgical 
trials.  
 
4.2. Methods 
Included studies 
We identified RCTs conducted in adult patients from a large empirical study 
investigating trial protocols approved between 2000 and 2003 by six Research 
Ethics Committees (RECs) in Canada, Germany and Switzerland (Kasenda et al. 
2014). Details of the study design have been previously described (Kasenda et al. 
2012).  
For the current analysis, we used the following pre-specified definitions: All RCTs 
conducted among adult patients in clinical areas with surgical or peri-operative 
activities were classified as “surgical”. These included: anaesthesiology, general 
surgery, vascular surgery, transplantation, orthopaedics, traumatology, 
cardiothoracic surgery, cardiovascular surgery, neurosurgery, urology, plastic 
surgery, maxillofacial surgery, ear-nose-throat surgery, obstetrics/gynaecology, 
ophthalmology and dentistry. All RCTs conducted among adult patients in clinical 
areas primarily relying on non-surgical activities were classified as “medical”. 
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Examples are cardiology, gastroenterology, infectious diseases, neurology, and 
oncology (for full details see AppendixTable S1). In both groups, study 
interventions were classified as non-invasive (e.g. disinfection with antiseptic 
agent in a “surgical” trial, antihypertensive medication in a “medical” trial) or 
invasive (e.g. colon resection in a “surgical” trial, colonoscopy in a “medical” trial).  
Data extraction  
We used a web-based password-protected database for data extraction 
(http://www.squiekero.org/). Collaborators trained in trial methodology signed 
confidentiality declarations for the participating RECs, completed a calibration 
process, and then extracted study characteristics such as information concerning 
the study population, intervention, control, sample size, and funding from the 
included RCT protocols. The first 310 (30%) trial protocols were extracted 
independently and in duplicate; disagreements were resolved by discussion. For 
pragmatic reasons, the remaining protocols were extracted by a single investigator 
with regular agreement checks using double data extraction We determined 
completion status and publication history of RCTs as of April 2013 by using 
information from REC files if available, by conducting comprehensive searches of 
electronic databases for corresponding publications, and directly contacting 
trialists as described previously (Kasenda, von Elm, You, Blumle, Tomonaga, 
Saccilotto, Amstutz, Bengough, Meerpohl, Stegert, Tikkinen, Neumann, Carrasco-
Labra, Faulhaber, Mulla, Mertz, Akl, Bassler, Busse, Ferreira-Gonzalez, 
Lamontagne, Nordmann, Rosenthal, Schandelmaier, Sun, Vandvik, Johnston, 
Walter, Burnand, Schwenkglenks, Bucher, Guyatt, & Briel 2012). Two 
investigators independently assessed whether the publications identified by 
electronic searches matched the corresponding protocol (Kasenda, von Elm, You, 
Blumle, Tomonaga, Saccilotto, Amstutz, Bengough, Meerpohl, Stegert, Tikkinen, 
Neumann, Carrasco-Labra, Faulhaber, Mulla, Mertz, Akl, Bassler, Busse, Ferreira-
Gonzalez, Lamontagne, Nordmann, Rosenthal, Schandelmaier, Sun, Vandvik, 
Johnston, Walter, Burnand, Schwenkglenks, Bucher, Guyatt, & Briel 2012). 
An RCT was considered as discontinued if the investigators indicated 
discontinuation with a reason in the correspondence with the REC, in a journal 
publication, or their response to our survey. If we could not elucidate the reason 
for trial discontinuation or if poor participant recruitment was mentioned, we used a 
pre-specified cut-off of less than 90% of achieved target sample size to determine 
discontinuation (Kasenda, von Elm, You, Blumle, Tomonaga, Saccilotto, Amstutz, 
Bengough, Meerpohl, Stegert, Tikkinen, Neumann, Carrasco-Labra, Faulhaber, 
Mulla, Mertz, Akl, Bassler, Busse, Ferreira-Gonzalez, Lamontagne, Nordmann, 
Rosenthal, Schandelmaier, Sun, Vandvik, Johnston, Walter, Burnand, 
Schwenkglenks, Bucher, Guyatt, & Briel 2012). In the rare case that several 
reasons per study were indicated, the primary reason reported was used. Results 
were regarded as not published at all if the REC files, the contacted investigators, 
and the electronic database search yielded no evidence that the data were 
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published in any format. Additionally, it was evaluated whether results were 
published as full journal article. We defined sponsorship depending on who took 
responsibility for the trial: We considered protocols as industry-sponsored, if they 
were written by industry employees, prominently displayed a company logo or 
name, reported full funding by the industry without any indication that the trial was 
investigator-sponsored, or mentioned a specific policy with respect to data 
ownership and publication rights suggesting sponsorship by the industry.  
In surgical trials, we explored whether authors reported a primary outcome for 
harm. One investigator coded this information based on the previously extracted 
information and any ambiguity was discussed with a second investigator. The 
rationale to include this variable is the fact that adverse events may be rare or 
occur late in the sequence of the trial, thus adequately powered studies reaching 
the targeted sample size and the defined follow-up are of utmost importance. 
Statistical analysis 
We used descriptive statistics to report the prevalence of, and reasons for 
discontinuation. We compared features of surgical and medical RCTs using the 
Chi-squared test or Fisher’s exact test, as appropriate, and calculated a risk 
difference and its 95% confidence interval (CI). We excluded trials that never 
started (according to REC files or our investigator survey) or that were still on-
going when calculating rates of trial completion and publication status.  
We built multivariable logistic regression models to identify predictors for 
discontinuation due to slow recruitment. Since there are well-justified reasons for 
trial discontinuation, we did not explore reasons for discontinuation overall, but for 
discontinuation due to slow recruitment only, which we estimated to be an 
inappropriate reason for early termination. In order to avoid overfitting, the number 
of included covariates was limited to one per 10 events/non-events, whichever 
was the smaller number in all multivariable regression analyses (Peduzzi, 
Concato, Kemper, Holford, & Feinstein 1996). Covariates were chosen a priori to 
explore the following two hypotheses: trial discontinuation due to slow recruitment 
is (1) less likely with industry-sponsored trials than with trials sponsored by an 
academic investigator, due to differences in the amount of financial and 
organisational resources between industry and academic sponsors; and (2) less 
likely with adverse events being the primary outcome than with efficacy outcomes 
only, due to more patient and health care provider preference for one treatment 
arm in the latter case hampering recruitment.  
Using a multivariable hierarchical logistic regression model, we examined the 
following pre-specified predictors for non-journal-publication of RCTs: ‘industry-
sponsorship (versus investigator-sponsorship)’, ‘primary outcome being an 
adverse event (yes versus no)’ and ‘trial discontinuation for any reason (yes 
versus no)’. We hypothesized (1) that non-publication was more likely in industry-
sponsored trials, as suggested by previous literature (Von Elm et al. 2008); (2) that 
trial non-publication was more likely in discontinued trials (assuming that only few 
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trials were discontinued due to compelling evidence of treatment benefit or harm); 
and (3) that trial non-publication was more likely with adverse events being the 
primary outcome than with efficacy outcomes only, due to the high interest in 
efficacy outcomes.  
We accounted for clustering by the approving REC using a random effect 
estimator. 
We conducted two sensitivity analyses. First, we conducted the multivariable 
analyses disregarding the clustering by the approving REC. Second, we used 
multiple imputation to replace missing data for independent and dependent 
variables (Kenward and Carpenter 2007).  
We conducted one posthoc analysis: Since trial comparisons (surgical versus 
medical) refer to the a priori defined clinical areas and not to study interventions, 
we compared trials with invasive interventions versus trials without invasive 
interventions using descriptive analyses (Appendix Figure S1).  
Analyses were conducted using Stata Version 12.1 (StataCorp LP, College 
Station, Texas, USA).  
4.3. Results 
Baseline characteristics of included studies 
We identified 863 protocols for RCTs involving 680,019 adult patients; 127 RCTs 
in the field of surgery (15%) and 736 in medicine (85%) (Figure 2). We excluded 
39 (5%) trials that were never started and 8 (1%) that were still recruiting. A total of 
816 trials (95%) involving 666,760 adult patients remained for the evaluation of 
completion and publication status (surgery: 115 (14%), medicine: 701(86%), 
(Figure 2).  
The specialties contributing to at least 10% of the trials were anesthesiology 
(13%), cardiothoracic surgery (13%), obstetrics/gynecology (16%), ophthalmology 
(14%) and orthopedics (10%) in surgical trials (Appendix Table S1a) and oncology 
(21%), cardiovascular (15%) and infectious diseases (11%) in medical trials 
(Appendix Table S1b).  
Table 10 presents an overview of RCT characteristics by clinical area.   
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Figure 2: Flow chart of included studies: Studies eligible for assessment of discontinuation and of non-publication, 
respectively 
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Table 10: Baseline characteristics by clinical area  
In categorical variables, numbers (column percentages) are displayed 
Characteristic  Clinical area 
  Surgery 
127 (100%) 
Medicine 
736 (100%) 
Intervention, n (%) Medication 85 (67) 618 (84) 
Invasive procedure 31 (24) 25 (3) 
Rehabilitation 2 (2) 14 (2) 
Behavioral 0 (0) 18 (3) 
Diagnostic test 1 (1) 14 (2) 
Other 8 (6) 47 (6) 
Sample size1, median (IQR2) 150 (60, 450) 288 (105, 628) 
Industry funding, n (%) Yes  76 (60) 552 (75) 
No 51 (40) 184 (25) 
Trial sponsor, n (%) Industry  59 (46) 470 (64) 
Academic investigator 71 (56) 276 (38) 
Center status3, n (%) Single-center 50 (40) 99 (14) 
Multi-center 75 (60) 633 (86) 
Planned interim 
analysis, n (%) 
Yes 30 (24) 249 (34) 
No 97 (76) 487 (66) 
Presence of DSMB4, n 
(%) 
Yes 24 (19) 223 (30) 
No 103 (81) 513 (70) 
Planned stopping rule, 
n (%) 
Yes 10 (8) 142 (19) 
No 117 (92) 594 (81) 
 
 
  
1 Surgery: 4 missings, Medicine: 5 missings 
2 IQR=Interquartile range 
3 Surgery: 2 missings, Medicine: 4 missings 
4 DSMB=Data and Safety Monitoring Board 
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Discontinuation of trials 
We excluded 66 trials (12 surgical, 54 medical) with unclear completion status 
(Figure 2). In the remaining 750 trials (103 surgical, 647 medical), the overall 
proportion of discontinued trials was 43% (44/103) in surgical trials and 27% 
(176/647) in medical trials with a risk difference of 16% (95% CI 5%, 26%; 
p=0.001; Table 11).  
 
Table 11 Trial completion and publication status by clinical area 
Numbers (column percentages) are displayed.1 
 
  Clinical area 
  Surgery 
115 (100) 
Medicine 
701 (100) 
Completion 
status 
Completed 59 (51) 471 (67) 
Discontinued 44 (38) 176 (25) 
Unclear  12 (11) 54 (8) 
Publication 
status 
Published 
- Abstract 
- Journal 
- Letter 
- Other 
69 (60) 
- 5 (4) 
- 64 (56) 
- 0 (0) 
- 0 (0) 
466 (66) 
- 31 (4) 
- 421 (60) 
- 7 (1) 
- 7 (1) 
Not published 46 (40) 235 (34) 
 
Reasons for RCT discontinuation by clinical area are presented in Table 12. Slow 
recruitment was the most frequent reason for discontinuation in both surgical 
(19/44, 43%) and medical (68/176, 39%) trials. Stopping for slow recruitment was 
more frequent in surgical than in medical trials (19/103 [18%] versus 68/647 [11%], 
risk difference 8%, 95% CI 0.1%, 16%; p=0.020).  
 
 
1 Exclusion of never started trials (surgery 10/127, 8%; medicine 29/736, 4%) and 
  Exclusion of still recruiting trials (surgery 2/127, 2%; medicine 6/736, 1%) 
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Table 12 Reasons for discontinuation by clinical area.  
Numbers of studies (column percentages) are displayed.     
 
Reason  Clinical area 
 Surgery 
44 (100) 
Medicine 
176 (100) 
Benefit 1 (2) 6 (3) 
Futility 5 (12) 28 (16) 
Harm 4 (9)   17 (10) 
Slow recruitment 19 (43) 68 (39) 
External evidence 1 (2) 7 (4) 
Lack of funding 0 (0) 4 (2) 
Administrative  7 (16) 27 (15) 
Other 0 (0) 7 (4) 
Unclear 7 (16)   12 (7) 
 
Results of our exploratory analysis comparing invasive to non-invasive trials 
suggested that RCTs with invasive interventions were more often discontinued for 
slow recruitment than RCTs with non-invasive interventions (Appendix Figure S1).   
Publication of trials 
No trials had to be excluded for unclear publication status (Figure 2). The overall 
percentage of trials not published in any format was 40% (46/115) among surgical 
trials and 34% (235/701) among medical trials with a risk difference of 6% (95% CI 
-3%, 16%; p=0.176; Table 11). Most trials were published as full journal articles 
(surgical 64/115 [56%], medical 421/701 [60%]) as opposed to abstracts, letters or 
other short-forms of publication (surgical 5/115 [4%], medical 45/701 [6%]).The 
overall percentage of trials not published as full journal article was 44% (51/115) 
among surgical trials and 40% (280/701) among medical trials with a risk 
difference of 4% (95% CI -5%, 14%; p=0.373.  
Of completed surgical trials, 76% (45/59) were published in any format and of 
completed medical trials 79% (371/471). Of discontinued surgical trials, 55% 
(24/44) were published and of discontinued medical trials 52% (92/176).   
49 
 
   
 
Results of the supplementary exploratory analysis comparing invasive to non-
invasive trials suggested no relevant differences in publication rates (Appendix 
Figure S1).   
Risk factors for surgical trial discontinuation due to slow recruitment 
Study discontinuation due to slow recruitment was neither influenced by the type 
of sponsor (industry versus academic investigator, adjusted odds ratio [OR] 0.60, 
95% CI 0.20, 1.85, p=0.377 (Table 13) nor by the type of primary outcome (i.e. 
efficacy or harm) (adjusted OR 0.51, 95% CI 0.14, 1.85, p=0.302). Sensitivity 
analyses did not affect these findings (Appendix Table S2).  
Risk factors for non-publication of surgical trials as full journal article 
In multivariable analysis, trials discontinued for any reason were significantly more 
likely to remain unpublished than completed trials (adjusted OR 4.18, 95% CI 1.45, 
12.06, p=0.008) (Table 14). Industry-sponsored trials were significantly more likely 
to remain unpublished than trials sponsored by an academic investigator (adjusted 
OR 2.99, 95% CI 1.05, 8.58, p=0.041). Trials with a primary harm outcome were 
less likely to remain unpublished than trials with primary efficacy outcomes only 
(adjusted OR 0.28, 95% CI 0.09, 0.92, p=0.035).  
Sensitivity analyses did not affect these findings with the exception of the effect of 
the sponsor which did not remain statistically significant in the model with multiple 
imputation (Appendix Table S3).  
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Table 13 Univariable and multivariable logistic regression for trial discontinuation of surgical trials for slow recruitment 
(using a random effect estimator to account for clustering by the approving research ethics committee) 
n=891 trials, 19 were discontinued and 70 completed or discontinued for other reasons.  
 
Potential predictor Univariable Multivariable 
 Odds Ratio 95% CI2 
 
P value Odds Ratio 95% CI 
 
P value 
Industry sponsor, yes versus no 0.66 0.22, 1.97 0.457 0.60 0.20, 1.85 0.377 
Primary harm outcome, 
yes versus no 
0.55 0.15, 1.96 0.354 0.51 0.14, 1.85 0.302 
 
 
  
1 Out of 115 trials, 12 had an unclear completion status and 14 had at least one missing covariate. 
2 CI=Confidence interval 
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Table 14 Univariable and multivariable logistic regression for non-publication as full journal article of surgical trials (using a 
random effect estimator to account for clustering by the approving research ethics committee). 
n=891, 56 trials published as full journal article and 33 not published as full journal article.  
 
Potential predictor Univariable Multivariable 
 Odds Ratio 95% CI2 
 
P value Odds Ratio 95% CI 
 
P value 
Industry sponsor, yes versus no  2.02 0.84, 4.88 0.119 2.99 1.05, 8.58 0.041 
Primary harm outcome, 
yes versus no 
0.32 0.11, 0.96 0.043 0.28 0.09, 0.92 0.035 
Trial discontinuation for any reason,  
yes versus no 
2.26 0.94, 5.44 0.068 4.18 1.45, 12.06 0.008 
 
 
 
1 Out of 115 trials, 26 had at least one missing covariate. 
2 CI=Confidence interval 
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4.4. Discussion 
This study suggests that the discontinuation rate is substantial in surgical RCTs 
and that discontinuation is more frequent in surgical than in medical RCTs. This 
applies to discontinuation for any reason as well as to discontinuation for slow 
recruitment, which is the predominant reason for discontinuation. Trial 
discontinuation was found to be a strong predictor for non-publication. 
Relation to other studies investigating trial discontinuation 
Slow recruitment is an important problem in clinical trials. In a cohort of 114 
publicly funded multi-center trials, only 31% reached their initial recruitment target, 
an additional 24% reached 80% of their recruitment target and 53% of the trials 
were extended (McDonald et al. 2006). The target recruitment size was revised in 
34% of trials, of which 86% downward (McDonald, Knight, Campbell, Entwistle, 
Grant, Cook, Elbourne, Francis, Garcia, Roberts, & Snowdon 2006). Slow 
recruitment may occur due to a variety of reasons, such as organisational failure, 
inadequate funding, or unrealistic projections regarding the number of eligible 
participants (Lievre et al. 2001). It may lead to longer study duration and increased 
resource consumption and early trial discontinuation with less precise study 
findings (Treweek et al. 2013). In a Cochrane review investigating methods to 
improve recruitment, a number of promising strategies have been described, 
among them telephone reminders and opt-out policies (Treweek, Lockhart, 
Pitkethly, Cook, Kjeldstrom, Johansen, Taskila, Sullivan, Wilson, Jackson, Jones, 
& Mitchell 2013). Most importantly, pilot studies may allow to estimate eligibility 
and consent rates more precisely and thus should be considered when planning a 
RCT (Lancaster, Dodd, & Williamson 2004).  
Our exploratory analysis showed that trials with invasive interventions tended to be 
more frequently discontinued for any reason and were significantly more often 
discontinued for slow recruitment. This result suggests that the type of intervention 
(invasive vs. non-invasive) rather than the setting (surgery vs. medicine) 
represents a barrier to successful recruitment (Boutron, Moher, Altman, Schulz, & 
Ravaud 2008). 
We found trial discontinuation to be more frequent in surgical than in medical trials, 
both overall and for slow recruitment. Potential explanations may be surgery-
specific aspects and challenges with clinical trials such as requirements 
concerning surgeon experience, standardization of the intervention, and 
recruitment (e.g. due to patient or caregiver preference) (Boutron, Moher, Altman, 
Schulz, & Ravaud 2008;Devereaux, Bhandari, Clarke, Montori, Cook, Yusuf, 
Sackett, Cina, Walter, Haynes, Schunemann, Norman, & Guyatt 2005;Solomon & 
McLeod 1995). Additionally, there are some fundamental differences concerning 
the premarket review and approval process of devices versus drugs. Whereas for 
U.S. Food and Drug Administration (FDA) approval, safety and efficacy have to be 
demonstrated in humans for all drugs, this is only required for high risk devices 
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(Sweet et al. 2011). Similarly in Europe, clinical data are not required for lower risk 
devices (Sorenson and Drummond 2014). Thus, depending on the risk class of 
surgical devices, regulatory approval may not be based on clinical evidence, which 
potentially impacts resource investment and other efforts to achieve trial 
completion. 
Relation to other studies investigating trial non-publication 
In the present study, 60% of surgical and 66% of medical trials were published in 
any format, 56% and 60%, respectively as full journal articles. These proportions 
are slightly higher compared to a previous investigation of study protocols 
submitted to a Swiss REC with 52% of trials getting published (233/451) (Von Elm, 
Rollin, Blumle, Huwiler, Witschi, & Egger 2008). In this previous Swiss study, the 
odds for publication was higher with non-commercial funding, which is in line with 
our results, higher with multicentre trials, international collaboration and a high 
sample size as assessed by median split (Von Elm, Rollin, Blumle, Huwiler, 
Witschi, & Egger 2008). This investigation comprised, however, mostly medical 
specialties and thus is not strictly comparable to the surgical trials evaluated in our 
sample. In a Cochrane review of 79 studies investigating the subsequent 
publication of abstracts presented at meetings, the weighted full publication rate 
was 44.5% (95% CI 43.9-45.1) and an estimated cumulative publication rate after 
9 years was 52.6% overall and 63.1% for RCTs or controlled clinical trials (Scherer 
et al. 2007). Abstract acceptance for presentation at a meeting was found to be 
associated with subsequent publication with an odds ratio of 1.78 (95% CI 1.50-
2.12) (Scherer, Langenberg, & Von 2007). 
We found trial discontinuation to be an independent risk factor for non-publication. 
This may be explained by the fact that the most frequent reasons of 
discontinuation of surgical RCTs were slow recruitment, futility or administrative 
reasons. These trials were thus potentially more difficult to publish than the few 
trials stopped early for benefit. Generally, in trials stopped early for benefit, 
treatment effects tend to be large (Bassler et al. 2008;Montori et al. 2005a), 
increasing the chance of a trial to be published. This is supported by a review of 
such trials in which the majority of RCTs (92/143) were published in 5 high-impact 
medical journals.(Montori, Devereaux, Adhikari, Burns, Eggert, Briel, Lacchetti, 
Leung, Darling, Bryant, Bucher, Schunemann, Meade, Cook, Erwin, Sood, Sood, 
Lo, Thompson, Zhou, Mills, & Guyatt 2005a).  
Strengths and limitations  
The collaborating RECs granted us unrestricted access to trial protocols. As 
outlined previously (Chan et al. 2006), this reduced the risk of selection bias; 
asking trialists or sponsors for permission would almost certainly have led to 
oversampling of successfully completed and published trials. However, some 
investigators may not have provided useful information about reasons for trial 
discontinuation. Additionally, our approach allowed us to collect more detailed 
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information about trial characteristics than investigations relying on trial registry 
entries only (World Health Organization 2013). Moreover, we obtained study 
protocols from several RECs in three countries, increasing the generalizability of 
our findings (Kasenda, von Elm, You, Blumle, Tomonaga, Saccilotto, Amstutz, 
Bengough, Meerpohl, Stegert, Tikkinen, Neumann, Carrasco-Labra, Faulhaber, 
Mulla, Mertz, Akl, Bassler, Busse, Ferreira-Gonzalez, Lamontagne, Nordmann, 
Rosenthal, Schandelmaier, Sun, Vandvik, Johnston, Walter, Burnand, 
Schwenkglenks, Bucher, Guyatt, & Briel 2012). Additionally, our data extractions 
were based on a priori definitions (Kasenda, von Elm, You, Blumle, Tomonaga, 
Saccilotto, Amstutz, Bengough, Meerpohl, Stegert, Tikkinen, Neumann, Carrasco-
Labra, Faulhaber, Mulla, Mertz, Akl, Bassler, Busse, Ferreira-Gonzalez, 
Lamontagne, Nordmann, Rosenthal, Schandelmaier, Sun, Vandvik, Johnston, 
Walter, Burnand, Schwenkglenks, Bucher, Guyatt, & Briel 2012) and validated 
through regular quality assessments. Finally, our sensitivity analyses support the 
robustness of the conducted statistical analyses.  
Our investigation has some limitations. Although we included a large number of 
approved RCTs, we were unable to adjust for additional confounders due to the 
low number of surgical trials and outcome events (Peduzzi, Concato, Kemper, 
Holford, & Feinstein 1996). We thus refrained from adjusting for trial 
characteristics such as sample size and center status (single-center versus multi-
center).  
Implication for daily practice and further research 
These findings of our study raise ethical concerns, as many patients who consent 
to enrol in surgical trials do not contribute to scientific knowledge, and suggest that 
considerable resources are being wasted. Thus, our findings may have the 
following implications during the different phases of a research pathway:  
i) Trial conception and design: Strategies to prevent discontinuation should be 
adopted already during the trial design phase, including training in research 
methodology, realistic resource estimation (e.g. time of personnel), creating 
research infrastructures, and working in networks and interdisciplinary teams 
involving trial methodologists, statisticians, data managers and trial managers. 
Pilot studies either as part of the trial (internal pilot) or stand-alone (external pilot) 
(Lancaster, Dodd, & Williamson 2004), i.e. a small version of the full-scale study or 
feasibility studies, are effective means to evaluate particular aspects such as 
recruitment, resource utilization and protocol feasibility (Dolgin 2013). This 
especially applies to trials involving surgical interventions, where recruitment may 
be more challenging due to patient preferences. Moreover, pilot studies may 
identify other challenges such as feasibility of standardization of the surgical 
interventions. Pilot studies should thus be considered when allocating sparse 
resources to surgical RCTs. Additionally, trials should be registered prior to 
enrolment of the first patient. This enhances transparency regarding the targeted 
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sample size and additionally allows identifying the study while on-going or after 
close-up before publication.  
ii) Trial conduct: Recruitment should be closely monitored and early modification of 
trial methods foreseen to enhance recruitment if necessary. The decision to 
discontinue a trial should be made by an independent Data and Safety Monitoring 
Board based on pre-defined criteria.  
iii) Trial reporting: Reasons for discontinuation and results of discontinued RCTs 
should be transparently communicated and thus made publicly available.  
iv) Healthcare decision making: When interpreting surgical literature, be it primary 
studies or systematic reviews, potential biases introduced by discontinued RCTs 
or by non-publication of trials need to be considered.  
 
Conclusions 
 
More than one in three surgical RCTs is discontinued. Discontinuation is more 
frequent among surgical than medical RCTs. Slow recruitment is the predominant 
reason for early termination. Furthermore, results from discontinued trials are more 
likely to remain unpublished. Rigorous planning within a multidisciplinary research 
framework, supported by pilot and feasibility studies, pre-defined criteria for 
stopping a trial, applied by independent boards, and transparent communication 
with stakeholders of surgical research and the public could help achieve the 
ultimate goal of high-quality research that improves the evidence base of surgical 
interventions.  
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Abstract  
Background: Reporting of surgical outcomes is important for healthcare decision 
making and includes the reporting of complications. For postoperative 
complications, however not for intraoperative complications, several classifications 
have been proposed and validated. The aim of the present study is to assess the 
current practice of complication reporting in surgical trials.  
Methods: We evaluated reporting of intra- and postoperative complications in all 
registered randomized-controlled trials that investigate surgery or invasive 
interventions in at least one study arm and were published in 2010 in the Annals of 
Surgery, JAMA Surgery and the British Journal of Surgery.  
Results: Forty six trials were identified and intra- and postoperative complications 
were reported separately in 42% and pooled in 15%. In 37% intraoperative, in 2% 
postoperative and in 4% both intra- and postoperative complications were not 
reported at all. Exact definitions were provided in 13% for intraoperative and in 
50% for postoperative complications. A classification was used in 9% for intra- and 
in 54% for postoperative complications, most frequently according to severity. The 
type of intervention (surgical versus other) or whether the primary outcome was 
the assessment of complications had no significant impact on reporting definitions 
of adverse events.  
Conclusions: Intraoperative complications are frequently pooled with 
postoperative complications, ill-defined or not reported at all, hampering informed 
decision-making. As further research, we propose to develop and validate a 
classification of intraoperative complications. This will facilitate the evaluation of 
safety and the continuous quality control of surgical interventions with the ultimate 
goal to contribute to patient safety.  
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5.1. Introduction 
High-level evidence is of utmost importance for decision making in healthcare.  
Therefore, reporting needs to be accurate and transparent. Reporting should 
follow standardized guidelines as proposed by CONSORT (Consolidated 
Standards of Reporting Trials Statement) (Schulz, Altman, & Moher 2010). Of 
specific interest to surgery are the CONSORT extensions for nonpharmacologic 
treatment (Boutron, Moher, Altman, Schulz, & Ravaud 2008). There, challenges to 
surgical trials such as blinding, experience of and clustering by care providers and 
centers and standardization of interventions are accounted for. The CONSORT 
statement was initially developed to improve reporting of efficacy randomized-
controlled trials (RCTs).  Since then, the group has published an extension for 
better reporting of harms in relation to interventions. There, it is specified that the 
methods section should include a list of addressed adverse events with definitions 
for each and information on how harms-related data were collected (Ioannidis et 
al. 2004). If relevant, information on grading and expectancy of adverse events 
and validation of definitions should be provided (Ioannidis, Evans, Gotzsche, 
O'Neill, Altman, Schulz, & Moher 2004). In surgery, reporting of adverse events is 
specifically challenging due to the potential complexity of these events (Boutron, 
Moher, Altman, Schulz, & Ravaud 2008;Martin, Brennan, & Jaques 2002a). An 
analysis of the quality of reporting of short-term postoperative surgical 
complications after pancreatectomy, hepatectomy and esophagectomy involving 
119 articles, revealed that definitions of complications were provided in 34% of the 
articles and the severity was graded in 20% only (Martin, Brennan, & Jaques 
2002a).  
Whereas several simple and reproducible classification systems for postoperative 
complications have been developed (Clavien, Sanabria, & Strasberg 
1992;Clavien, Barkun, de Oliveira, Vauthey, Dindo, Schulick, de, Pekolj, 
Slankamenac, Bassi, Graf, Vonlanthen, Padbury, Cameron, & Makuuchi 
2009;Dindo, Demartines, & Clavien 2004;Pillai, van Rij, Williams, Thomson, 
Putterill, & Greig 1999;Pomposelli, Gupta, Zacharoulis, Landa, Miller, & Nanda 
1997;Slankamenac et al. 2013;Strasberg, Linehan, & Hawkins 2009), to our 
knowledge there is still no such classification specifically addressing intraoperative 
complications. To date, reporting of intraoperative complications in the literature is 
frequently either not present at all or intraoperative complications are pooled with 
postoperative complications (Tou et al. 2011). If intraoperative complications are 
reported separately, they tend to be ill-defined or only roughly classified according 
to severity (Morino et al. 2005), for example as „minor“ versus „major“, lacking 
exact classification criteria and/or classified according to the injured organ (e.g. 
vascular, visceral, solid organ injury) without accounting for different degrees of 
severity (Ahmad et al. 2012). A classification system of intraoperative 
complications is of particular interest and increasing importance in studies 
evaluating new surgical techniques and devices. It would allow for better 
transparency and more objective comparison between different surgical 
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techniques and their outcomes. Such a system would inform a more differentiated 
judgment of the evidence and provide a better rationale for more individualized 
decision-making in surgery. Additionally, standardization allows more adequate 
outcome reporting in educational and training settings (individual surgeon’s 
outcome) and in institution benchmarking (institution outcome).  
The aim of the proposed research is to systematically assess the current practice 
of reporting intra- and postoperative adverse events in randomized controlled trials 
published during one year in three major general surgery journals. This is of 
relevance to the subsequent development of a classification system for 
intraoperative complications.  
5.2. Methods 
Included studies 
This is a secondary analysis of a review investigating discrepancies between 
registry entries and final reports in three general (non-speciality) surgical journals 
(Rosenthal & Dwan 2013). The journals with the highest 2010 impact factor under 
the category “surgery”, the Annals of Surgery, Archives of Surgery, today JAMA 
Surgery and British Journal of Surgery were screened for all RCTs published 
between 01.01.2010 and 31.12.2010. Preclinical studies, duplicate publications, 
secondary analyses, interim reports and trials with lacking trial registry information 
(since in the primary review registry entries were compared to final reports) were 
excluded.  
For the current investigation, trials not involving surgery or invasive treatments (be 
it as study intervention or not), such as trials investigating drug treatment unrelated 
to surgical or invasive interventions or trials evaluating the informed consent 
process, were excluded. Invasive interventions were defined as interventions 
requiring either percutaneous access (such as radiofrequency ablation of liver 
metastases) or access through natural orifices (such as endoscopic retrograde 
cholangio-pancreatography, but not natural orifice transluminal endoscopic 
surgery). The study intervention was defined as perioperative, if surgery was part 
of the study, but the intervention in itself was not, such as peri- or intraoperative 
administration of a drug, nutrition, bowel preparation, or transplant organ 
preparation.   
Data extraction 
The three Journals were screened for RCTs and data concerning the study 
population, interventions and outcomes were extracted as previously described 
(Rosenthal & Dwan 2013). The reviewers were not blinded for the names of the 
authors and journals of the evaluated RCTs. In the current investigation, two 
reviewers (RR and HH) independently additionally retrieved the following 
information concerning adverse events: whether the occurrence of adverse events 
was reported (or whether there was a statement that none occurred), whether 
adverse events were the primary outcome, whether both 
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intraoperative/intrainterventional and postoperative/postinterventional adverse 
events were reported and if yes, separately or not. Moreover, the reviewers 
assessed, whether a definition of adverse events was given in the methods 
section, whether a classification system was used and if yes, according to which 
specifier the events were classified. Adverse events were considered “reported” if 
any deviation from the normal intra- or postoperative/-interventional course 
(excluding sequelae and failures of cure) was reported or if it was reported that no 
such events occurred. Conversion, such as from laparoscopy to open surgery in 
itself was not considered as complication (i.e. it could be due to extensive tumour 
burden or adhesions), but in case of conversion due to complications (e.g. 
bleeding), the event was considered as complication. Adverse events were 
classified as “intraoperative”, if they were reported to occur during the surgical or 
invasive intervention or “postoperative”, if they were reported to occur after the 
intervention.  
Complications were considered as “completely defined” if either an exact definition 
was provided such as for postoperative complications “any deviation from the 
normal postoperative course excluding sequelae and failures of cure” (Dindo, 
Demartines, & Clavien 2004) or if a complete list of events considered as 
complications was provided. Complications were considered as “not completely 
defined” if examples, but not a complete list, of events considered as 
complications were provided. If in the methods section it was mentioned that 
complications or the postoperative course were recorded without any further 
elaboration or if complications were listed in the results section only and not 
mentioned in the methods, complications were considered as “not defined”.  
Complications were considered as “classified”, if some type of classification was 
used such as according to severity or according to affected organ, regardless as to 
whether the classification had previously been validated and as “not classified” if 
they were individually listed. Discrepancies between the two reviewers were 
resolved by discussion and agreement. For data extraction, an Excel spreadsheet 
(Microsoft Office XP, Microsoft Corporation, Redmond, WA, USA) was used.  
Statistical Analysis  
Descriptive statistics were used to present the proportions of trials with definition of 
intraoperative and postoperative complications and with information concerning 
grading systems, if applicable. In an explorative analysis, i) trials with surgical 
procedures in at least one study arm as the primary study intervention versus 
those with invasive interventions or perioperative interventions as study 
intervention and ii) trials with adverse events being the primary outcome and those 
with other types of primary outcomes were compared concerning definition of 
intra- and postoperative adverse events. For the comparisons, Fisher’s exact test 
was used. The comparisons were posthoc analyses explorative in nature without 
any correction for multiple testing. Analyses were conducted using Intercooled 
Stata Version 12.1; StataCorp LP, College Station, Texas, USA.  
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5.3. Results 
Characteristics of included studies 
The flow of screened and included studies has been previously described 
(Rosenthal & Dwan 2013). In brief, out of 596 studies identified through the search 
of the three journals, 65 were retrieved in full text, while the remaining studies 
were not RCTs and excluded. Out of these, a further 14 trials were excluded as 
they were interim reports (n=1), secondary analyses (n=5), not an RCT in contrast 
to the information provided in the heading or abstract (n=4), not registered RCTs 
(author information) (n=2) or with no registration information (n=2). Therefore, 51 
studies were included (n=21 Annals of Surgery, n= 4 Archives of Surgery and 
n=26 British Journal of Surgery) (Rosenthal & Dwan 2013). The references of 
these 51 studies are given in the Appendix References R1. For the current 
investigation, two studies investigating the informed consent process (Online only 
reference 10*, 24*) and three studies evaluating medical treatment options without 
any related surgical or invasive intervention, (Online only reference 43*, 45*, 48*) 
were additionally excluded, leaving a total of 46 studies for this review. Out of 
these, 20 studies (43%) included surgery, five studies (11%) an invasive 
intervention and four studies (9%) both surgery and an invasive intervention. In 17 
studies (37%), the study intervention consisted of perioperative interventions, but 
surgery was part of the study.  
The baseline characteristics of all 46 studies with details on the population, the 
intervention, control, primary outcome and result are presented in the Appendix 
Tables, Table S4.   
Intraoperative and postoperative adverse event reporting 
All 46 studies included some kind of adverse event reporting. The primary 
outcome was unrelated to adverse events in 67% (n=31), whereas the primary 
outcome was defined as the occurrence of any kind of adverse event in 33% 
(n=15). Out of the latter, the adverse event related to postoperative complications 
in 14 studies, to intraoperative complications in none of the studies and to adverse 
events unrelated to surgery in one study.  
Intraoperative complications were reported separately from postoperative 
complications in 42% (n=19) and pooled in 15% (n=7), whereas in 37% (n=17) 
intraoperative, in 2% (n=1) postoperative and in 4% (n=2) both intra- and 
postoperative complications were not reported at all. 
Intraoperative and postoperative complications were completely defined in 13% 
(n=6) and 50% (n=23), respectively; they were not completely defined in 4% (n=2) 
and 2% (n=1), respectively; and in 44% (n=20) and 41% (n=19), respectively, they 
were not defined at all. A classification was used in 9% (n=4) for intraoperative and 
in 54% (n=25) for postoperative complications, most frequently according to 
severity (intraoperative complications: 3 out of 4, postoperative complications: 21 
62 
 
   
 
out of 25, table 15).  Details on definition, classification and occurrence of 
intraoperative and postoperative adverse events of the individual studies are 
presented in the Appendix Table S5. Out of the 21 studies grading postoperative 
complications according to severity, 7 used the generic classification of 
postoperative complications according to severity by Clavien et al., taking into 
account the resulting type of complication management, e.g. the possibility of 
spontaneous resolution versus bedside procedure versus invasive procedure 
(Appendix Table S6) (Dindo, Demartines, & Clavien 2004). One study referenced 
the generic classification used at the Memorial Sloan-Kettering Cancer Center 
(Martin et al. 2002b). Six studies used complication-specific classifications: Three 
studies graded surgical site infections according to the definitions of the Centers 
for Disease Control and Prevention (Appendix Table S7) (Horan et al. 
1992;Mangram et al. 1999b), one according to the ASEPSIS score (Wilson et al. 
1986) , one study graded complications after pancreatic surgery according to 
study group definitions (Bassi et al. 2005;Wente et al. 2007a;Wente et al. 2007b), 
and one graded bleeding according to criteria defined in a randomized controlled 
trial (Fox et al. 2004). The remaining 7 studies used own definitions or did not 
provide any reference, respectively. As for the 3 studies grading intraoperative 
complications according to severity, one used the classification according to 
Clavien et al. (Dindo, Demartines, & Clavien 2004), one derived the classification 
from a previous trial and one used an own definition.   
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Table 15: Definitions and classification of intra- and postoperative adverse events 
(n=46) 
  Period 
 
  Intraoperative  Postoperative 
 
    n (%)   n (%) 
 
Definition Complete definition    6 (13%) 23 (50%) 
No complete definition   2 (  4%)   1 (  2%) 
No definition 20 (44%) 19 (41%) 
No reporting of intra- respectively 
postoperative adverse events 
18 (39%)   3 (  7%) 
Classification Yes   4 (  9%) 25 (54%) 
No 24 (52%) 18 (39%) 
No reporting of intra- respectively 
postoperative adverse events 
18 (39%)   3 (  7%) 
Type of 
classification 
Severity   3 (  7%) 21 (45%) 
Organ   1 (  2%)   4 (  9%) 
No classification 24 (52%) 18 (39%) 
No reporting of intra- respectively 
postoperative adverse events 
18 (39%)   3 (  7%) 
 
Comparison of trials with surgical interventions versus those with invasive or 
perioperative interventions  
Three trials (all without surgery as primary study intervention) did not report 
postoperative adverse events and were therefore excluded. In the remaining trials, 
46% (11/24) provided any type of definition of postoperative adverse events in 
trials with surgery as study intervention versus 68% (n=13/19) in trials without 
surgery as study intervention (p=0.217). 
Eighteen trials (3 with and 15 without surgery as primary study intervention) did 
not report intraoperative adverse events and were therefore excluded. In the 
remaining trials, 18% (2/11) provided any type of definition of intraoperative 
complications in trials with surgical interventions versus 35% (6/17) in trials without 
surgical interventions (p=0.419). 
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Comparison of trials with the primary outcome being adverse events versus not 
Three trials did not report postoperative adverse events (1 with and 2 without a 
primary outcome for adverse events) and were therefore excluded. In the 
remaining trials, 71% (n=10/14) provided any type of definition of postoperative 
adverse events in trials where an adverse event was the primary outcome versus 
48% (n=14/29) in trials with other types of primary outcomes (p=0.199). 
Eighteen trials did not report intraoperative adverse events (7 with and 11 without 
a primary outcome for adverse events) and were therefore excluded. In the 
remaining trials, 25% (n=2/8) provided any type of definition of intraoperative 
adverse events in trials where an adverse event was the primary outcome versus 
30% (6/20) in trials with other types of primary outcomes (p=1.000).  
5.4. Discussion 
This review of publications in three major surgical journals shows that 
intraoperative complications are rarely reported or they are subsumed with 
postoperative complications. If intraoperative complications are reported, they 
mostly lack a definition. This is in contrast to postoperative complications, for 
which about half of the studies provide these details. The type of study intervention 
or whether the primary outcome was an adverse event did not significantly impact 
on these results.  
Relation to other studies  
To our knowledge, this is the first review assessing the quality of reporting adverse 
events in surgery with a specific focus on intraoperative complications. The 
assessment of technical errors, mostly in the context of surgeon training and 
safety evaluation, has however been previously investigated. As pointed out in the 
presidential address of the European Surgical Association by Clavien, targeting 
safety and quality in surgery including standardization of outcome measures is of 
utmost importance (Clavien 2013). In a review of studies describing technical 
errors during laparoscopy, Bonrath et al. found 8 out of 21 studies investigating 
surgical performance in terms of errors during routine laparoscopic 
cholecystectomy, whereas in the remaining 13 studies, errors were evaluated as a 
surrogate for surgical skills in an educational context (Bonrath et al. 2013a). Error 
definitions were found to vary considerably and hamper a direct comparison 
(Bonrath, Dedy, Zevin, & Grantcharov 2013a).  
Several studies have investigated the reporting of postoperative surgical 
complications. A systematic review of the definition of anastomotic leak in 
gastrointestinal surgery based on 97 studies revealed 56 different definitions of 
anastomotic leak (Bruce et al. 2001a). None of the studies used the standard 
definition for anastomotic leak that had previously been proposed at a consensus 
workshop (Peel and Taylor 1991). Similarly, a systematic review of 90 studies on 
definitions of surgical wound infection revealed 41 different definitions. Of these, 5 
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may be considered as “standard” definitions based on work by multidisciplinary 
groups (Bruce et al. 2001c). Another review on the quality of surgery-related 
mortality reporting revealed considerable differences in follow-up time and post-
discharge mortality was rarely taken into account (Russell et al. 2003).   
Thus, surgery-related complications and relevant outcomes in surgery lack 
standard definitions and therefore do not allow for comparison across studies and 
between surgical disciplines. However, this problem is not only related to surgery. 
Adverse event reporting in drug trials is also often lacking appropriate information 
about drug discontinuation, and adequate reporting on toxicity and severity of 
adverse events (Ioannidis and Contopoulos-Ioannidis 1998;Ioannidis and Lau 
2001).   
Definition and classification of surgical complications 
Surgical complications are not uniformly defined. One option is to define surgical 
complications as “any undesirable, unintended, and direct result of an operation 
affecting the patient, which would not have occurred had the operation gone as 
well as could reasonably be hoped“ (Sokol and Wilson 2008). This definition thus 
may apply to intra- and postoperative complications, but has been controversially 
discussed, because it may not always be possible to establish or rule out whether 
there is a causal relationship between surgery and the undesirable result. 
Moreover, not all undesirable results are complications, but they may as well be 
inherent to the intervention or related to the severity of the underlying disease 
(Dindo and Clavien 2008). Thus, complications may be defined as “any deviation 
from the normal postoperative course” (Dindo, Demartines, & Clavien 2004) and 
are distinguished from inherent effects of surgery (sequelae, such as the inability 
to walk after an amputation of a leg) or failures to cure (such as residual tumor 
after surgery) (Clavien, Sanabria, & Strasberg 1992). This definition, however, is 
limited to postoperative complications. In a five-year follow-up of the classification 
by Clavien et al., it was discussed to capture death during surgery or to “record as 
complication all events occurring in the operating room from the time of 
preparation for anesthesia” (Clavien, Barkun, de Oliveira, Vauthey, Dindo, 
Schulick, de, Pekolj, Slankamenac, Bassi, Graf, Vonlanthen, Padbury, Cameron, & 
Makuuchi 2009). 
The need for a classification system of intraoperative complications 
The need for an intraoperative classification of complication is subject to debate.  
Cunningham and Kavic (Cunningham and Kavic 2009) correctly point out that the 
definition of complications as deviation from the normal postoperative course 
(Clavien, Sanabria, & Strasberg 1992;Dindo, Demartines, & Clavien 2004) does 
not capture intraoperative events that do not directly result in clinically relevant 
postoperative complications. They proposed to monitor any “deviation from the 
ideal operative course” and to distinguish between “simple errors” (adverse 
intraoperative events not leading to postoperative manifestations or additional risk 
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for postoperative complications, e.g. burn to the lateral parietal peritoneum), and 
“complications” with potential risk for postoperative complications (e.g. inadvertent, 
but treated enterotomy or splenic injury) (Cunningham & Kavic 2009). The concept 
was questioned by Wilson and Sokol (Wilson and Sokol 2009). They argue that 
intraoperative complications which do result in a postoperative complication are 
anyhow captured as surgical complications, whereas the others theoretically add 
information, but may complicate monitoring concepts. The authors propose to refer 
in such cases to “intraoperative errors”, which of course need to be avoided.  
Conversely, the documentation of intraoperative events may be especially 
important when new surgical techniques are introduced. In studies investigating 
new surgical procedures, the event rate of postoperative complications resulting 
from intraoperative complications may not be high enough to be captured with 
sample sizes resulting from calculations for efficacy outcomes. In contrast, 
documentation of intraoperative adverse events should prompt more extensive 
safety evaluation before wide application. The Global Harmonisation Task Force 
on Medical Devices (GHTF, see International Medical Device Regulators Forum 
IMDRF, www.imdrf.org) has provided guidance to standardize the reporting of 
adverse events and device failures (Mehran et al. 2004). In their guidelines, the 
GHTF study group distinguishes death, serious injury and events potentially 
leading to death or serious injuries, for instance if they occurred again (Lalis G for 
the Global Harmonization Task Force Study Group 2 2006). This concept is in line 
with a safety culture not limited to investigating actual patient injury in order to 
prevent reoccurrence of such an injury. Instead, such a concept also addresses 
critical incidents without actual patient injury and evaluates why such critical 
incidents and errors occur (Kram 2008;Leape 1994;Reason 2000). This is in 
accordance with the assumption that adverse events may arise from a build-up of 
several minor errors (Catchpole 2010). As a matter of fact, an error-outcome 
hierarchy may be described with the option of being uneventful on every hierarchy 
level (Bonrath, Dedy, Zevin, & Grantcharov 2013a;Bonrath et al. 2013b). Starting 
with an error, such as inserting a trocar without visualization, a technical event 
may or may not occur, such as an enteric injury. This injury may or may not be 
detected and rectified leading or not to a postoperative complication such as an 
enteric leak. The latter in turn may or may not be detected and managed and 
finally may or may not end up in an adverse outcome such as sepsis or death 
(Bonrath, Zevin, Dedy, & Grantcharov 2013b).  
Additionally, some complications are just not captured when focussing on the 
immediate postoperative phase only, because the consequences are only evident 
at long-term or immediately and definitively treated during surgery, for instance 
haemorrhage with intraoperative blood transfusion only.  
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Limitations 
Our study presents some limitations. First, all RCTs published in three major 
surgical journals except those with strictly medical or informed consent process-
interventions were considered for review. Therefore, some of the interventions 
were not involving surgery only, but as well invasive or perioperative interventions. 
We addressed this issue by evaluating in an exploratory analysis the impact of 
studies including surgery as primary study intervention (yes versus no) on 
complication reporting. Results from three journals may not be extrapolated to all 
surgical journals. We focused on three high-impact journals with endorsed 
CONSORT reporting guidelines policy and it is therefore unlikely that an 
investigation in other surgical journals would yield a lower frequencies of lacking 
definition and classification of intra- and postoperative adverse. Second, reviewers 
were not blinded regarding authors and journals of the published RCTs. However 
data abstraction was done by two independent reviewers who used a standardized 
objective extraction protocol. We consider the lack of blinded data abstraction as a 
minor risk of bias (Morissette et al. 2011).  
Implications for daily practice and further research 
Reports on adverse events from surgical interventions often do not use uniform 
definitions for adverse events or do not distinguish between intra- and 
postoperative complications and therefore have to be scrutinized. For these 
reasons, we plan to develop and validate a simple and reproducible classification 
for intraoperative complications, similar to the existing classifications of 
postoperative adverse events (Clavien, Sanabria, & Strasberg 1992;Clavien, 
Barkun, de Oliveira, Vauthey, Dindo, Schulick, de, Pekolj, Slankamenac, Bassi, 
Graf, Vonlanthen, Padbury, Cameron, & Makuuchi 2009;Dindo, Demartines, & 
Clavien 2004;Pillai, van Rij, Williams, Thomson, Putterill, & Greig 
1999;Pomposelli, Gupta, Zacharoulis, Landa, Miller, & Nanda 1997;Strasberg, 
Linehan, & Hawkins 2009).  
The ultimate goal will be to propose a definition and classification of intraoperative 
complications that can be used for standardized outcome data collection. 
Therewith, a core outcome set that may be used as reporting guideline for trials 
involving surgical procedures may be developed. This is in line with the COMET 
initiative (Core Outcome Measures in Effectiveness Trials, www.comet-
initiative.org) with the goal to develop reporting standards that allow for 
comparisons across studies, health care providers and patients (Williamson et al. 
2012).   
Conclusions 
There is a lack of universal reporting of adverse events in surgery. This 
compromises the comparison of reports on intra- and postoperative complications 
in surgical innovation and clinical research as well as continuous quality 
assessment and benchmarking. Several straightforward postoperative 
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complications classifications have been developed and validated, but 
intraoperative complications are frequently not reported, ill-defined or pooled with 
postoperative complications. A clear distinction and classification of intraoperative 
complications is therefore needed to capture intraoperative events that eventually 
result in postoperative complications or increase the risk for such complications. 
This would also allow standardizing critical incident reporting systems that may be 
needed for quality control, trainee assessments or evaluation of surgeons’ 
performance.   
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Abstract 
Background: Standardized reporting of intraoperative adverse events is important 
to enhance transparency. To the best of our knowledge, there is no validated 
definition and classification of intraoperative complications.  
Study Design: We conducted a two-round Delphi study to develop a definition 
and classification of intraoperative complications. Experts were contacted by email 
and sent a link to the online questionnaire. In a pilot study, 2 independent raters 
applied the definition and classification in a sample of 60 surgical interventions of 
low, intermediate and high complexity, and evaluated practicability. Interrater 
agreement of the classification was determined (raw categorical agreement, 
weighted kappa and intraclass correlation).  
Results: In the Delphi study, 40 of 52 experts (77% return rate) from 14 countries 
took part in each round. The Delphi study resulted in a comprehensive definition of 
intraoperative complications as any deviation from the ideal intraoperative course 
occurring between skin incision and skin closure and a straightforward 
classification with four severity grades. A number of specifiers were elaborated for 
further distinction of the definition. The pilot study showed good practicability (6 on 
a 7-point scale) and a high raw agreement of 87%, a weighted kappa of 0.83 (95% 
confidence interval [CI] 0.73, 0.94) and an intraclass correlation coefficient of 0.83 
(95% CI 0.73, 0.90). 
Conclusions: While the Delphi process enabled to develop definitions and 
classification of intraoperative complications by severity, further research including 
a multicentre international full-scale validation needs to be conducted with the 
ultimate goal to contribute to standardized reporting in surgical practice and 
research.  
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6.1. Introduction 
Reporting of surgical outcomes is important for informed decision making. This not 
only includes efficacy parameters, but also the reporting of adverse events, i.e. 
intra- and postoperative complications. For postoperative complications, several 
definitions and classification systems have been proposed (Clavien, Sanabria, & 
Strasberg 1992;Clavien, Barkun, de Oliveira, Vauthey, Dindo, Schulick, de, Pekolj, 
Slankamenac, Bassi, Graf, Vonlanthen, Padbury, Cameron, & Makuuchi 
2009;Dindo, Demartines, & Clavien 2004;Pillai, van Rij, Williams, Thomson, 
Putterill, & Greig 1999;Pomposelli, Gupta, Zacharoulis, Landa, Miller, & Nanda 
1997;Strasberg, Linehan, & Hawkins 2009), whereas we are not aware of any 
reporting system addressing intraoperative complications.  
In our opinion, standardization of the definition and classification of intraoperative 
complications is important in a number of settings: first, in research and 
development, when assessing new surgical techniques and devices; second, in 
educational and training settings (individual surgeon’s performance) and in 
institution benchmarking (institution performance); third, for risk management, 
capturing intraoperative events with an increased risk of postoperative 
complications within a critical incidents reporting system (Kram 2008;Leape 
1994;Reason 2000) or in clinical research where postoperative event rates may be 
too low to capture potential safety concerns; and last for patient management, 
enhancing quality of patient handover after surgery with anticipated postoperative 
problems (Manser et al. 2013;Nagpal et al. 2011). 
A preliminary investigation of the current practice of reporting intra- and 
postoperative complications in a cohort of 46 randomized-controlled trials 
published in 2010 in the Annals of Surgery, JAMA Surgery and the BJS revealed 
that 41% of the trials failed to report intraoperative complications at all (submitted 
for publication). Only 13% provided a definition of and 9% used a classification for 
intraoperative complications.  
The aim of the present study is to develop a definition and classification for 
intraoperative complications within a Delphi study and to conduct a pilot study 
evaluating practicability and interrater agreement. 
 
6.2. Methods 
1. Delphi study 
Participants 
International experts with a surgical or methodological background were invited to 
participate in the Delphi study. Prerequisite was board-certification in surgery for at 
least 2 years or a higher academic degree (MSc/PhD) in trial methodology with 
experience in trial design for at least 2 years. Different subspecialty surgeons were 
invited to participate with the intention to develop a classification applicable to any 
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surgical subspecialty. Experts were recruited through personal contacts and 
surgical associations with the goal to get a representative sample of different 
expertise and location of practice across the world.   
Questionnaire dissemination 
This Delphi study consisted of two rounds (February 21 to March 09, 2014 and 
March 26 to April 03, 2014). The questionnaires were prepared using 
SurveyMonkey® (www.surveymonkey. com). The experts were sent a link to the 
online questionnaire by email. The anonymous responses were downloaded as 
Excel spreadsheet (Microsoft Office XP, Microsoft Corporation, Redmond, WA, 
USA). One email reminder per round was sent out before the end of the deadline 
to all experts regardless whether they had answered or not, the anonymous 
process not allowing for differentiation between responders and non-responders. 
Content first round  
Since there is abundant literature on the classification of postoperative 
complications, we refrained from a first round with open questions, as suggested 
in such instances (Hsu and Sandford 2013). 
Participants were provided with some background information about surgical 
complications and were asked to answer baseline demographics and background 
questions. They were then invited to indicate their level of agreement on a 9-point 
rating scale with the inclusion of a number of items concerning the definition and 
classification of intraoperative complications. We chose a 9-point scale because of 
the known limit in accuracy of raters to give an absolute judgment. This span is  
about seven (MILLER 1956); we rounded up to nine in order to account for a 
potential end-aversion bias (i.e. have two extra categories to address the tendency 
to avoid extreme categories). Scales with too low numbers of items, such as two-, 
three- and four-point scales have been found to show poor reliability, validity and 
discriminating power (Preston and Colman 2000). Raters could not move on with 
the questionnaire without having rated every item. Additionally, experts were 
strongly encouraged to comment on any of the items.  
Data analysis first round 
Descriptive statistics including graphs were used to analyse quantitative data. All 
statistical analyses of the present research were conducted using Intercooled 
Stata Version 12.1; StataCorp LP, College Station, Texas, USA. Comments 
(qualitative data) were summarized within a narrative review. Since the 
questionnaire prompted extensive comments and a fruitful extensive discussion, 
the manuscript only contains the main findings. To enhance transparency and to 
allow for a detailed insight in the iterative discussion, the entire Delphi report is 
included in two online-only appendices. 
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Content second round  
The quantitative and qualitative results of the first round were presented to the 
participants and, where applicable the questions concerning the proposed 
definition and classification were updated accordingly.  
Data analysis second round 
Data were analysed as outlined for the first round. Since sufficient consensus was 
obtained after two rounds, no third round was conducted.  
2. Pilot study 
Surgical interventions 
The pilot study was conducted in a retrospective cohort of patients operated 
between 01.01.2013 and 31.12.2013 in a tertiary referral and teaching hospital. A 
random sample of 60 records of patients having undergone surgeries of different 
complexity (20 type A, 20 type B and 20 type C) was selected. Type A, B and C 
surgery was defined according to previous investigations (Dindo, Demartines, & 
Clavien 2004;Klotz et al. 1996). In brief, type A surgery includes surgical 
procedures without opening the abdominal cavity. Type B surgery includes 
abdominal procedures with the exception of liver surgery and major retroperitoneal 
surgery. Type C surgeries include highly specialized procedures such as surgery 
on the liver, oesophagus, pancreas and rectum. The scheme for the selection of a 
random sample from individual records was generated with the use of the web 
page Randomization.com (http://www.randomization.com). 
Classification 
Two investigators (RR and HH), both board-certified surgeons, independently 
applied the definition and classification resulting from the Delphi process based on 
the information given in the operation records. Additionally, postoperative 
complications were classified according to Clavien and Dindo (Dindo, Demartines, 
& Clavien 2004) based on the entire patient record including the discharge letter. 
Disagreements were resolved by consensus.  
Practicability 
We evaluated practicability on a seven-point scale.  
Data analysis 
Agreement between the judgment of the two raters (before resolving 
disagreements) was evaluated investigating raw categorical agreement (number of 
exact categorical matches between two raters divided by the total number of 
records) (Streiner 1995), kappa with Fleiss-Cohen (quadratic) weights (Fleiss and 
Cohen 1973;Warrens 2011) and intraclass correlation (Shrout and Fleiss 1979). 
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6.3. Results 
1. Delphi study 
Participants 
The link to the questionnaire was sent out to 52 experts, of whom 40 answered 
within the given deadline in both rounds (77% return rate). In Delphi round 1, one 
participant submitted an incomplete questionnaire containing only baseline 
characteristics as well as a judgment concerning the overall usefulness of a 
classification. Two additional contacted experts returned the questionnaire after 
the given deadline and therefore their answers could not be included in the 
feedback to round 2 and the pilot evaluation, respectively (81% [42/52] return rate 
in total). Experts from 14 countries in the US, Europe, Asia and Australia from a 
large variety of surgical disciplines (n=37) as also experts in epidemiology and 
statistics (n=3) took part in the study. Their median work experience was 25 years 
with an interquartile range [IQR] from 12 to 29 years (Table 16). 
Results first round 
The full report with a workup of all quantitative and qualitative data is given in 
Appendix Text S1. The overall usefulness of a classification of intraoperative 
complications was rated as high (Figure 3).   
Definition of intraoperative complications 
Experts mostly agreed to distinguish intraoperative complications from sequelae, 
i.e. effects inherent to the surgery (such as the inability to walk after an amputation 
of a leg), from failures of cure (such as residual tumor after surgery) (Clavien, 
Sanabria, & Strasberg 1992) and from events related to the underlying disease 
(such as bleeding from a ruptured abdominal aortic aneurysm). As prerequisite, 
experts further suggested adding to the definition and classification that the 
indication for surgery and the interventions has to conform to current guidelines. 
Additionally, experts pointed out that complications should refer to the index 
surgery, not to potential follow-up surgeries to treat a complication. Experts 
discussed controversially whether errors in indication should be included in the 
definition or not. The discussion of the exact wording for the definition, for example 
‘any deviation from the ideal intraoperative course’ remained inconclusive after the 
first round, it was however suggested to only consider events that are preventable. 
The time-period to be taken into consideration was also controversially discussed: 
while some felt that only surgery (i.e. time between skin incision and skin closure) 
should be included, others were more in favor of including induction and 
termination of anesthesia, thus focussing on the entire team and not the individual 
surgeon.  
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Table 16: Baseline characteristics1 of participants in the Delphi study (n=40) 
Characteristic Category Value 
   
Primary discipline, n (%) Surgery 37 (92.5%) 
Public health/epidemiology 2 (5.0%) 
Statistics 1 (2.5%) 
Primary subspecialty, n (%) Breast surgery 1 (2.5%) 
Cardiac surgery 1 (2.5%) 
Colorectal surgery 3 (7.5%) 
Neurosurgery 1 (2.5%) 
Orthopedic surgery 4 (10%) 
Pediatric surgery 2 (5.0%) 
Plastic and reconstructive surgery 1 (2.5%) 
Surgical oncology 1 (2.5%) 
Thoracic surgery 2 (5.0%) 
Traumatology 1 (2.5%) 
Urology 1 (2.5%) 
Vascular surgery 2 (5.0%) 
Visceral surgery 14 (35%) 
Other surgical specialty 3 (7.5%) 
Epidemiology 2 (5.0%) 
Statistics 1 (2.5%) 
Country, n (%) Switzerland 23 (57.5%) 
Germany 1 (2.5%) 
Austria 2 (5.0%) 
Netherlands 1 (2.5%) 
Ireland 1 (2.5%) 
United Kingdom 3 (7.5%) 
France 2 (5.0%) 
Italy 1 (2.5%) 
Spain 1 (2.5%) 
Turkey 1 (2.5%) 
USA 1 (2.5%) 
Singapore 1 (2.5%) 
Hongkong 1 (2.5%) 
Australia 1 (2.5%) 
Involved in clinical research as 
(several options applicable), n (%) 
Principal investigator 37 (92.5%) 
Co-investigator 35 (87.5%) 
Biostatistician 2 (5.0%) 
Years of overall work experience, median (IQR2) 25 (12, 29) 
Years of surgical work experience, median (IQR)3 24 (12, 29) 
Years of clinical research experience, median (IQR) 20 (8, 24) 
Gender, n (%) Male 36 (90%) 
Female 4 (10%) 
 
 
1 Assessed in round 1 
2 IQR=Interquartile range 
3 n=3 with primary non-surgical discipline excluded 
76 
 
                                                            
   
 
 
Figure 3: Delphi study round 1: Answers to the question concerning overall 
usefulness of a classification of intraoperative complications (1=not useful at 
all, 9=very useful) 
 
 
 
 
Classification of intraoperative complications 
The experts were in favor of considering the severity of complications in the 
classification system. Experts extensively discussed which time-period should be 
considered when filling in the classification, i.e. whether it should be filled in 
directly after surgery or whether it should be updated during follow-up, such as 
after 30 days, since some complications do not become evident until after surgery. 
It was argued that in an update during follow-up it would be difficult to distinguish 
an intraoperative complication becoming evident after surgery from a 
postoperative complication, since it may be difficult to establish a definitive causal 
relationship between the intervention and the complication. Next, a draft of a 
classification with five grades, one of which with two subgrades, was discussed 
with several examples. The majority of the experts felt that the classification 
should be simplified further.  
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Results second round 
The full report with a workup of all quantitative and qualitative data is given in 
Appendix Text S2. 
Definition of intraoperative complications 
Experts were in favor of the updated definition, which distinguishes intraoperative 
complications from sequelae, failure to cure, and disease-inherent events and is 
related to best praxis indication and surgery of the index procedure. The distinction 
from wrong-side or wrong-patient surgery and errors in indication was not 
uniformly accepted (Figure 4). For practicability reasons and in order not to 
underestimate errors in indication and wrong-side/wrong-patient surgery, we 
decided to exclude these items. Based on the feedback from round 1 we decided 
to change our wording to ‘preventable deviation from the ideal course’, but experts 
gave us mixed feedback and we decided to stay with the former wording and to 
drop the term ‘preventable’. Experts seemed to be rather in favor of only including 
the time between skin incision and closure, and to record any event during that 
period, be it surgical or not (e.g. anesthesia-related). As for the number of raters, 
there was no uniform opinion. Although having two raters seemed favourable to 
most, provided they were really independent, it was judged not to be very practical 
having more than one rater, especially in clinical practice. In a research setting, it 
might however be important to have complications rated by more than one 
reviewer. We therefore suggest including in the study report a statement on how 
many raters were involved and whether or not they themselves were involved in 
the surgical procedure and in the case of multiple raters, how consensus was 
reached.   
Classification of intraoperative complications 
Experts mostly were in favor of grading complications according to severity and 
also of grading immediately after surgery. The reasons were practicability and the 
distinction from classifications of postoperative complications (Figure 5). 
Additionally, it was proposed to consider the option of a classification not based on 
the actual outcome, but on the potential outcome, thus avoiding the 
underestimation of severe complications. This could be handled by including the 
term ‘potentially’ (i.e. ‘potentially life-threatening’ or ‘potentially leading to 
permanent disability), with the disadvantage however of leaving quite a range for 
interpretation. Within the pilot study, we decided to test the option of filling in the 
classification immediately after surgery (i.e. in a retrospective study considering 
only the operation report for classification). Some experts suggested dichotomizing 
the severity grading of complications, but we decided to keep the originally 
proposed classification with four levels. If it is still used for investigating minor 
versus major complications, both results from the original classification and the 
contracted classification should be reported providing a clear definition for the cut-
off. 
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Figure 4: Delphi study round 2: Answers to the questions concerning the 
distinction of intraoperative complications from sequelae, failure to cure, 
events related to the underlying disease and error in indication:  
Based on these answers of round 1, we kindly ask you to rate the following 
updated definition (1= not at all appropriate, 9 = completely appropriate): 
Sequelae: A definition of intraoperative complications needs to distinguish 
complications from sequelae, i.e. effects inherent to current best practice surgery 
(such as the inability to walk after amputation of a leg). It should refer to the index 
surgery and not to potential follow-up surgeries to treat a complication. 
Failure to cure: A definition of intraoperative complications needs to distinguish 
complications from failures of cure (such as residual tumor after surgery), under 
the condition the indication for surgery and the interventions conform to current 
guidelines.  
Disease: A definition of intraoperative complications needs to distinguish 
complications from events related to the underlying disease (such as bleeding 
from a ruptured abdominal aortic aneurysm or intraoperative sepsis due to a 
purulent peritonitis associated to a perforated appendicitis), under the condition 
the indication for surgery and the interventions conform to current guidelines.  
Indication error: A definition of intraoperative complications should NOT refer to 
wrong-site or wrong-patient surgery and NOT to errors in indication (such as 
inappropriate indication for surgery according to current guidelines) 
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Figure 5: Delphi study round 2: Answers to the questions concerning type of 
grading, classification overall, timepoint of grading, dichotomisation:  
We kindly ask you to rate the following (1= not at all appropriate, 9 = completely 
appropriate): 
Graded according to severity: A classification of intraoperative complications 
should consider the severity of the complication and take into account both the 
necessary treatment and permanent sequelae resulting from the complication. 
Immediately after surgery: Should it be possible to definitively fill in a classification 
of intraoperative complications directly after surgery, whereas complications 
apparent only after surgery are handled with a classification system for 
postoperative complications? 
Classification overall: We kindly ask you to rate the updated classification: 
Prerequisite for all grades: under the condition the indication for surgery and the 
interventions conform to current guidelines. Grade 0: no preventable deviation (an 
unpreventable deviation could be for instance a deviation due to an unexpected 
anatomical situation); grade 1 preventable deviation from the ideal intraoperative 
course without the need for any additional treatment or intervention; grade 2 and 3 
with the need for any additional treatment or intervention, grade 3 if life-threatening 
and/or leading to permanent disability, else grade 2; grade 4 with patient death.  
Minor/major complications: Should complications needed to be dichotomised for 
further analysis (which we not necessarily advocate), we propose to summarize 
grades I-II together as “minor complications” versus grades III-IV as “major 
complications”. 
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Resulting definition and classification 
The Delphi study provided the following definition and classification of 
intraoperative complications (Table 17): Any deviation from the ideal intraoperative 
course, given the indication for surgery and the interventions conform to current 
guidelines. The classification exclusively relates to any event occurring between 
skin incision and skin closure, and should be rated directly after surgery. Any 
event during the index-surgery must be considered, regardless whether it is 
surgery or anesthesia-related. The following events are not defined as 
intraoperative complications: 1. Sequelae, i.e. effects inherent to current best 
practice surgery (such as the inability to walk after a leg amputation), 2. Failures of 
cure (such as residual tumor after surgery), 3. Events related to the underlying 
disease (such as bleeding from a ruptured abdominal aortic aneurysm or 
intraoperative sepsis due to a purulent peritonitis associated to a perforated 
appendicitis), 4. Wrong-side or wrong-patient surgery or errors in indication (such 
as inappropriate indication for surgery according to current guidelines). 
Complications evident only after skin closure are captured with the classification 
for postoperative complications.  
The classification is based on severity, considering whether an additional 
treatment is necessary, the complication is life-threatening or leading to permanent 
disability or results in death of the patient (Table 17). The classification is not 
intended to get dichotomized. Any report on intraoperative complications should 
state the number of raters involved in the assessment and whether they were 
involved in the procedure. If they were involved in the procedure, it should be 
stated in which role and if not, whether the classification was based on records or 
on videotapes of the intervention. In case of multiple raters it should additionally be 
reported how a consensus was reached. 
2. Pilot study 
Patient and procedure characteristics 
A total of 60 records of patients with a median age of 69 (IQR 54, 77) were 
reviewed. Out of these, 39 (65%) were male, 23 (38%) had an ASA (American 
Society of Anesthesiologists) – score of three or higher and 17 (28%) were 
emergency admissions (Appendix Table S8). Type A surgery was represented by 
inguinal/femoral hernia repair (n=10) and thyroid/parathyroid surgery (n=10), type 
B surgery by cholecystectomy (n=10) and colon surgery (n=10), and type C 
surgery by major liver (n=5), pancreatic (n=5) oesophageal (n=5) and rectal 
surgery (n=5) (Appendix Table S9).  
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Table 17: Proposed Classification of intraoperative complications (CLASSIC) 
 
Grade Definition  
The classification exclusively relates to any event 
occurring between skin incision and skin closure and 
should be rated directly after surgery. Any event during 
the index-surgery must be considered, regardless 
whether it is surgery or anesthesia-related.1 
Prerequisite: the indication for surgery and the 
interventions conform to current guidelines 
Grade 0 No deviation from the ideal intraoperative course  
Grade I Any deviation from the ideal intraoperative course 
· Without the need for any additional treatment or 
intervention  
Grade II Any deviation from the ideal intraoperative course 
· With the need for any additional treatment or 
intervention 
· Not life-threatening and not leading to permanent 
disability  
Grade III Any deviation from the ideal intraoperative course 
· With the need for any additional treatment or 
intervention 
· Life-threatening and/or leading to permanent 
disability 
Grade IV Any deviation from the ideal intraoperative course 
· With death of the patient 
 
Outcomes 
The median length of hospital stay was 8 days (IQR 3, 15). Based on the judgment 
after resolving disagreement, intraoperative complications were recorded in 19 
(32%) patients and postoperative complications in 27 (45%) patients. The spread 
of complications over the grades was higher for postoperative than for 
intraoperative complications due to the higher number of low grade intraoperative 
complications. Details of the grade and outcomes by complexity of the intervention 
are given in Appendix Table S10.  
Agreement 
The raw categorical agreement between the two investigators was 87% for both 
intra- and postoperative complications. Details of the kappa statistics and 
intraclass correlation coefficient are provided in Table 18 
 
 
1 The following events are not defined as intraoperative complications: sequelae, failures of cure, events related to the 
underlying disease, wrong-site or wrong-patient surgery or errors in indication 
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Table 18: Agreement of the pilot study (n=60 cases, n=2 raters) 
Characteristic Category Intraoperative 
complications1,2 
Postoperative 
complications3 
(Dindo, 
Demartines, & 
Clavien 2004) 
Kappa 
statistics 
Agreement (%) 87% 87% 
Kappa (95% CI4) 0.72 (0.48, 0.89) 0.79 (0.69, 0.94) 
Quadratic 
weighted kappa 
(95% CI) 
0.83 (0.73, 0.94) 0.97 (0.94, 1.00) 
Intraclass 
correlation 
Intraclass 
correlation (95% 
CI) 
0.83 (0.73, 0.90) 0.97(0.95, 0.98) 
 
Practicability 
Both investigators rated the practicability of the definition as well as of the 
classification as 6 on the scale between one and seven. 
 
6.4.  Discussion 
The Delphi study provides a comprehensive definition of intraoperative 
complications as any deviation from the ideal intraoperative course occurring 
between skin incision and skin closure, given that the indication for surgery 
and the interventions conform to current guidelines. The classification is 
intended to be applied directly after surgery. The pilot study demonstrated 
practicability as well as a good interrater agreement.  
Strengths and limitations 
To the best of our knowledge, there is no validated definition and 
classification specifically addressing intraoperative complications. With the 
involvement of a diverse team of experts in terms of experience in practice 
and of nationality as well as with a high return rate, we were able to launch 
an extensive discussion about the definition and classification of 
intraoperative complications. It became evident that the ideal choices were 
not uniformly the most practical; hence some decisions on definitions and 
1 Based on agreement of both reviewers 
2 Classification applied immediately postoperatively without including the option “potentially” life-threatening/leading to 
permanent disability 
3 Based on agreement of both reviewers 
4 CI=Confidence interval 
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grading were rather pragmatic, resulting in a comprehensive definition and 
rather simple classification. We are, however, well aware that we are 
presenting results of the Delphi process and pilot study, which may be 
subject to further modification and refinement upon full-scale validation. 
Moreover, the retrospective setting of the pilot study with its small sample is 
unlikely to cover all possible complications. This is supported by the findings 
of a review of over eight-thousand interventions, where operative reports 
missed 13% and discharge summaries missed 14% of complications (Platz 
and Hyman 2012). Moreover, we found a lower spread of complications 
across grades for intra- than for postoperative complications, thus our similar 
interrater agreement for intra- and postoperative complications needs to be 
interpreted with care. As further research, we intend to conduct a full-scale 
validation of this instrument in a prospective international multicenter cohort.  
Relation to other studies developing classification systems  
Many previous attempts to address intraoperative complications origin in 
either human factor and system errors perspectives or in individual surgeon 
performance related to surgical education, surgical experience and technical 
skills. This is reflected by the findings of a review of studies describing 
technical errors during laparoscopy, in which error analysis was applied in 
38% of the studies, whereas in 62% errors were used to quantify surgical 
performance in an educational setting (Bonrath, Dedy, Zevin, & Grantcharov 
2013a). However, while there are several classification systems for 
postoperative complications, we are unaware of any validated definition and 
classification system strictly applying to intraoperative complications only. 
Fabri et al. developed a classification system of error in operative therapy in 
an iterative process, interacting with faculty members of one major surgical 
academic university department (Fabri and Zayas-Castro 2008). The system 
was then validated three-fold: by the personal judgement of practicability of 
four experts (50% return rate), by evaluation of agreement between two 
senior academic surgeons scoring 72 incidences reported upon departmental 
morbidity and mortality conferences, and by a national survey rating three 
scenarios. There, medical errors were evaluated as follows: occurrence 
during evaluation versus execution, slip (‘doing the correct thing, incorrectly’) 
versus mistake (‘doing the wrong thing, but correctly’), type of error (11 
different types, allowing for up to 5 types per complication, e.g. health system 
error, error in diagnosis, incomplete understanding of problem, judgment 
error, equipment failure, etc.), corresponding ACGME (Accreditation Council 
for Graduate Medical Education) core competency, and percentage of 
adverse outcome attributable to the error. Additionally, the complication was 
graded as 1: ’definite complication but no injury to patient and no 
prolongation of length of stay’, 2: ‘no injury but prolongation of 
hospitalization’, 3: ‘injury occurred with temporary disability’, 4: ‘injury 
84 
 
   
 
occurred with permanent disability’ and 5: ‘death’. Agreement was found to 
be over 70% in all error categories in both the paired comparison and the 
national survey (return rate 29.5%). The system was then applied to over 
nine thousand surgical procedures taking advantage of an established 
electronic complication self-reporting system. The results suggested that 
complications are mainly caused by individual surgeons. The study was 
however controversially discussed, since it suggested systems errors to play 
a less important role than human deficiencies, while some of the 
complications caused by individual surgeons could still have their origin in 
latent factors hidden in the system (Nagpal et al. 2009). Our study shows 
similar results concerning interrater agreement. The definition and 
classification are however not strictly comparable, since our system is 
focussing on the time between skin incision and closure, relying on a second 
system to capture postoperative events.  
In comparison, the classification for postoperative complications proposed by 
Clavien and Dindo (Dindo, Demartines, & Clavien 2004) was validated as 
follows: first, in a sample of over six thousand patients, the classification was 
prospectively applied and the correlation between the complication grades 
and the complexity of surgery as well as the length of hospital stay was 
evaluated and found to be high; second, acceptability and reproducibility 
based on 14 clinical cases was assessed in an international survey involving 
10 centers around the world. Acceptability was high and the answers to the 
scenarios were correct in 90%, independent of the level of training or origin of 
the surgeon.   
Implications for current practice and further research 
In order to enhance patient safety and transparency in reporting, there is an 
urgent need for standardized reporting of intraoperative events. In an 
evaluation of surgical adverse event reporting with a specific focus on 
surgical wound infection, anastomotic leak, deep vein thrombosis and 
surgical mortality, important differences in definitions and duration of follow-
up were found, hampering comparisons (Bruce et al. 2001b). In our own 
study based on a cohort of 46 randomized-controlled trials published in 
surgical journals, only half of the studies provided exact definitions of 
postoperative complications, and only 13% of the studies provided definitions 
of intraoperative complications (submitted for publication). We believe that 
this classification can be used prospectively and retrospectively, i.e. with 
direct rating after surgery, and based on the operation record or for ratings of 
video-recorded interventions. When used retrospectively, the limitation of not 
capturing all complications due to the likely absence of low grade 
complications has to be kept in mind. As further research, we plan to refine 
and validate the proposed definition and classification of intraoperative 
complications in a multinational, prospective cohort study. We will evaluate 
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whether there is an association between the classification and the complexity 
of surgery, as well as between the classification and the duration of surgery. 
Furthermore, an explorative analysis shall evaluate whether the classification 
is predictive for a number of adverse postoperative outcomes, adjusted for 
the most relevant confounders.  
Conclusions 
We provide a comprehensive definition of intraoperative complications and a 
straightforward classification with a high interrater agreement and 
practicability, as evaluated in a pilot study. This classification shall now 
undergo full-scale validation.  
With the proposed work we are contributing to standardized reporting in 
clinical practice, research and educational settings, ultimately enhancing 
patient safety and allowing for informed healthcare decision making.    
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Abstract 
Background: Virtual reality (VR) simulation is increasingly used in surgical 
disciplines. Since VR simulators measure multiple outcomes, suitable methods are 
needed to address multiplicity or combine evidence into a lower dimensional 
outcome. We aim to present an algorithm for summarizing multiple VR outcome 
metrics into a total score and to illustrate the approach with two real data 
examples.  
Methods: We present an algorithm for combining multiple VR outcomes into 
dimension summary measures, which are integrated into a meaningful total score. 
We re-analyzed the data of two VR studies applying the algorithm. First, 9 children 
with low, 23 with high experience in videogames, 20 residents and 14 board-
certified surgeons were compared concerning VR laparoscopy performance. 
Second, surgical novices randomized to free versus structured VR training were 
compared with each other and with experts during simulated cholecystectomy. 
Results: The suggested algorithm was successfully applied to both studies. First, 
video gaming in children improved VR performance, but children were 
outperformed by residents and board-certified surgeons performed best, as 
confirmed when taking board-certified surgeons instead of all participants as the 
reference group. Second, cholecystectomy performance increased from free to 
structured training to experts, as confirmed by learning curves.  
Conclusions: We present and applied an algorithm for combining multiple VR 
outcome metrics into a meaningful total score. We herewith address selective 
outcome reporting and multiplicity. Given the increasing number of articles in the 
field, standardized and transparent analysis and reporting of VR outcomes is 
important to enhance the validity of VR-related research.  
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7.1. Introduction 
Virtual reality (VR) simulation is increasingly being used for training purposes. A 
recent Cochrane review investigating the impact of VR training on surgical 
performance in trainees with limited laparoscopic experience showed an 
advantage of VR training over no training as well as over box-training: VR training 
decreased the duration of surgery and improved operative performance 
(Nagendran et al. 2013).  
Tightly linked to the use of VR for training purposes, VR may be used for 
assessment of surgical skills. A prerequisite is the simulator’s construct validity, 
referring to the ability of the simulator to capture the hypothetical quality it was 
designed to assess (Oropresa et al. 2010). In other words, the simulator should 
discriminate between different levels of experience, such as between experts and 
novices (Feinstein and Cannon 2001;Gallagher et al. 2003;Oropresa, Lamata, 
Sanchez-Gonzalez, Pagador J.B., Garcia M.E., Sanchez-Margallo, & Gomez 
2010). Using VR for assessment may be important to compare the performance 
(1) of different training groups with each other and (2) of one trainee or different 
training groups to a reference group (e.g. benchmark). According to a European 
consensus, a competency-based VR curriculum should consist of tasks of varying 
difficulty levels, each performed until thresholds - which are pre-defined based on 
expert performance - are passed twice within a single training session (van 
Dongen et al. 2011). The consensus was based on a multicenter validated training 
program developed within a large international team extensively experienced in 
VR training and assessment (van Dongen, Ahlberg, Bonavina, Carter, 
Grantcharov, Hyltander, Schijven, Stefani, van der Zee, & Broeders 2011). 
Alternatively, the upper quartile of peer group performance may serve as target 
level of performance (von Websky et al. 2012).  
VR simulators objectively measure a large number of different outcome metrics. 
As a consequence, when analyzing and reporting such data, a number of 
challenges must be faced: Should all outcomes or only parts of them be analyzed 
and reported and in the latter case based on which selection process? Can 
outcomes be summarized in a meaningful way? How can outcomes on different 
scales be handled? Is it possible to weigh outcomes of different clinical 
importance? Can outcomes from different simulators be compared? Can 
outcomes from different studies be compared?  
The aim of this article is to present an algorithm for summarizing multiple 
outcomes of different dimensions and weighing them within a total score. We 
describe a framework for reporting VR outcome metrics, where we (1) summarize 
results from multiple outcomes of the same dimension in a suitable summary 
measure, and (2) integrate the dimension summary measures into a meaningful 
total score. We illustrate the approach with two real data examples. Given the 
increasing number of articles in the field, a standardized and transparent 
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approach, minimizing the risk of selective outcome reporting bias and addressing 
multiplicity issues, is of utmost importance. 
 
7.2. Methods 
Framework for analyzing and reporting multiple VR outcome metrics 
To summarize multiple VR outcomes into a total score, we propose to proceed as 
follows. First, dimensions of outcomes need to be defined according to a priori 
expert judgment. We propose to summarize outcomes under “accuracy” and 
“efficiency”. With accuracy we refer to “safety” (no harm) and “efficacy” 
(completion of the task as intended) parameters. With “efficiency” we refer to “time 
to complete the task” and “economy of movement” (i.e. instrument path length) 
parameters. Then, the following four-step procedure is carried out (underlying 
algorithm: Table 19): 
Standardize each original outcome (stated a priori to be incorporated into a 
summary measure of VR performance) so that outcomes are on comparable 
scales. To obtain easily comparable scales, we propose to standardize to mean 
100 and standard deviation (SD) 15 (Streiner and Norman 2008).  
Replace outcomes grouped within the three dimensions (accuracy, time and path 
length) by their average to obtain summary measures according to the a priori 
defined standard.  
Standardize each new summary measure to mean 100 and SD 15 while reversing 
the directionality of the measures where necessary, so that higher values are 
favourable for all three mean summary measures.  
Finally, based on a proposal to combine multiple outcomes in clinical trials by 
Schouten (Schouten 2000) and earlier work by Goldsmith (Goldsmith et al. 1993), 
compute a total score with the option of weighing the dimensions. In our examples, 
we considered accuracy twice as important as the efficiency parameters, i.e. time 
and path length, together.  
The rationale for standardizing to mean 100 and SD 15 (rather than mean 0 and 
SD 1 (z-score)) is to end up with positive numbers to which most people are more 
accustomed. This procedure is supported by the norming procedure of many 
intelligence tests to mean 100 and SD 15 (Streiner & Norman 2008). The inclusion 
of weighing is for illustrative purposes only; the chosen weights need to be 
interpreted as examples.  
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Table 19: Algorithm for handling multiple outcomes, step 4 derived from 
Schouten et al. (Schouten 2000) 
 
  
Standardize each original 
outcome stated a priori to be 
considered for analysis to mean 
100 and standard deviation (SD) 
15  
 
Outcomes are on comparable 
scales prior to calculating mean 
summary measures of VR 
performance representing the 
pre-specified dimensions (e.g. 
accuracy, time and path length) 
Replace outcomes grouped within 
the pre-specified dimensions (e.g. 
accuracy, time and path length) 
by their average  
Reduce multiplicity and obtain 
mean summary measures 
defined according to a priori 
expert judgment 
Standardize each new summary 
measure (e.g. accuracy, time and 
path length) to mean 100 and SD 
15 while reversing the measures 
so that higher values correspond 
to better performance throughout 
(e.g. for time and path length)  
Calculate a total performance 
score for each study participant 
as the weighted average of the 
dimension summary measures  
 
Outcomes are on comparable 
scales and higher values 
correspond to better performance 
for all summary measures  
Obtain a clinically meaningful 
total performance score for each 
study participant where 
dimensions are weighted (e.g. 
considering accuracy twice as 
important as efficiency, i.e. time 
and path length together)  
 
1.  
Standardization 
 
2.   
Calculation of 
mean summary 
measures for each 
dimension 
3. 
Re-
Standardization & 
unification 
directionality 
4.   
 Calculation of a 
weighted average 
as total 
performance 
score 
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Data examples  
To illustrate the above framework with real data examples from VR assessment, 
we re-analyzed the data of two previously published VR studies (Rosenthal, 
Geuss, Dell-Kuster, Schafer, Hahnloser, & Demartines 2011;von Websky, Raptis, 
Vitz, Rosenthal, Clavien, & Hahnloser 2013). 
In the first study, 9 children with low experience in videogames, 23 with high 
experience in videogames, 20 residents and 14 board-certified surgeons were 
compared for VR laparoscopy performance. A total of 23 outcomes of 6 basic VR 
tasks in the three dimensions accuracy, time and path length were considered 
(Rosenthal, Geuss, Dell-Kuster, Schafer, Hahnloser, & Demartines 2011). Each 
task was carried out twice. 
In the second study, surgical novices were randomized to either self-controlled 
basic VR training (“free training”, n=32) or VR training based on peer-group-
derived benchmarks (“structured training”, n=34). Thereafter the two training 
groups were compared with each other as well as with a group of three experts 
during a foreseen minimum of 60 iterations of simulated cholecystectomy 
performance, 10 for each of 6 anatomically different cases (von Websky, Raptis, 
Vitz, Rosenthal, Clavien, & Hahnloser 2013). Measurement of simulated 
cholecystectomy performance consisted of 5 outcomes in the three dimensions 
accuracy, time and path length. 
In both studies the Simbionix laparoscopic modules were used (Simbionix USA 
Corp, Cleveland OH). In the first study, the software was running on a 
Xitact/Mentice hardware (Mentice SA; formerly Xitact SA, Morges, Switzerland) 
and in the second study on the LAP MentorTM (Simbionix USA Corp, Cleveland 
OH).   
Statistical analyses 
Using the algorithm described above (Table 19), we calculated mean summary 
measures within the three dimensions (accuracy, time and path length) and the 
total performance score with accuracy considered twice as important as time and 
path length together.  
We used analysis of variance to compare the different participant groups in each 
study. To perform these analyses, we first calculated the mean of the two task 
repetitions in the first data set and summarized the repeated measures over time 
into a single mean summary measure per participant in the second data set. For 
each analysis, we report estimates (with simultaneous 95% confidence intervals) 
of the difference in outcome for all pairwise comparisons. We used Tukey’s honest 
significant difference to adjust the confidence intervals (Tukey 1953).  
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To visualize the mean summary measures and total score by participant group, we 
used box plots. For the second data example, we used dot plots to display the 
results because only three experts were involved.  
We carried out one additional analysis for each data set. In the first data set 
(Rosenthal, Geuss, Dell-Kuster, Schafer, Hahnloser, & Demartines 2011), we 
calculated the dimension summary measures and the total score with the results 
of the board-certified surgeons taken as the reference population, as suggested 
for proficiency-based learning (van Dongen, Ahlberg, Bonavina, Carter, 
Grantcharov, Hyltander, Schijven, Stefani, van der Zee, & Broeders 2011). We 
then contrasted the performance of children with low/high experience in 
videogames and of residents with that of the board-certified surgeons. In the 
second dataset (von Websky, Raptis, Vitz, Rosenthal, Clavien, & Hahnloser 2013), 
we used a linear mixed-effects model, fit to the first 10 iterations of 
cholecystectomy case number 1 per participant, to assess the learning curves for 
the three participant groups. For this analysis, the overall mean and standard 
deviation of all first iterations were taken as the reference. To accommodate 
curved data, we included a linear and a quadratic effect of iteration in our model. 
To indicate that the different groups may not only show different linear trends over 
iterations but also show different quadratic trends, we included interaction effects 
of both with participant group. 
For our analyses, we used R version 3.0.1 (R Foundation for Statistical 
Computing, Vienna, Austria) and the R add-on packages lme4 version 1.0-5 
(Bates et al. 2013) and lattice version 0.20-24 (Sarkar 2008).  
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7.3. Results 
Results example 1: Basic VR laparoscopy performance of children, residents 
and board-certified surgeons (Rosenthal, Geuss, Dell-Kuster, Schafer, 
Hahnloser, & Demartines 2011) 
Participant characteristics by group are presented in table 1 of the original 
publication (Rosenthal, Geuss, Dell-Kuster, Schafer, Hahnloser, & Demartines 
2011). For the present analysis, one participant who did not complete basic task 
number 3 was not considered for analysis. The mean summary measures within 
the three dimensions of accuracy, time and path length and the total score 
gradually increased from children with low/high experience in videogames to 
residents and board-certified surgeons (Figure 6a, b). So in summary, our re-
analysis of these data confirmed that video gaming in children improves 
performance on a VR trainer, but expectedly children were outperformed by 
residents and board-certified surgeons performed best (Table 20). The variance of 
the mean summary measures and the total score decreased from children with 
low/high experience in videogames to residents to board-certified surgeons 
(Figure 6a, b).  
Our additional analysis using the board-certified surgeons as the reference 
population (instead of all study participants) showed that children with low/high 
experience in videogames and residents both presented less favourable mean 
summary measures and lower total score than the board-certified surgeons 
(Figure 7a, b). 
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Table 20: Difference in mean summary measure or total performance score between the four participant groups: children with low (n=9) and high 
(n=22) experience in videogames, residents (n=20) and board-certified surgeons (n=14) (Rosenthal, Geuss, Dell-Kuster, Schafer, 
Hahnloser, & Demartines 2011). 
Difference in mean summary 
measure or total performance 
score (95% simultaneous¶ CI) 
Accuracy Time Path length Total 
Children HE – Children LE 
Residents – Children LE 
Board-cert. – Children LE 
Residents – Children HE 
Board-cert. – Children HE 
Board-cert. – Residents 
4.9 (-2.1, 11.9) 
17.3 (10.2, 24.4)*** 
19.4 (11.8, 26.9) *** 
12.4 (6.9, 17.9) *** 
14.4 (8.4, 20.5) *** 
2.1 (-4.1, 8.2) 
-6.2 (-14.4, 2.0) 
-20.4 (-28.8, -12.1) *** 
-28.5 (-37.4, -19.7) *** 
-14.2 (-20.6, -7.8) *** 
-22.3 (-29.4, -15.2) *** 
-8.1 (-15.3, -0.9) * 
-10.2 (-18.2, -2.2) ** 
-21.9 (-30.0, -13.8) *** 
-23.6 (-32.2, -15.0) *** 
-11.7 (-18.0, -5.5) *** 
-13.4 (-20.3, -6.5) *** 
-1.7 (-8.7, 5.4) 
8.4 (-0.7, 17.5) 
26.1 (16.9, 35.4) *** 
30.1 (20.3, 40.0) *** 
17.7 (10.6, 24.8) *** 
21.7 (13.9, 29.6) *** 
4.0 (-4.0, 12.0) 
Abbreviations: CI, confidence interval; Children HE/LE, children with high/low experience in videogames; Board-cert., board-certified surgeons. 
¶Tukey honest significant differences (Tukey 1953)  
*** P<0.001; ** P<0.01; * P<0.05. 
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Figure 6: Boxplots comparing children with low (n=9) and high (n=22) experience in videogames (LE and HE), residents 
(n=20) and board-certified surgeons (n=14) (Board-cert.) (Rosenthal, Geuss, Dell-Kuster, Schafer, Hahnloser, & Demartines 
2011). (A) Accuracy, time and path length mean summary measures.  
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(B) Total virtual reality (VR) performance score with accuracy considered twice as important as time and path length together. 
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Figure 7: Boxplots comparing all three children with low (n=9) and high (n=22) experience in videogames (LE and HE) and 
residents (n=20) with board-certified surgeons (n=14) (Board-cert.) with the latter taken as the reference population 
(Rosenthal, Geuss, Dell-Kuster, Schafer, Hahnloser, & Demartines 2011) (A) Accuracy, time and path length mean summary 
measures.  
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(B) Total virtual reality (VR) performance score with accuracy considered twice as important as time and path length together. 
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Results example 2: VR cholecystectomy performance of the free training 
group, structured training group and experts (von Websky, Raptis, Vitz, 
Rosenthal, Clavien, & Hahnloser 2013)  
Trainee demographics are described in the original publication (von Websky, 
Raptis, Vitz, Rosenthal, Clavien, & Hahnloser 2013). For the present analysis, one 
participant with missing values in the number of serious complications was not 
considered for analysis. The median (interquartile range) number of iterations was 
55 (42.5, 63.5), 57 (35.75, 64.25) and 44 (43.5, 51) for participants in the free 
training, structured training and expert group, respectively.  
With repeated measures over time summarized into a single mean summary 
measure per participant, VR cholecystectomy performance gradually increased 
from free training to structured training to experts (Figure 8a, b; Table 21).  
When accounting for a maximum of 10 iterations of cholecystectomy case number 
1 per participant, the three experts showed the best total performance score and 
steepest learning curve, followed by the structured and the free training group 
(Figure 9a). The smooth curves represent local averages. From figure 9b we see 
the same pattern, with predicted values (smooth curves, based on the fixed part of 
the model) and actual values of the total score. Experts started off with the best 
performance – followed by participants in the structured and the free training group 
– and then showed a modest learning curve over 10 iterations that may reach a 
plateau, whereas the learning curves of surgical novices in both the free and the 
structured training group may continue to increase beyond 10 iterations. 
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Table 21: Difference in mean summary measure or total performance score between the three participant groups: free training group (n=31), 
structured training group (n=34) and experts (n=3) (von Websky, Raptis, Vitz, Rosenthal, Clavien, & Hahnloser 2013). 
Difference in mean summary 
measure or total performance score 
(95% simultaneous¶ CI) 
Accuracy Time Path length Total 
Structured training – Free training 
Experts – Free training 
Experts – Structured training 
4.2 (-3.8, 12.3) 
11.6 (-8.1, 31.3) 
7.3 (-12.3, 27.0) 
-7.1 (-15.5, 1.3) 
-25.3 (-45.7, -4.8) * 
-18.2 (-38.6, 2.1) 
-9.1 (-17.0, -1.2) * 
-22.9 (-42.2, -3.7) * 
-13.8 (-33.9, 5.4) 
5.9 (-0.7, 12.4) 
16.7 (0.7, 32.7) * 
10.8 (-5.1, 26.8) 
Abbreviations: CI, confidence interval. 
¶Tukey honest significant differences (Tukey 1953) 
* P<0.05. 
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Figure 8: Dotplots comparing surgical novices in the free training (n=31), structured training (n=34) and expert group (n=3) 
(von Websky, Raptis, Vitz, Rosenthal, Clavien, & Hahnloser 2013) (A) Accuracy, time and path length mean summary measures.  
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(B) Total virtual reality (VR) performance score with accuracy considered twice as important as time and path length together. 
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Figure 9: Total virtual reality (VR) performance score – with accuracy considered twice as important as time and path 
length together – over iterations for participants in the free training (n=31), structured training (n=34) and expert group 
(n=3) (von Websky, Raptis, Vitz, Rosenthal, Clavien, & Hahnloser 2013) (A) The smooth curves are local averages found using the 
default loess smoother in R version 3.0.1 (R Foundation for Statistical Computing, Vienna, Austria).  
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(B) The smooth curves are the predicted values (based on the fixed part of the linear mixed-effects model) of the total VR 
performance score. 
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7.4. Discussion 
We present an algorithm for (1) combining multiple VR outcome metrics into 
suitable summary measures of the same dimension, and (2) integrating the 
dimension summary measures into a meaningful total score. We herewith address 
the risk of selective outcome reporting bias and multiplicity issues.  
When analyzing and reporting multiple outcomes, three different strategies are 
possible, the choice depending on the study goal and setting: (1) reporting all 
measured metrics, (2) reporting part of them, or (3) summarizing multiple 
outcomes to mean summary measures within dimensions or to a total score, as 
presented within this work. If the results of all measured metrics are presented, a 
graphical display of all individual outcomes may be an appropriate choice, 
especially in exploratory studies. If groups are compared for all measured metrics 
using hypothesis testing with no adjustment for multiplicity, the chance to find at 
least one significant difference when in fact there is none (family-wise type I error) 
may increase (Neuhauser 2006;Sterne and Davey 2001). In such instances, 
procedures to control the family-wise type I error rate are recommended 
(Neuhauser 2006;Sterne & Davey 2001) or summarizing outcomes as described 
within our framework. If only parts of the data are reported, there is a risk of data-
driven selective reporting. On the other hand, some of the metrics are most likely 
related to each other, for example economy of movement and path length are 
similar outcomes. In this case, one of these two variables may be selected as a 
representative for both variables. Such a decision must be taken a priori based on 
expert knowledge, and may not be a post-hoc data-driven selection. Importantly, 
the selection process needs to be transparently communicated in the final report. 
Our approach of summarizing multiple outcomes is simple and straightforward: We 
choose outcomes a priori and (1) if they are not on comparable scales, 
standardize them and (2) then summarize them within a priori defined dimensions. 
To obtain a total score, (3) we standardize the dimension summary measures, 
unify their directionality and then (4) calculate the total score. The approach allows 
for variations: During step 2 and 4, either the average or a weighted average may 
be calculated. The choice of weights may be based on clinical judgment, by giving 
more weight to accuracy parameters, i.e. safety and efficacy, than to efficiency 
parameters, i.e. time to complete a task or economy of movement. In the 
examples presented in this article, we a priori chose to weigh accuracy, time, and 
path length in a 4 to 1 to 1 ratio. Alternatively, principal component analysis may 
be applied. With this approach, the first principal component, which spreads out 
the scores as much as possible, may be used as a summary measure in step 2 
and 4 (Hotelling 1933;Pearson K 1901).  
Once the summary measures or total score are calculated, they can be further 
analyzed as any other continuous outcome. However for data interpretation it has 
to be kept in mind that the units are standard deviations and the score has been 
inflated by 15. In our two examples, we used analysis of variance to compare 
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different participant groups and addressed two additional aspects of data analysis: 
benchmarking and the analysis of repeated measures over time. In proficiency-
based learning, a single new observation from another trainee or several new 
observations from one or more groups of trainees may be compared to a 
reference group, for instance a group of experts. Importantly, the reference 
population needs to be large enough to serve as a benchmark. Benchmark values 
may be established once and then serve as a reference for subsequent 
observations. Some intelligence tests for instance are taking advantage of a 
norming sample from the general population with a mean of 100 and a standard 
deviation of 15 IQ points (Streiner & Norman 2008). To generate however such a 
representative reference population, the sample size of the reference population 
by far needs to exceed the one presented in this paper. Since we standardize all 
observations with the overall mean and standard deviation of the reference 
population, no assumptions concerning the distribution of the reference population 
are being made. The resulting score, as any other continuous outcome, does 
however not necessarily present a normal distribution. Our results suggest that the 
total score, as described within the present work, may readily be used for 
comparing the results of individuals or groups of individuals to a reference group, 
an important issue in proficiency-based training. The second aspect is as well 
important in the setting of training: the analysis of repeated measures over time. 
Repeated observations within the same individual generate clustered data, which 
need to be addressed with appropriate statistical methods. The reason is that 
observations within an individual (i.e. the cluster) tend to be more similar than 
those between individuals, which in turn has an impact on measures of uncertainty 
associated with effect estimates. Disregarding clustered data may lead to wrong 
conclusions. In the simplest case, only one task repetition per participant is 
important and analyzed, such as the first or the last observation, and thus data 
may be handled as independent observations. However this approach has 
disadvantages, because most of the available information is not taken into 
account. If overall performance disregarding training effects from task repetitions is 
important, repeated measures over time may be summarized into a single 
summary measure per participant prior to data analysis, as in the first analysis of 
the second data set. If however the learning curve – with all repeated measures 
over time – is of interest, a linear mixed-effects model may be used, as illustrated 
in the second analysis of the second data set. Other options for the analysis of 
clustered data are beyond the scope of this article.  
In conclusion, VR simulation is increasingly being used for assessment and 
training purposes, especially in minimally invasive surgery. VR allows group 
comparisons, unlimited task repetition and measurement of a large number of 
outcome metrics. When analyzing and reporting such outcome data, the use of 
standardized, statistically sound and transparent methods is of utmost importance. 
We describe an algorithm to combine the evidence from multiple outcome metrics 
into a lower dimensional outcome. As further research for the future, test-retest 
reliability of the mean summary measures and the total score on the same 
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simulator, followed by test-retest reliability on different simulators should be 
explored. The ultimate goal of this work and of future research is to enhance the 
validity of VR-related research reports. 
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8.1. Introduction 
In surgical studies, paired data resulting from multiple interventions in a single 
patient (e.g. bilateral hernia, bilateral interventions in extremity surgery) and from 
multiple outcome assessments over time are relatively common. If clustered data 
are not accounted for in the statistical analysis, the standard errors of the 
estimates might be under- or overestimated, which may have an effect on the 
overall study conclusions (Campbell et al. 2004;Campbell et al. 2012;Lee and 
Thompson 2005).  
 
Clustered data need be accounted for in both the design phase and the analysis 
phase of the study. As for the study design, this concerns in particular the 
definition of the in-/exclusion criteria (allowing or not to generate clustered data), 
randomization procedure (for instance randomization of the individual versus 
randomization of the hernia) and sample size calculation (accounting for clustered 
data) (Lee et al. 2012;Lee & Thompson 2005). Concerning data analysis, the 
statistical methodology for handling clustered data has been extensively described 
(Hanley et al. 2003;Zeger and Liang 1986), but not systematically implemented in 
current practice. 
 
In a systematic review of oral health reports, the clustered nature of data had been 
accounted for in sample size calculations in 65% of the analyzed studies (Froud et 
al. 2012). As for data analysis, clustered data do not seem to be systematically 
accounted for: In a systematic review of implant dentistry, clustered data were not 
accounted for in 33% of the analyzed RCTs (Cairo et al. 2012). Of note, in a 
review of 69 ophthalmic RCTs, none of them accounted for clustering in sample 
size calculation and only 5 studies accounted for non-independence in the 
statistical analysis (Durkalski et al. 2003;Lee, Cheng, & Fong 2012). To the best of 
our knowledge, a systematic analysis on the appropriateness of methods used for 
handling clustered data in surgery has not yet been conducted, neither has the 
effect of bias from disregarding clustered data been estimated. 
 
The aim of this study is to analyze in randomized-controlled trials in patients 
undergoing hernia repair without exclusion of bilateral surgery i) to what extent the 
presence of clustered data has been accounted for in the study design (in-
/exclusion criteria, randomization, sample size calculation) and statistical analysis 
(type and appropriateness of used methods) and ii) to estimate the effect of 
disregarding clustered data on the overall results.  
 
8.2. Methods 
 
We included in this evaluation RCTs with patients undergoing inguinal hernia 
repair comparing any type of intervention that is applicable on each side 
separately, for which the outcome is assessable on each side separately and in 
which patients with bilateral hernias were not excluded. Studies with ongoing 
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recruitment and follow-up trials were excluded. RCTs were identified through 
Medline, Embase and Cochrane library search.  
Two independent reviewers with medical content expertise judged the eligibility of 
the RCTs and extracted data on study baseline characteristics, study quality (risk 
of bias) and handling of clustered data in study design and analysis. 
Disagreements were resolved by discussion, Descriptive statistics were used for 
analysis. 
We applied a conceptual framework of different approaches to handle paired data 
(Figure 10).  
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Figure 10: Conceptual Framework for handling paired data 
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8.3. Preliminary results 
 
A total of 4024 records were identified through database search, 2613 after 
duplicate removal. Out of these, 2326 studies were excluded due to in-/exclusion 
criteria with 287 studies remaining for full-text eligibility assessment and data 
extraction, if applicable. The evaluation of these 287 RCTs and the extraction are 
still ongoing. Preliminary findings suggest that many studies do not use 
appropriate methods to account for the paired data structure.   
 
8.4. Outlook 
To estimate the effect of disregarding clustered data on the overall results, we will 
attempt to obtain original individual patient data of published RCTs with different 
proportions of clustered data from the respective authors. The original data of 
these trials will be analyzed twice, once with appropriate statistical methods 
accounting for clustered data and once disregarding the presence of clustered 
data allowing estimating the difference in overall conclusions depending on the 
type of analysis. Should no original data be available, a simulation study will be 
conducted to estimate the impact of disregarding paired data on overall trial 
conclusions. 
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9. General discussion and conclusion 
 
9.1. Principal findings 
Our investigation of reporting in surgical research focused on the assessment of 
current practice and the development of potential solutions to identified 
challenges. Our main findings are summarized as follows:  
Studies investigating current practice 
When designing and reporting surgical trials, trialists referenced systematic 
reviews to summarize findings, but not explicitly to inform trial design and not to 
integrate the new trial results.  
During study conduct, slow recruitment was the predominant cause for early trial 
discontinuation. Trial discontinuation was more frequent in surgical than in medical 
trials, both for any reason and for slow recruitment. Trial discontinuation in turn 
was found to be a strong predictor for non-publication and thus had an impact on 
reporting.  
As for adverse intraoperative events, we found intraoperative complications rarely 
to be reported; some were subsumed with postoperative complications. In case 
they were reported, they mostly lacked a definition. In contrast, for postoperative 
complications, for which several classification systems have been published, about 
half of the studies provided this information. Neither the type of study intervention 
nor whether the primary outcome was an adverse event did significantly impact on 
these results.  
In regard to the handling of paired data, preliminary findings suggest that many 
studies in hernia surgery do not use appropriate methods to account for paired 
data in the study design, analysis and report.   
Studies addressing potential solutions 
In order to address some identified challenges when reporting surgical research, 
we developed a 10-step practical guide to write a clinical study protocol. We 
outlined key methodological issues important when planning an ethically and 
scientifically sound surgical research project, thus anticipating in the study design 
phase critical issues of the reporting phase.  
As for the reporting of intraoperative complications, our Delphi study provided a 
comprehensive definition of intraoperative complications as any deviation from the 
ideal intraoperative course occurring between skin incision and skin closure, given 
the indication for surgery and the interventions conform to current guidelines. The 
classification comprises four severity grades. The pilot study demonstrated 
practicability as well as good interrater agreement.  
Concerning the handling of multiple VR outcome metrics on different scales, we 
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present an algorithm for combining these outcomes into suitable summary 
measures of the same dimension and for integrating the dimension summary 
measures into a meaningful total score.  
9.2. Relation to other studies and possible mechanisms 
Studies investigating current practice 
Our findings concerning the use of systematic reviews were in line with previous 
findings (Clarke & Chalmers 1998),(Clarke, Alderson, & Chalmers 2002),(Clarke, 
Hopewell, & Chalmers 2007),(Clarke, Hopewell, & Chalmers 2010),(Clarke & 
Hopewell 2013), although even more marked. However, the findings need to be 
interpreted in light of the possibility that trialists used systematic reviews to inform 
trial design, but did not explicitly state so. 
We found slow recruitment to be the most frequent cause for early trial 
discontinuation. This is in line with previous findings. In a cohort of 114 publicly 
funded multi-center trials, only 31% reached their initial recruitment target, an 
additional 24% reached 80% of their recruitment target and 53% of the trials were 
extended (McDonald, Knight, Campbell, Entwistle, Grant, Cook, Elbourne, Francis, 
Garcia, Roberts, & Snowdon 2006). Potential explanations for more surgical than 
medical trials being discontinued may be surgery-specific aspects and challenges 
with clinical trials such as requirements concerning surgeon experience, 
standardization of the intervention, and recruitment (e.g. due to patient or 
caregiver preference) (Boutron, Moher, Altman, Schulz, & Ravaud 
2008;Devereaux, Bhandari, Clarke, Montori, Cook, Yusuf, Sackett, Cina, Walter, 
Haynes, Schunemann, Norman, & Guyatt 2005;Solomon & McLeod 1995). 
Additionally, there are some fundamental differences in the premarket review and 
approval process of devices versus drugs (Sweet, Schwemm, & Parsons 
2011),(Sorenson & Drummond 2014). Since depending on the risk class of 
surgical devices, regulatory approval may not be based on clinical evidence, 
potentially less resources and other efforts to achieve trial completion may be 
invested in such instances. The proportions of published trials were slightly higher 
compared to a previous investigation of study protocols submitted to a Swiss 
research ethics committee (Von Elm, Rollin, Blumle, Huwiler, Witschi, & Egger 
2008). In this previous study, the odds for publication was higher with non-
commercial funding, which is in line with our results, higher with multicenter trials, 
international collaboration and a high sample size as assessed by median split 
((Von Elm, Rollin, Blumle, Huwiler, Witschi, & Egger 2008). This investigation 
comprised, however, mostly medical specialties and thus is not strictly comparable 
to the surgical trials evaluated in our sample.  
We found trial discontinuation to be an independent risk factor for non-publication. 
This may be explained by the fact that the most frequent reasons for 
discontinuation of surgical RCTs were slow recruitment, futility or administrative 
reasons. These trials were thus potentially more difficult to publish than the few 
trials stopped early for benefit. Generally, in trials stopped early for benefit, 
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treatment effects tend to be large (Bassler, Montori, Briel, Glasziou, & Guyatt 
2008;Montori, Devereaux, Adhikari, Burns, Eggert, Briel, Lacchetti, Leung, Darling, 
Bryant, Bucher, Schunemann, Meade, Cook, Erwin, Sood, Sood, Lo, Thompson, 
Zhou, Mills, & Guyatt 2005a), increasing the chance of a trial to be published. This 
is supported by a review of such trials in which the majority of RCTs (92/143) were 
published in 5 high-impact medical journals.(Montori, Devereaux, Adhikari, Burns, 
Eggert, Briel, Lacchetti, Leung, Darling, Bryant, Bucher, Schunemann, Meade, 
Cook, Erwin, Sood, Sood, Lo, Thompson, Zhou, Mills, & Guyatt 2005a).  
To our knowledge, our review of intraoperative complication reporting is the first 
review assessing the quality of reporting adverse events in surgery with a specific 
focus on intraoperative complications. However, several investigations of reporting 
of postoperative surgical complications found a lack in standardized definitions 
(Bruce, Russell, Mollison, & Krukowski 2001b). 
We are unaware of any systematic analysis of the appropriateness of methods 
used for handling paired data in surgery and of the effect of bias from disregarding 
clustered data. Should our preliminary findings of a lack of systematic use of 
appropriate methods to analyze paired data be confirmed, this would be in line 
with previous findings in other fields. In a systematic review of oral health reports, 
the clustered nature of data had been accounted for in sample size calculations in 
65% of the analyzed studies (Froud, Eldridge, Diaz, Marinho, & Donner 2012). As 
for data analysis, in a systematic review of implant dentistry, clustered data were 
not accounted for in 33% of the analyzed RCTs (Cairo, Sanz, Matesanz, Nieri, & 
Pagliaro 2012). Importantly, in a review of 69 ophthalmic RCTs, none of them 
accounted for clustering in sample size calculation and only 5 studies accounted 
for non-independence in the statistical analysis (Durkalski, Palesch, Lipsitz, & Rust 
2003;Lee, Cheng, & Fong 2012).  
 
Studies addressing potential solutions 
While there are several classification systems for postoperative complications, we 
are unaware of any validated definition and classification system strictly applying 
to intraoperative complications. Fabri et al. developed a classification system for 
errors in operative therapy in an iterative process, interacting with faculty members 
of one major surgical academic university department (Fabri & Zayas-Castro 
2008). Agreement was found to be over 70% in all error categories and thus 
similar to our findings, which are however not strictly comparable, since our 
classification is limited to events between skin incision and closure. The 
classification for postoperative complications proposed by Clavien and Dindo 
(Dindo, Demartines, & Clavien 2004) showed - in an international survey taking 
advantage of clinical cases - 90% of the answers to the scenarios to be correct, 
independent of the level of training or origin of the surgeon.   
As for VR outcome reporting, we are unaware of any attempts to address the 
multiplicity issue when reporting simulator outcomes. Some intelligence tests 
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however are taking advantage of a norming sample from the general population 
with a mean of 100 and a standard deviation of 15 (Streiner & Norman 2008).   
 
9.3. Strengths and limitations 
Studies investigating current practice 
To the best of our knowledge, our study represents the first investigation of the 
use of systematic reviews to inform trial design and for evidence synthesis 
specifically addressing surgical trials. A potential limitation of the investigation is 
the fact that we did not cross-check any claims of the study reports, such as a 
claim to be the first RCT addressing a specific research question. Additionally, 
we refrained from contacting the authors for additional information. 
The strength of our investigation concerning early trial discontinuation is the fact 
that the collaborating RECs granted us unrestricted access to trial protocols, thus 
reducing the risk of a selection bias. Additionally, our approach allowed us to 
collect more detailed information about trial characteristics than investigating trial 
registry entries only (World Health Organization 2013). Moreover, we obtained 
study protocols from several RECs in three countries, increasing the 
generalizability of our findings (Kasenda, von Elm, You, Blumle, Tomonaga, 
Saccilotto, Amstutz, Bengough, Meerpohl, Stegert, Tikkinen, Neumann, 
Carrasco-Labra, Faulhaber, Mulla, Mertz, Akl, Bassler, Busse, Ferreira-
Gonzalez, Lamontagne, Nordmann, Rosenthal, Schandelmaier, Sun, Vandvik, 
Johnston, Walter, Burnand, Schwenkglenks, Bucher, Guyatt, & Briel 2012). 
Additionally, our data extractions were based on a priori definitions and validated 
through regular quality assessments. Finally, our sensitivity analyses support the 
robustness of the conducted statistical analyses. As limitation, the relatively low 
number of surgical trials and outcome events did not allow us to adjust for 
additional confounders (Peduzzi, Concato, Kemper, Holford, & Feinstein 1996).  
Our investigation concerning the current practice of reporting intra- and 
postoperative complications is limited by the fact that all RCTs published in three 
major surgical journals were considered for review. Therefore, some of the 
interventions were not involving surgery only, but as well invasive or 
perioperative interventions. We addressed this issue by evaluating in an 
exploratory analysis the impact of studies including surgery as primary study 
intervention on complication reporting.  
Additionally, the results from three journals may not be extrapolated to all surgical 
journals. We focused on three high-impact journals with endorsed CONSORT 
reporting guidelines policy and it is therefore unlikely that an investigation in other 
surgical journals would yield lower frequencies of lacking definition and 
classification of intra- and postoperative adverse.  
Moreover, reviewers were not blinded regarding authors and journals of the 
published RCTs. However, data abstraction was undertaken by two independent 
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reviewers who used a standardized objective extraction protocol. We consider 
the lack of blinded data abstraction as a minor risk of bias (Morissette, Tricco, 
Horsley, Chen, & Moher 2011).  
The evaluation of the use of appropriate methods to account for paired data was 
limited by the fact that many trial reports were lacking clear information in the 
methods section concerning trial design and analysis, such as concerning the 
included trial population, the primary outcome, the sample size calculation, and 
the unit of analysis. We therefore had to infer some of the information from the 
results section. To enhance reliability of our extractions, all data were extracted in 
double and disagreements were resolved by discussion. We additionally 
recorded whether relevant issues were explicitly stated or whether they had to be 
derived from other information. 
Studies addressing potential solutions 
Since a prerequisite for adequate reporting in surgical research is a thoroughly 
planned and sound research protocol, we developed a comprehensive, but 
hands-on guide to develop a clinical surgical research protocol. We illustrated 
methodological issues with practical examples and provided reference to cardinal 
trials in surgery. Given the nature of a journal article, not all topics could be 
addressed in full detail. We thus provided references for further reading.  
To the best of our knowledge, there is no validated definition and classification 
specifically addressing intraoperative complications. We were able to launch an 
extensive discussion about the definition and classification of intraoperative 
complications, involving an international and interdisciplinary expert team with a 
high return-rate in both Delphi rounds. It became evident that the ideal choices 
were not uniformly the most practical; hence some decisions on definitions and 
grading were rather pragmatic, resulting in a comprehensive definition and simple 
classification. We are, however, well aware that here we present results of the 
Delphi process and pilot study, which may be subject to further modification and 
refinement upon full-scale validation. Moreover, the retrospective setting of the 
pilot study with its small sample size is unlikely to cover all possible 
complications. Additionally, we found a lower spread of complications across 
grades for intra- than for postoperative complications, thus our similar interrater 
agreement for intra- and postoperative complications needs to be interpreted with 
care.  
We are unaware of any guideline on how to analyse and report multiple VR 
outcome metrics. We here proposed an algorithm to combine the evidence from 
multiple outcome metrics into a lower dimensional outcome. This concept may be 
applied in proficiency-based learning, where a single new observation from 
another trainee or several new observations from one or more groups of trainees 
may be compared to a reference group, for instance a group of experts. 
Benchmark values may be established once and then serve as a reference for 
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subsequent observations. To generate however such a representative reference 
population, the sample size of the reference population by far needs to exceed 
the one presented in this paper. Moreover, it needs to be taken into account that 
the inclusion of weights was for illustrative purposes only; the chosen weights 
need to be interpreted as examples.  
9.4. Implications for current practice 
Implications from studies investigating current practice 
In practice, the following four-step framework was suggested for the use of 
systematic reviews to inform the design of new trials: In step one, the research 
question of the proposed trial is formulated focussing on definition of the 
populations, interventions, comparators, outcomes, timing and setting (PICOTS) 
(Thompson, Tiwari, Fu, Moe, & Buckley 2013). In step two, an up-to-date 
relevant and valid systematic review is identified or conducted, and in step three 
the systematic review is used to inform the planned trial. If there are several 
RCTs, but no systematic review in the field, we propose to first synthesize the 
body of evidence within a systematic review and if appropriate conduct a meta-
analysis. Finally, in step four the implications for the proposed trial are 
summarised. This procedure is important to justify any research from a scientific, 
ethical and economic point of view. Similarly, we propose that trialists attempt to 
report their results in the context of other trials in the field, whenever possible 
integrating the new findings by updating a systematic review. Only when 
evaluating study results within the overall body of evidence, well-informed 
decisions in health care are possible.   
 
The findings concerning our evaluation of early trial discontinuation may have the 
following implications during the different phases of a research pathway:  
i) Trial conception and design: Strategies to prevent discontinuation should be 
adopted already during the trial design phase, including training in research 
methodology, realistic resource estimation (e.g. time of personnel), creating 
research infrastructures, and working in networks and interdisciplinary teams 
involving trial methodologists, statisticians, data managers and trial managers. 
Pilot studies either as part of the trial (internal pilot) or stand-alone (external pilot) 
(Lancaster, Dodd, & Williamson 2004), i.e. a small version of the full-scale study 
or feasibility studies, are effective means to evaluate particular aspects such as 
recruitment, resource utilization and protocol feasibility (Dolgin 2013). This 
especially applies to trials involving surgical interventions, where recruitment may 
be more challenging due to patient preferences. Moreover, pilot studies may 
identify other challenges such as feasibility of standardization of the surgical 
interventions. Pilot studies should thus be considered when allocating sparse 
resources to surgical RCTs. Additionally, trials should be registered prior to 
enrolment of the first patient. This enhances transparency regarding the targeted 
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sample size and additionally allows identifying the study while on-going or after 
close-up before publication.  
ii) Trial conduct: Recruitment should be closely monitored and early modification 
foreseen to enhance recruitment if necessary. The decision to discontinue a trial 
should be made by an independent Data and Safety Monitoring Board based on 
pre-defined criteria.  
iii) Trial reporting: Reasons for discontinuation and results of discontinued RCTs 
should be transparently communicated and thus made publicly available.  
iv) Healthcare decision making: When interpreting surgical literature, be it primary 
studies or systematic reviews, potential biases introduced by discontinued RCTs 
or by non-publication of trials need to be considered.  
 
Since there is a lack of standardized reporting of intra- and postoperative 
complications, comparisons between adverse events in surgical practice, clinical 
research, and training settings need to be interpreted with care. 
 
In case our preliminary findings of a lack of systematic use of appropriate 
methods to analyze paired data hold true, published results from trials with a 
paired data structure need to be critically evaluated for appropriate methodology 
and results interpreted accordingly. 
Implications from studies addressing potential solutions 
The study protocol is the core document when planning and conducting clinical 
research and thus has a major impact on the study report. It should be created in 
an interdisciplinary setting, approved and strictly followed. Any changes require 
an amendment approved by an IEC and the regulatory authorities. To enhance 
transparency, trial protocols may be made available, be it as publication in a 
peer-reviewed journal or be it to journal editors and reviewers, as it is already 
requested by some journals.    
We propose to prospectively collect any intraoperative complications with a 
validated instrument. In our opinion, standardization of definition and 
classification of intraoperative complications is important in a number of settings: 
first, in research and development, when reporting assessments of new surgical 
techniques and devices; second, in educational and training settings (individual 
surgeon’s performance) and in institution benchmarking (institution performance); 
third for risk management, capturing intraoperative events with an increased risk 
of postoperative complications within a critical incidents reporting system (Kram 
2008;Leape 1994;Reason 2000) or in clinical research where postoperative event 
rates may be too low to capture potential safety concerns; and last for patient 
management, enhancing quality of patient handover after surgery concerning 
anticipated problems (Manser, Foster, Flin, & Patey 2013;Nagpal, Abboudi, 
Fischler, Schmidt, Vats, Manchanda, Sevdalis, Scheidegger, Vincent, & Moorthy 
2011). 
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When analyzing and reporting virtual reality outcome data, the use of 
standardized, statistically sound and transparent methods is of utmost 
importance. This will allow for comparison across studies. When interpreting VR 
outcome metrics from reports, the possibility of selective reporting or multiple 
testing needs to be critically evaluated.  
9.5. Implications for future research 
Implications from studies investigating current practice 
Concerning the use of systematic reviews to inform trial design and to synthesize 
evidence, future investigations could address the impact of evidence synthesis 
on successful grant acquisition and regulatory approval in the design phase, on 
successful and timely study conduct including meeting the assumptions made for 
sample size calculation, on timely and high-ranked study publication and on 
treatment coverage (payers’ perspective). Additionally, it could be explored, to 
what extent network meta-analysis is used for comparison of interventions that 
may or may not have been directly compared against each other (Mills et al. 
2013). 
To further support our key message from the investigation of early trial 
discontinuation - which may be summarized as ‘to conduct pilot studies’ - it could 
be evaluated in the investigated set of trials by contacting the investigators i) to 
what extent pilot studies were used, ii) for which specific purposes (e.g. 
evaluation of consent rates, feasibility and standardization of the intervention, 
generation of preliminary data for sample size calculation), and iii) whether there 
was an association between conducting a pilot study and successful trial 
completion and publication. 
Our findings of inconsistent reporting of intraoperative complications prompted us 
to conduct at Delphi study with pilot evaluation of a classification of intraoperative 
complications.  
To estimate the effect of disregarding paired data on the overall results, we will 
attempt to obtain original individual patient data of published RCTs with different 
proportions of paired data from the respective authors. The original data of these 
trials will be analyzed twice, once with appropriate statistical methods accounting 
for clustered data and once disregarding the presence of clustered data in order 
to estimate differences in overall conclusions depending on the type of analysis. 
Should no original data be available, a simulation study will be conducted to 
estimate the impact of disregarding paired data on overall trial conclusions. 
 
Implications from studies addressing potential solutions 
We believe that a thoroughly planned and well-designed study with a 
comprehensive study protocol is at lower risk for modification throughout the 
study conduct and reporting phase. Yet, should amendments to the protocol be 
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necessary, they should transparently be communicated. We have previously 
investigated discrepancies between trial registry entries and final reports and 
found a relevant percentages of discrepancies, for instance concerning outcomes 
(Rosenthal & Dwan 2013). As further research we suggest evaluating 
discrepancies between clinical trial protocols and final reports. This could be 
undertaken in the trial set investigated for early discontinuation. Although 
previous studies have investigated such discrepancies (Dwan et al. 2011), to the 
best of our knowledge this has never been evaluated in surgical trials.   
As further research, we plan to refine and validate the definition and classification 
of intraoperative complications in a multinational, prospective cohort study. We 
will assess, whether there is an association between the classification and the 
complexity of surgery, as well as between the classification and the duration of 
surgery. Furthermore, an explorative analysis shall evaluate, whether the 
classification is predictive for a number of adverse postoperative outcomes, 
adjusted for the most relevant confounders.  
Concerning our proposed algorithm for combining the evidence from multiple 
outcome metrics into a lower dimensional outcome, we propose to evaluate as 
further research project test-retest reliability of the mean summary measures and 
the total score on the same simulator, followed by test-retest reliability on 
different simulators. The ultimate goal of this work and of future research is to 
enhance the validity of VR-related research reports. 
9.6. Conclusions 
In conclusion, we investigated reporting in surgical research by addressing 
current practice and by developing solutions to identified challenges at different 
phases of a surgical research project. Our findings are relevant not only in clinical 
research, but also in clinical practice and educational settings.  
Specifically, we addressed standardization and therewith transparency by 
developing a classification for intraoperative adverse events, by proposing an 
algorithm for summarizing multiple outcomes, and by investigating the impact of 
not taking into account paired data. For optimal reporting, we strongly advocate 
meticulous planning of surgical research and thus present a guide for writing a 
well-designed study protocol. This allows for justification of the planned research 
from a scientific, ethical and economic perspective. We recommend setting the 
planned research in the context of the overall body of evidence using systematic 
reviews. To lower the risk of early trial discontinuation and therewith as found by 
our investigation of non-publication of trial results, we suggest conducting pilot 
studies should there be any doubts concerning trial feasibility. Ultimately, well 
designed and transparently reported surgical research allows for well-informed 
healthcare decision making.    
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Appendix Table S1: Subspecialties of RCTs 
S1a: Subspecialties of surgical RCTs (n=127) 
Numbers (column percentages) are displayed. 
Subspecialty Frequency (%) 
total 127 (100) 
anesthesiology   17 ( 13) 
cardiothoracic   16 ( 13) 
dentistry               2 (   2) 
ear-nose-throat (ENT)               6 (   5) 
general surgery                8 (   6) 
maxillofacial surgery               2 (   2) 
neurosurgery      6 (   5) 
obstetrics / gynecology             20 ( 16) 
ophthalmology            18 ( 14) 
orthopedics          13 ( 10) 
plastic surgery             1 (   1) 
transplantation              3 (   2) 
traumatology               3 (   2) 
urology               8 (   6) 
vascular surgery               4 (   3) 
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 S1b: Subspecialties of medical RCTs (n=736) 
Numbers (column percentages) are displayed. 
Subspecialty Frequency (%) 
total 736 (100) 
alternative medicine      1 ( <1) 
cardiovascular   111 ( 15) 
dermatology               22 (   3) 
emergency medicine                 2 ( <1) 
endocrinology                57 (   8) 
gastroenterology              48 (   6) 
haematology     35 (   5) 
immunology                 6 (   1) 
infectious diseases        80 (  11) 
intensive care          13 (    2) 
nephrology             15 (    2) 
neurology             58 (    8) 
oncology   155 (   21) 
physiotherapy               1 (   <1) 
psychiatry     41 (     5) 
psychotherapy       3 (   <1) 
radiology                 7 (     1) 
rehabilitation                 6 (     1) 
pneumology          44 (     6) 
rheumatology            30 (     4) 
sports medicine          1 (   <1) 
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Appendix Table S2: Multivariable regression for trial discontinuation for slow recruitment of surgical trials disregarding 
clustering by the approving research ethics committee (n=891) and after multiple imputation of missing predictor and 
outcome variables (n=1152) 
Potential predictor Multivariable, disregarding clustering 
by research ethics committee 
Multivariable, multiple imputations 
 Odds ratio 95% CI3 
 
P value Odds ratio 95% CI 
 
P value 
Industry sponsor, yes versus no 0.53 0.19, 1.51 0.235 0.64 0.23, 1.81 0.402 
Primary harm outcome, yes versus no 0.55 0.16, 1.91 0.348 0.50 0.14, 1.80 0.291 
 
  
1 Out of 115 trials, 12 had an unclear completion status and 14 had at least one missing covariate. 
2 Exclusion of 10 trials that never started and of 2 that were still recruiting 
3 CI=Confidence interval 
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Appendix Table S3: Multivariable regression for non-publication as full journal article of surgical trials disregarding 
clustering by the approving research ethics committee (n=891) and after multiple imputation of missing predictor and 
outcome variables (n=1152) 
Potential predictor Multivariable, disregarding clustering 
by research ethics committee 
Multivariable, multiple imputations 
 Odds ratio 95% CI3 
 
P value Odds ratio 95% CI 
 
P value 
Industry sponsor, yes versus no 2.99 1.05, 8.58 0.041 1.92 0.81, 4.53 0.137 
Primary harm outcome, yes versus no 0.28 0.09, 0.92 0.035 0.30 0.10, 0.90 0.031 
Trial discontinuation for any reason, yes 
versus no 
4.18 1.45, 12.05 0.008 3.32 1.33, 8.33 0.010 
 
 
  
1 Out of 115 trials, 26 had at least one missing covariate. 
2 Exclusion of 10 trials that never started and of 2 that were still recruiting 
3 CI=Confidence interval 
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Appendix Figure S1  
Flow chart of included studies, eligibility, descriptive results and risk differences (95% confidence intervals) comparing invasive to non-
invasive trials 
 
 
 
 
 
 
 
 
 
 
863 RCTs involving adult patients  
 
56 invasive 
 
807 non-invasive 
 
49 
 
767 
 
7 exclusions 
5 never started 
2 still recruiting 
 
40 exclusions 
34 never started 
  6 still recruiting 
 
767 
 
  
 
   
   
 
           
  
    
  
 
 
   
   
     
  
    
   
 
   
    
 
 
    
     
  
Discontinuation 
8 unclear 
 
58 unclear 
 
Non-publication 
0 unclear 
 
0 unclear 
                                
41 
 
17 (41%) discontinued 
24 (59%) completed 
 
9 (22%)  discontinued for       
slow recruitment 
32(78%) not discontinued for 
slow recruitment 
709 
 
203 (29%) discontinued 
506 (71%) completed 
78 (11%)  discontinued for 
slow recruitment 
631(89%) not discontinued for  
slow recruitment  
 
 
risk difference 13% 
95% CI -3%, 28% 
p=0.079 
 
risk difference 11%,  
95% CI -2%, 24%,  
p =0.033 
 49 
 
18 (37%) not published 
31 (63%) published (any        
format) 
20 (41%) not published 
29 (59%) published (journal        
publication) 
 
767 
 
263 (34%) not published 
504 (66%) published (any             
format) 
311 (41%) not published 
456 (59%) published (journal            
publication) 
 
risk difference 2%,  
95% CI -11%, 16%,  
p =0.727 
49 
 
767 
 
  
 
   
   
 
           
  
    
  
 
 
   
   
     
  
    
   
 
   
    
 
 
    
     
  
49 
 
risk difference 0.2%,  
95% CI -14%, 14%,  
p =0.970 
144 
 
 
   
 
Appendix References R1: References of the 51 studies included in the analysis 
 
* references of the studies included in the analysis (other references in the manuscript are 
presented without *) 
add additional publications concerning a specific RCT 
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Appendix Table S4: Baseline characteristics of all studies included in the summary statistics (n=46) 
* References of the studies included in the analysis mentioned in the Online Only References. NA=not applicable 
First 
Author 
Condition/ 
Population 
Intervention Control Primary outcome  
(Result) 
Adverse 
event 
reporting 
 
Comments 
Schouten 
1* 
Planned 
bariatric 
surgery 
Endoscopic implant mimicking 
duodenal-jejunal bypass  
Diet Weight loss (intervention  higher 
than control) 
Yes  
Aboulian 2* 
 
Mild 
pancreatitis 
Early laporoscopic chole- 
cystectomy 
Control laparoscopic chole- 
cystectomy 
Length of hospital stay 
(intervention  
shorter than control) 
Yes Interim report, 
which is the final 
report, since the 
study was termi-
nated thereafter. 
Ishikawa 3* 
 
Central venous 
catheter 
insertion 
Maximal sterile barrier Standard sterile barrier Incidence of catheter-related 
bloodstream infections 
(intervention = control) 
Yes  
Parés4* 
 
Varicose vein 
surgery 
Ambulatory conservative 
hemodynamic management of 
varicose veins  
Stripping (2 groups: with clinical 
marking and with duplex 
marking) 
Clinical recurrence within 5 
years (intervention  
less than control) 
Yes  
Lange-
veld5* 
 
Inguinal hernia Laparoscopic total 
extraperitoneal  repair 
Open mesh repair (Lichtenstein) Postoperative pain, length of 
hospital stay, time until complete 
recovery, quality of life (pain and 
time to recovery: intervention 
less/shorter than control, length 
of hospital stay and quality of 
life: intervention= control) 
Yes  
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Table S4: Baseline characteristics (continued) 
First 
Author 
Condition/ 
Population 
Intervention Control Primary outcome  
(Result) 
Adverse 
event 
reporting 
 
Comments 
Daniel-
sen6* 
 
Trocar site 
wounds in 
laparoscopic 
chole-
cystectomy 
Autologous platelet-rich fibrin Human albumin Incisional wound breaking 
strength (intervention = control) 
and subcutaneous 
collagen deposition (intervention 
lower concentration than control) 
Yes  
Morris7* 
 
Asymptomatic 
primary 
hyperpara-
thyroidism 
Parathyreoidectomy Observation Functional/ physical capacity  
(Six-minute walking distance 
improved in intervention group, 
unchanged in control group, 
Fifty foot walk and repeated sit-
to-stand times unchanged in 
both groups) 
Yes  
Daraï8* 
 
Colorectal 
endometriosis 
Laparoscopically assisted 
colorectal resection 
Open colorectal resection Improvement in dyschesia 
(intervention = control) 
Yes  
Sam-
mour9* 
Laparoscopic 
colon surgery 
Warming and humidification of 
insufflation carbon dioxide 
Standard dry carbon dioxide Total opiate analgesia use 
(intervention = control) 
Yes  
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Table S4: Baseline characteristics (continued) 
 
First 
Author 
Condition/ 
Population 
Intervention Control Primary outcome  Adverse 
event 
reporting 
 
Comments 
Burdess 11* 
 
Surgery for 
critical limb 
ischemia 
Preoperative dual anti-platelet 
therapy  
Preoperative single anti-platelet 
therapy  
Platelet-monocyte aggregation 
(reduction by intervention, not 
control) 
Yes  
Peeters 12* 
 
Laparoscopic 
inguinal hernia 
repair 
Lightweight Vypro II or 
TiMesh prostheses 
Heavyweight Marlex prosthesis Fertility aspects (intervention 
decreased sperm motility (vs. 
preoperatively) compared with 
control) 
 
Yes  
Awad13* 
 
Laparoscopic 
chole-
cystectomy 
Preoperative oral nutritional 
supplement 
Placebo Drink-related side-effects (non 
occurred) 
Yes 
(nutrition-
nal supple-
ment inter-
vention). 
No (opera-
tion). 
Labelled as pilot 
study.  
For summary 
statistics, primary 
outcome was 
regarded as 
assessment of an 
adverse event. 
Joch-
mans14* 
 
Kidneys 
donated after 
cardiac death 
Machine perfusion Cold storage Delayed graft function 
(Intervention less frequently than 
control) 
Yes  
Petrow-
sky15* 
 
Major liver 
surgery 
Pentoxyfylline Placebo Liver regeneration (overall 
intervention = control, 
intervention better regeneration 
in small remnant livers) 
Yes  
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Table S4: Baseline characteristics (continued) 
 
First 
Author 
Condition/ 
Population 
Intervention Control Primary outcome  Adverse 
event 
reporting 
 
Comments 
Bre-
tagnol16* 
Elective rectal 
cancer surgery 
No bowel preparation Bowel preparation Overall 30-day morbidity rate 
(higher in intervention than 
control) 
Yes  
Fischer 17* Pancreatico-
duodenec-
tomy 
Normovolemic hemodilution Standard management Proportion of patients requiring 
allogeneic red blood cell 
products ≤ 30 days (intervention 
= control) 
Yes In summary 
statistics, primary 
outcome was 
regarded as 
assessment of an 
adverse event. 
Bernard 18* 
 
Severe 
traumatic brain 
injury 
Prehospital rapid sequence 
intubation 
Hospital intubation Median extended Glasgow 
Outcome Scale (GOSe) 
(intervention = control. 
Proportion of patients with 
favourable GOSe: intervention 
higher than control (2° outcome) 
Yes  
Gervaz19* Diverticulitis 
scheduled for 
elective 
sigmoidec-
tomy 
Laparoscopic sigmoid colectomy Open sigmoid colectomy Postoperative pain, duration of 
postoperative ileus, total 
morphine intake (intervention 
similar pain compared to control, 
shorter ileus and lower morphine 
intake) 
Yes Third primary 
outcome: 
discrepancy 
between abstract 
and rest of the 
manuscript. 
Bassi20* Standard 
pancreatic 
resections 
Early (postoperative day 3) drain 
removal 
Standard (postoperative day ≥5) 
drain removal 
Pancreatic fistula (intervention 
lower rate than control) 
Yes  
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Table S4: Baseline characteristics (continued) 
 
First 
Author 
Condition/ 
Population 
Intervention Control Primary outcome  Adverse 
event 
reporting 
 
Comments 
Huang21* Small 
hepatocellular 
carcinoma 
Radiofrequency ablation Surgical resection Overall survival (intervention 
lower than control) 
Yes  
Rogers 22* Common bile 
duct stone 
disease 
Laparoscopic cholecystectomy 
plus laparoscopic common 
bile duct exploration 
Endoscopic retrograde 
cholangiopancreatography, 
sphincterotomy plus 
laparoscopic cholecystectomy 
Efficacy of stone clearance 
(Intervention = control) 
Yes  
Itani23* 
 
Ventral 
incisional 
hernia 
Laparoscopic mesh repair Open mesh repair % Patients with at least 1 
complication within 8 weeks 
(intervention overall less 
complications than control; in 
patients with complications, 
more severe complications more 
frequently in intervention than 
control) 
Yes Primary outcome: 
discrepancy 
between abstract 
and rest of the 
manuscript. 
Futier25* 
 
Major 
abdominal 
surgery 
Restrictive fluid administration 
 
Conservative fluid 
administration 
Incidence of overall 
postoperative complications 
(intervention higher than control) 
Yes  
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Table S4: Baseline characteristics (continued) 
 
First 
Author 
Condition/ 
Population 
Intervention Control Primary outcome  Adverse 
event 
reporting 
 
Comments 
Schmitt-
ner26* 
 
Perianal 
surgery  
Spinal saddle block Total intravenous anaesthesia 
 
Analgesic consumption within 
24h after surgery (intervention 
lower than control) 
Yes  
Mekako 27* 
 
Varicose vein 
surgery 
Co-amoxiclav No antibiotic prophylaxis Satisfactory wound outcome, 
defined as an ASEPSIS 
score of 10 or less (intervention 
more frequent than control) 
Yes  
Søvik28* 
 
Superobesity Laparoscopic biliopancreatic 
diversion with duodenal switch 
Laparoscopic Roux-en-Y gastric 
bypass 
1-year weight loss (intervention 
greater than control) 
Yes Planned duration of 
follow-up is 5 years 
(registry 
information). This 
report includes 1-
year data. 
Nyström 29* 
 
Haemorrhoid 
prolapse 
Stapled anopexy 
 
Milligan-Morgan 
haemorrhoidectomy 
Resolution of symptoms 1 year 
after operation (control higher 
percentage than intervention) 
Yes  
Hess-
man30* 
 
Primary 
hyperpara-
thyroidism 
Video-assisted minimally 
invasive parathyreoidectomy 
Open parathyreoidectomy Duration of surgery and 
postoperative pain (duration: 
control quicker than intervention; 
pain: intervention=control) 
Yes  
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Table S4: Baseline characteristics (continued) 
 
First 
Author 
Condition/ 
Population 
Intervention Control Primary outcome  Adverse 
event 
reporting 
 
Comments 
Wang31* Colorectal 
cancer surgery 
Preoperative oral 
carbohydrate supplement 
Placebo or fasting Whole-body insulin sensitivity 
(postoperative insulin resistance 
placebo/fasting higher than 
intervention) 
Yes Outcome used for 
sample size 
calculation 
assumed to be  the 
primary outcome 
Subra-
monia32* 
Great 
saphenous 
varicose veins 
Radiofrequency ablation Conventional high ligation and 
stripping 
Time to return to normal 
household activities (intervention 
earlier than control) 
Yes Planned long-term 
follow-up. This 
report includes 
short-term results. 
Maggiori 
33* 
 
Elective 
sphincter-
saving rectal 
cancer surgery 
Pelvic calcium alginate No haemostatic agent Volume of fluid collected by the 
pelvic suction drain (intervention 
lower than control) 
Yes  
Mathur34* 
 
Major 
abdominal 
surgery 
Oral carbohydrate drink Placebo Postoperative fatigue and length 
of stay (intervention=control) 
Yes  
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Table S4: Baseline characteristics (continued) 
 
First 
Author 
Condition/ 
Population 
Intervention Control Primary outcome  Adverse 
event 
reporting 
 
Comments 
Degiuli35* 
 
Gastric cancer D2 gastrectomy D1 gastrectomy Overall survival (long-term 
follow-up). Current report: 
morbidity (prespecified 12% 
difference non-inferiority margin) 
and 30d-mortality. Intervention 
slightly exceeding non inferiority 
margin (95% confidence interval 
for the difference 0-13%).  
Yes Planned long-term 
follow-up. This 
report includes 
short-term results. 
For summary 
statistics primary 
outcome regarded 
as evaluation of 
adverse even.t 
O’Hare 36* 
 
Foam 
sclerotherapy 
for varicose 
veins 
Compression bandaging for 24 h 
 
Compression bandaging for 5 
days 
 
Change in Aberdeen Varicose 
Vein Severity Score 6 weeks 
after foam sclerotherapy 
compared with pretreatment 
score (intervention=control) 
Yes  
Jiang37* 
 
Gastro-
intestinal 
cancer surgery 
Intravenous soybean oil plus fish 
oil emulsion  
Intravenous soybean oil alone 
 
Number of in-hospital 
postoperative infectious 
complications (intervention 
<control, p = 0.066) and 
Occurrence of SIRS 
(Intervention significantly less 
than control) 
Yes  
She-
pherd38* 
 
Varicose veins Radiofrequency ablation Endovenous laser Mean postprocedural pain over 
first 3 days (intervention lower 
pain score than control) 
Yes Primary outcome 
definition: discre-
pancy in abstract 
versus main text 
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Table S4: Baseline characteristics (continued) 
 
First 
Author 
Condition/ 
Population 
Intervention Control Primary outcome  Adverse 
event 
reporting 
 
Comments 
Steffen 39* Thyroid 
surgery 
Pre- or postoperative superficial 
cervical block with bupivacaine  
Pre- or postoperative cervical 
placebo  
 
Postoperative pain (intervention 
less than control) 
Yes  
Braga40* 
 
Elective left 
colonic 
resection 
Laparoscopic surgery  Open surgery 30-day morbidity rate (outcome 
used for sample size calculation) 
(intervention = control) 
Yes A subgroup of 
patients had 
been included in a 
previous study. 
Carli41* 
 
Colorectal 
surgery 
Prehabilitation regimen of 
stationary cycling and 
strengthening 
Simple regimen of walking and 
breathing 
6-minute walk test (6MWT) 
(intervention= control) 
Yes  
Hendry 42* 
 
Liver resection Laxatives or oral nutritional 
supplements (ONS) or both 
Control Time to first passage of stool 
(Laxatives reduced time. ONS 
not significant trend for reduced 
time)  
Yes  
Bevis44* 
 
Open 
abdominal 
aortic 
aneurysm 
surgery 
Mesh wound closure Sutured wound closure Incisional hernia within 3 years 
of surgery (intervention <control) 
Yes In summary 
statistics, incisional 
hernia considered 
as postoperative 
complication 
Reid46* 
 
Closure of 
ileostomy 
wounds 
Purse string closure 
 
Linear closure Surgical site infection 
(intervention fewer than control) 
Yes Interim report, 
which is the final 
report, since the 
study was termi-
nated thereafter. 
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Table S4: Baseline characteristics (continued) 
 
First 
Author 
Condition/ 
Population 
Intervention Control Primary outcome  Adverse 
event 
reporting 
 
Comments 
       
Nthumba 
47* 
 
Rub for 
surgical hand 
preparation in 
rural hospital in 
Kenya 
Alcohol based Plain soap and water Surgical site infection 
(intervention=control) 
Yes  
Jayne49* 
 
Colorectal 
cancer 
Laparoscopically assisted 
surgery  
Conventional surgery Report includes long-term 
secondary outcomes 5-year 
overall survival, disease-free 
survival (DFS), and  
recurrences (intervention = 
control). [Primary short term 
outcomes49*add1  were positivity 
rates of resection 
margins, proportion of Dukes’ 
C2 tumours, and in-hospital 
mortality ] 
Yes (49*add1) This report includes 
5-year data. Short-
term49*add1 and 3-
year49*add2 results 
were published 
previously. For 
summary statistics, 
short-term results 
are 
considered49*add1 
Chal-
mers50* 
 
Polytetra-
fluoro-ethylene 
arterial 
anastomoses 
Tranexamic acid-free fibrin 
sealant  
Manual compression  Absence of bleeding at the 
anastomosis at 4 min after 
randomization (intervention 
higher percentage than control) 
Yes  
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Table S4: Baseline characteristics (continued) 
 
First 
Author 
Condition/ 
Population 
Intervention Control Primary outcome  Adverse 
event 
reporting 
 
Comments 
Watana-
be51* 
 
Colonic 
cancer 
resection 
Mechanical bowel 
preparation  
No mechanical bowel 
preparation 
Bacterial microflora and faecal 
organic acid content of faecal 
material obtained at operation 
(bacterial microflora lower in 
inter-vention than control, levels 
of faecal organic acids lower in 
intervention than control) 
Yes  
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Appendix Table S5: Adverse event reporting in all studies included in the summary statistics (n=46) 
* References of the studies included in the analysis mentioned in the Online Only References. 
**postoperative and intraoperative refers not only to operations in the operating room, but as well to other invasive interventions. Conversions were 
not regarded as complication. However, some reasons for conversion were regarded as complications, e.g. bleeding.   
M=retrieved from the methods section, R=retrieved from the results section. NA=not applicable. AE=adverse events.   
 
First 
Author 
Condition/ 
Population 
Definition and 
occurrence of 
intraoperative** adverse 
event 
Definition and 
occurrence of 
postoperative** adverse 
event 
Classification of **intra-
operative adverse event 
Classification of 
**postoperative adverse 
event 
Comments 
Schouten 
1* 
Planned 
bariatric 
surgery 
No definition (M).  
None occurred. In 4 
patients no implantation 
due to anatomical 
difficulties (R). 
Yes, definition given with 
classification of AE (M). 
List of AE provided (R). 
No classification (M, R). 
 
Yes, according to severity 
in mild, moderate and 
severe (M). Percentages of 
patients with AE per 
severity grade reported 
(R). 
 
Aboulian 2* 
 
Mild 
pancreatitis 
Yes, pooled with 
postoperative AE and 
defined by complete list 
(bleeding requiring 
transfusion) (M). None 
occurred (R). 
Yes, pooled with 
intraoperative AE and 
defined by complete list 
(bile duct injury, bleeding 
requiring transfusion or 
reoperation, wound 
infection, pneumonia, and 
need for readmission within 
30d) (M). None occurred 
(R). 
No classification (M, R). 
 
No classification (M, R). 
 
 
Ishikawa 3* 
 
Central venous 
catheter 
insertion 
No exact definition, 
examples given (pneumo-, 
hemo- and hydro-thorax) 
(M). Pneumo-thorax and 
malposition rates reported 
(R). 
Catheter-related (blood-
stream) infection defined, 
other complications not 
defined (M). Infection and 
occlusion rates reported 
(R). 
No classification (M, R). 
 
No classification (M, R). 
 
In summary 
statistics, 
postoperative 
complications 
counted as not 
defined. 
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 Table S5: Adverse event reporting  (continued) 
 
First 
Author 
Condition/ 
Population 
Definition and occurrence 
of intraoperative adverse 
event 
Definition and 
occurrence of 
postoperative adverse 
event 
Classification of intra-
operative adverse event 
Classification of 
postoperative adverse 
event 
Comments 
Parés4* 
 
Varicose vein 
surgery 
No definition (M). 
Not reported (R).  
Yes, given with classi-
fication of AE (M). There 
were no major AE, rates 
for minor AE reported (R). 
No classification (M, R). 
 
Yes, according to severity 
in minor and major (M). 
Percentages with minor AE 
reported, no major 
complications (R). 
 
Lange-
veld5* 
 
Inguinal hernia No definition (M). 
Rates for a list of 
intraoperative 
complications reported (R). 
Definition for wound 
infection given with 
classification (M). No 
definition for other 
complications. Rates for a 
list of postoperative AE 
reported (R). 
No classification (M, R). 
  
Yes, for wound infection 
according to severity in 
light, medium and severe) 
(M). Rates of patients with 
light wound infection 
reported (R). 
In summary 
statistics, 
complications 
counted as not 
defined. 
Daniel-
sen6* 
 
Trocar site 
wounds in 
laparoscopic 
chole-
cystectomy 
No definition, no invasive 
intervention (M). Not 
reported (R). 
 
No definition, indication 
that wounds were 
monitored for clinical 
signs of infections (M). 
None occurred (R). 
No classification (M, R). 
 
No classification (M, R). 
 
 
Morris7* 
 
Asymptomatic 
primary 
hyperpara-
thyroidism 
No definition (M). 
None occurred, pooled with 
postoperative adverse 
events (R). 
No definition, indication 
that patients were 
checked for bleeding, 
ability to swallow, nausea 
and pain prior discharge 
(M). None occurred, 
pooled with intraoperative 
AE (R). 
No classification (M, R). 
 
No classification (M, R). 
 
In summary 
statistics, 
complications 
counted as not 
defined. 
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Table S5: Adverse event reporting  (continued) 
 
First 
Author 
Condition/ 
Population 
Definition and occurrence 
of intraoperative adverse 
event 
Definition and 
occurrence of 
postoperative adverse 
event 
Classification of intra-
operative adverse event 
Classification of 
postoperative adverse 
event 
Comments 
Daraï8* 
 
Colorectal 
endometriosis 
Yes, definition given with 
classification of adverse 
events, although this 
classification originally was 
published for postoperative 
complications (M). Number 
and grading of AE provided 
(R). 
Yes, definition given with 
classification of AE (M). 
Number and grading of 
AE provided (R). 
Yes, according to severity 
in Grade I to V, although 
this classification originally 
was published for 
postoperative complications 
(M, R). 
Yes, according to severity 
in Grade I to V (M, R). 
 
Sammour9* 
 
Laparoscopic 
colon surgery 
No definition (M).Two 
intraoperative 
complications reported in 
the context of reasons for 
conversion to open surgery 
(R). 
Yes, defined based on a 
reference (minor/ 
intermediate/ major 
septic/ nonseptic), ileus 
was additionally defined 
(M). Number and grading 
of complications provided 
(R). 
No classification (M, R). 
 
Yes, according to severity 
in Grade I to V (M, R). 
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Table S5: Adverse event reporting  (continued) 
 
First 
Author 
Condition/ 
Population 
Definition and occurrence 
of intraoperative adverse 
event 
Definition and 
occurrence of 
postoperative adverse 
event 
Classification of intra-
operative adverse event 
Classification of 
postoperative adverse 
event 
Comments 
Burdess 11* 
 
Surgery for 
critical limb 
ischemia 
Yes, definition given for 
bleeding events with 
classification (M).  
Numbers, grading of 
bleeding complications, 
pooled with postoperative 
bleeding events reported 
(R). 
Yes, definition given for 
bleeding events with 
classification. Indication 
that patients were 
checked for gastro-
intestinal bleeding, 
persistent (>3 days) 
wound leak, hematoma, 
or infection (M). Num-
bers, grading and num-
bers of reoperations for 
bleeding events reported, 
pooled with intra-
operative bleeding events. 
Numbers for 
gastrointestinal bleeding 
and wound leaks 
reported. Indication that 
there were no in-patient 
deaths, intracranial 
haemorrhages, 
incidences of inotrope use 
or early graft failures (R). 
Yes, classification given for 
bleeding according to 
severity in major (life-
threatening or nonlife-
threatening) and minor (M, 
R).  
Yes, classification given for 
bleeding according to 
severity in major (life-
threatening or nonlife-
threatening) and minor (M, 
R). 
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Table S5: Adverse event reporting  (continued) 
 
First 
Author 
Condition/ 
Population 
Definition and occurrence 
of intraoperative adverse 
event 
Definition and 
occurrence of 
postoperative adverse 
event 
Classification of intra-
operative adverse event 
Classification of 
postoperative adverse 
event 
Comments 
Peeters 12* 
 
Laparoscopic 
inguinal hernia 
repair 
No definition (M). 
Numbers of post-operative 
suction drain in case of 
intraoperative oozing 
reported (R). 
 
No definition, indication 
that patients were 
followed concerning 
complications (M). 
Numbers of haematoma 
and seroma reported. No 
wound complications 
occurred (R). 
No classification (M, R). 
 
No classification (M, R). 
 
In summary 
statistics, 
intraoperative 
oozing  regarded as 
reporting of 
intraoperative 
complication, since 
labelled as 
intraoperative 
morbidity (R) 
Awad13* 
 
Laparoscopic 
chole-
cystectomy 
Examples for drink-related 
side-effects given. 
No definition for 
intraoperative AE (M). 
There were no drink-related 
complications. 
Intraoperative compli-
cations not reported (R).  
Examples for drink-related 
side-effects given. No 
definition of postoperative 
AE (M). Postoperative 
complications not 
reported (R). 
No classification (M, R). 
 
No classification (M, R). 
 
In summary 
statistics, 
complications 
counted as not 
reported. 
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Table S5: Adverse event reporting  (continued) 
 
First 
Author 
Condition/ 
Population 
Definition and occurrence 
of intraoperative adverse 
event 
Definition and 
occurrence of 
postoperative adverse 
event 
Classification of intra-
operative adverse event 
Classification of 
postoperative adverse 
event 
Comments 
Joch-
mans14* 
 
Kidneys 
donated after 
cardiac death 
No definition (M). Potential 
intraoperative 
complications pooled with 
postoperative: indication 
that no vascular 
complications of the graft  
were seen and that 
cardiovascular, gastro-
intestinal, infectious, 
metabolic, urinary, and 
technical complications 
were comparable between 
the groups and to literature 
(data not shown) (R). 
No definition (M). 
Postoperative com-
plications pooled with 
intraoperative: indication 
that no vascular 
complications of the graft 
were seen and that 
cardiovascular, gastro-
intestinal, infectious, 
metabolic, urinary, and 
technical complications 
were comparable be-
tween the groups and to 
literature (data not shown) 
(R). 
No classification (M, R). 
 
No classification (M, R). 
 
 
Petrow-
sky15* 
 
Major liver 
surgery 
No definition (M). 
Numbers of intra-
operatively transfused 
patients and central venous 
pressure reported (R). 
Yes, definition given with 
classification of AE (M). 
Number and grading of 
AE provided (R). 
No classification (M, R). Yes, according to severity 
in Grade I to V (M, R). 
Grade I, II and IIIa were 
considered as minor, Grade 
IIIb, IV and V as major.  
Additionally, list of 
complications sorted 
according to organ system 
provided. 
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Table S5: Adverse event reporting  (continued) 
 
First 
Author 
Condition/ 
Population 
Definition and occurrence 
of intraoperative adverse 
event 
Definition and 
occurrence of 
postoperative adverse 
event 
Classification of intra-
operative adverse event 
Classification of 
postoperative adverse 
event 
Comments 
Bre-
tagnol16* 
Elective rectal 
cancer surgery 
No definition (M). 
Numbers of intra-operative 
complications and rates of 
intra-operative faecal 
spillage reported (R). 
Yes, definition given with 
classification of AE. 
Definition for anastomotic 
leakage and wound 
abscess given (M). Rates 
of overall morbidity and 
mortality and of major 
morbidity, infectious and 
non-infectious morbidity 
as well as of types of 
infectious and non-
infectious morbidity 
reported (R). 
No classification (M, R) Yes, according to severity 
in Grade I to V. Grade I and 
II were considered as 
minor, Grade III, IV and V 
as major (M, R). 
 
 
Fischer 17* Pancreatico-
duodenec-
tomy 
Definition only of intra-
operative transfusion, not of 
other intraoperative 
complications (M). Number 
of intraoperative transfusion 
rates reported (R). 
Yes, definition given with 
classification of AE. In 
addition, definitions and 
grading schema for 
pancreatic leak, fistula, 
and abscess (M). Rates of 
overall morbidity and 
mortality and of Grade ³3 
morbidity reported (R). 
No classification (M, R). Yes, according to severity 
in Grade 0 to 5 overall and 
for pancreatic leak, fistula 
and abscess in Grade 1 to 
5 (M, R). 
 
In summary 
statistics, 
intraoperative 
complications 
regarded as 
defined. 
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Table S5: Adverse event reporting  (continued) 
 
First 
Author 
Condition/ 
Population 
Definition and occurrence 
of intraoperative adverse 
event 
Definition and 
occurrence of 
postoperative adverse 
event 
Classification of intra-
operative adverse event 
Classification of 
postoperative adverse 
event 
Comments 
Bernard 18* 
 
Severe 
traumatic brain 
injury 
No exact definition. 
Indication that esophageal 
intubation was recorded as 
example of complication 
(M). Numbers of failed and 
esophageal intubation re-
ported (R). 
No definition of 
postinterventional AE. 
Extended Glasgow 
outcome scale (GOSe) 
defined. Indication that 
prehospital cardiac arrest 
was recorded (M). 
Number of prehospital 
cardiac arrests and GOSe 
reported (R). 
No classification (M, R). No classification for 
postinterventional adverse 
events. GOSe classification 
from 1 to 8 (M, R). 
GOSe and cardiac 
arrest not 
considered as 
measure of 
intubation-related 
complication, since 
strongly related to 
brain injury.  
Gervaz 19* Diverticulitis 
scheduled for 
elective 
sigmoidec-
tomy 
No definition (M). 
Only number of patients 
with small bowel per-
foration reported not 
indicating whether this 
corresponds to an intra-
operative complication (R).   
No definition. Indication 
that morbidity, mortality 
and reoperations were 
recorded (M). Numbers 
for a list of major (small 
bowel perforation, intra-
abdominal abscess and 
small bowel obstruction) 
and minor complications 
provided (R). 
No classification (M, R). No classification (M). 
Classification in major 
(requiring reoperation) and 
minor (R). 
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Table S5: Adverse event reporting  (continued) 
 
First 
Author 
Condition/ 
Population 
Definition and occurrence 
of intraoperative adverse 
event 
Definition and 
occurrence of 
postoperative adverse 
event 
Classification of intra-
operative adverse event 
Classification of 
postoperative adverse 
event 
Comments 
Bassi20* Standard 
pancreatic 
resections 
No definition (M). Numbers 
of intraoperatively 
transfused patients re-
ported (R). 
Definitions for haemor-
rhage, pancreatic and 
enteric fistula, abdominal 
collection and abscess, 
acute pancreatitis and 
delayed gastric emptying 
provided. Indication that 
rates of pulmonary 
complications, 
reinterventions and 
mortality were assessed 
(M). Rates for these 
complications as well as 
for the occurrence of any 
complication reported, no 
deaths occurred (R). 
No classification (M, R) Grading of postpancrea-
tectomy haemorrhage, 
pancreatic fistula and 
delayed gastric emptying 
according to severity 
provided in the papers 
referred to for definitions of 
complications (M, R).  
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Table S5: Adverse event reporting  (continued) 
 
First 
Author 
Condition/ 
Population 
Definition and occurrence 
of intraoperative adverse 
event 
Definition and 
occurrence of 
postoperative adverse 
event 
Classification of intra-
operative adverse event 
Classification of 
postoperative adverse 
event 
Comments 
Huang21* Small 
hepatocellular 
carcinoma 
No definition (M). 
Rates of procedure-related 
haemorrhage reported (R). 
No definition. Indication 
that patients were 
followed until disap-
pearance of AE and 
complications (M). No 
mortality, rates for various 
AE (e.g. hepatic failure, 
bile leakage, 
postoperative blee-
ding/procedure-related 
haemorrhage) reported 
(R).  
No classification (M, R). No classification (M, R).   
Rogers 22* Common bile 
duct stone 
disease 
No definition (M). 
Pooled with postoperative 
complications: numbers for 
minor and major (none 
major occured) 
complications reported as 
well as that no patient 
developed bleeding, 
minor/major not defined 
(R). 
No definition, morbidity 
(no definition) and 
mortality listed as 
secondary outcomes (M). 
Pooled with intraoperative 
complications. Numbers 
for minor and major (none 
major occured) compli-
cations reported as well 
as that no patient deve-
loped bleeding, pancre-
atitis, cholangitis, aspi-
ration pneumonia. (R) 
No classification (M, R).  No definition (M). 
Minor/major classification 
without definition (R).  
In summary 
statistics, 
postoperative 
complications 
regarded as not 
defined, but 
classified 
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Table S5: Adverse event reporting  (continued) 
 
First 
Author 
Condition/ 
Population 
Definition and occurrence 
of intraoperative adverse 
event 
Definition and 
occurrence of 
postoperative adverse 
event 
Classification of intra-
operative adverse event 
Classification of 
postoperative adverse 
event 
Comments 
Itani23* 
 
Ventral 
incisional 
hernia 
No definition, indication that 
intraoperative 
complications were 
recorded (M). Rates of 
intraoperative compli-
cations (Injury to bowel, 
problems related to 
anaesthesia, other and 
overall) reported (R). 
Yes, definition given with 
classification of AE (M). 
Rates of short-term and 
long-term (8weeks) 
postoperative 
complications and of 
serious complications 
(Sepsis, urinary tract 
infection, other, overall) 
within 30 days reported 
(R). 
No pre-specified 
classification, referenced 
severity grading refers to 
postoperative compli-
cations (M). Might 
contribute (pooled with 
postoperative compli-
cations) to the figure 
reporting numbers of 
severe/nonsevere 
complications (R). 
Yes, according to severity 
in Grade I to V (M). 
According to severity in 2 
grades: nonsevere and 
severe, cutoff unclear, and 
additionally in serious (R). 
In summary 
statistics, 
intraoperative 
complications not 
considered as 
classified. 
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Table S5: Adverse event reporting  (continued) 
 
First 
Author 
Condition/ 
Population 
Definition and occurrence 
of intraoperative adverse 
event 
Definition and 
occurrence of 
postoperative adverse 
event 
Classification of intra-
operative adverse event 
Classification of 
postoperative adverse 
event 
Comments 
Futier25* 
 
Major 
abdominal 
surgery 
No definition. Indication that 
intraoperative hypovolemia 
and need for vasoactive 
support were recorded (M). 
Mean hypovolemic 
episodes reported, 
numbers of patients with 
vasoactive support and 
blood transfusion reported 
(R). 
Yes, definition given with 
classification of AE. 
Definitions provided for 
wound infection, for 
anastomotic leak and 
intraabdominal 
perianastomotic abscess, 
definitions for urinary tract 
infection, pneumonia, 
sepsis, acute lung injury, 
acute respiratory distress 
syndrome, renal dys-
function, recording 
information for reinter-
ventions, cardiac failure, 
pulmonary embolism, 
pneumothorax, 
neurological 
complications, postop-
erative haemorrhage and 
death (M).Numbers of 
patients with any/>1  
complication, and 
complications per 
individual reported (R).  
No classification (M, R). Yes, according to severity 
in Grade I to V (M, R). 
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Table S5: Adverse event reporting  (continued) 
 
First 
Author 
Condition/ 
Population 
Definition and occurrence 
of intraoperative adverse 
event 
Definition and 
occurrence of 
postoperative adverse 
event 
Classification of intra-
operative adverse event 
Classification of 
postoperative adverse 
event 
Comments 
Schmitt-
ner26* 
 
Perianal 
surgery  
No definition (M). 
Number of attempts to 
place laryngeal mask/for 
spinal puncture and 
numbers of patients with 
allergic reaction and need 
for intubation reported. 
Indication that bradycardia 
and hypotension after 
disinfection and no 
respiratory problems 
occurred. No surgery-
related intraoperative 
complications reported (R). 
No definition. Indication 
that side effects were 
monitored with a patient 
questionnaire (M). 
Numbers of patients with 
post-operative nausea 
and vomiting reported and 
indication that no life-
threatening complication 
occurred. Numbers of 
patients with a list of side 
effects reported (R). 
No classification (M, R). No classification (M, R). In summary 
statistics, 
intraoperative 
complications not 
considered as 
reported. 
Mekako 27* 
 
Varicose vein 
surgery 
No definition (M). 
Not reported (R). 
Definition and grading of 
wound complications (M). 
Number of patients with 
different grades of wound 
complications and with 
new-onset lower leg 
paraesthesia reported (R). 
No classification (M, R). Classification of wound 
healing according to 
severity in 5 groups (M, R).  
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Table S5: Adverse event reporting  (continued) 
 
First 
Author 
Condition/ 
Population 
Definition and occurrence 
of intraoperative adverse 
event 
Definition and 
occurrence of 
postoperative adverse 
event 
Classification of intra-
operative adverse event 
Classification of 
postoperative adverse 
event 
Comments 
Søvik28* 
 
Superobesity No definition. Indication that 
perioperative com-
plications (occurring within 
30 days of surgery) were 
recorded (M). 
Number for complications 
reported, without 
separating intra- and 
postoperative, e.g. 
haemorrhage (R). 
No definition. Indication 
that perioperative and late 
complications were 
recorded (M). Numbers 
for complications 
reported, e.g. 
haemorrhage, anas-
tomotic leak, leak from 
duodenal stump, abscess 
(intraabdominal, 
cutaneous), total number 
of complications. No 
deaths occurred (R). 
No classification (M, R). No classification (M, R).  
Nyström 29* 
 
Haemorrhoid 
prolapse 
No definition (M). 
Percentages of patients 
with blood loss>10ml 
reported. Percentage of 
patients with complete 
doughnut after stapled 
anopexy reported (R). 
No definition (M). Types 
of common complications 
indicated, rates for major 
complications (excessive 
or protracted pain, exces-
sive bowel function 
disturbance, postope-
rative bleed, anal ste-
nosis, thrombosed re-
sidual haemorrhoid, anal 
spasm, fissure) recorded 
(R).  
No classification (M, R). No classification (M). 
Common and major 
complications reported (R). 
In summary 
statistics, 
intraoperative 
complications not 
considered as 
reported. 
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Table S5: Adverse event reporting  (continued) 
 
First 
Author 
Condition/ 
Population 
Definition and occurrence 
of intraoperative adverse 
event 
Definition and 
occurrence of 
postoperative adverse 
event 
Classification of intra-
operative adverse event 
Classification of 
postoperative adverse 
event 
Comments 
Hess-
man30* 
 
Primary 
hyperpara-
thyroidism 
No definition (M). Indication 
that there were no 
differences in perioperative 
data. Numbers of patients 
with bleeding as reason for 
conversion reported (R). 
No definition. Indication 
that complications were 
recorded (M). Rates for 
postoperative haematoma 
without intervention, 
wound infection, urinary 
tract infection, deep vein 
thrombosis, hypocal-
caemia requiring 
supplementation and 
unilateral temporary or 
permanent vocal cord 
paresis reported (R). 
No classification (M, R). No classification (M, R).  
Wang31* Colorectal 
cancer surgery 
No definition (M). 
Intraoperative blood loss 
and fluid transfusion 
reported, intraoperative 
complications not reported 
(R). 
 
No definition. Indication 
that patient-reported 
discomfort was re-corded 
(M). Tolerance of 
intervention and 
subjective discomfort 
reported, indication that 
there were no pulmonary 
aspirations. No 
information on 
postoperative surgical 
complications (R). 
No classification (M, R). No classification (M, R).  
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Table S5: Adverse event reporting  (continued) 
 
First 
Author 
Condition/ 
Population 
Definition and occurrence 
of intraoperative adverse 
event 
Definition and 
occurrence of 
postoperative adverse 
event 
Classification of intra-
operative adverse event 
Classification of 
postoperative adverse 
event 
Comments 
Subra-
monia32* 
Great 
saphenous 
varicose veins 
No definition. Intra-
operative complications 
listed as secondary 
outcome (M). In the 
intervention group, rates for 
unsuccessful tumescent 
infiltration, great saphenous 
vein perforation, catheter 
tip thrombus reported, skin 
burns (none) reported, in 
the control group rates for 
incomplete stripping 
reported (R). 
Postoperative morbidity 
(pain (VAS-scale and as 
none, very mild, mild, 
moderate, severe, very 
severe), analgesic 
requirements, sensory 
abnormalities, wound 
problems, phlebitis, skin 
burns, pigmentation) 
listed as secondary 
outcome (M). Median 
(IQR) for pain, analgesic 
requirements, rates for 
pain category ratings and 
under minor complications 
sensory abnormalities, 
groin wound problems 
(mild inflammation, serous 
wound discharge, hae-
matoma, wound break-
down, all with sponta-
neous resolution), tigh 
haematomas, pigmen-
tation reported (R). 
No classification (M, R). No classification (M). 
Complications listed under 
minor complications, 
without definition and 
without referral to major 
complications (R). 
In summary 
statistics, 
complications 
considered as non-
classified. 
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Table S5: Adverse event reporting  (continued) 
 
First 
Author 
Condition/ 
Population 
Definition and occurrence 
of intraoperative adverse 
event 
Definition and 
occurrence of 
postoperative adverse 
event 
Classification of intra-
operative adverse event 
Classification of 
postoperative adverse 
event 
Comments 
Maggiori 
33* 
 
Elective 
sphincter-
saving rectal 
cancer surgery 
No definition (M). Number 
of patients requiring 
intraoperative blood 
transfusion reported, 
intraoperative surgical 
complications not reported 
(R).  
No definition. Total and 
daily pelvic suction drain 
volume, postoperative 
mortality and morbidity 
recorded. Indication that 
anastomotic leakage 
included clinical leaks 
(symptomatic, requiring 
specific medical, surgical 
or radiological treatment) 
and abnormalities dia-
gnosed solely by contrast 
enema (M). Numbers of 
patients for mortality and 
morbidity (anastomotic 
leakage, isolated pelvic 
abscess, rectal 
haemorrhage, prolonged 
ileus, intestinal 
obstruction, anastomotic 
stricture, stoma 
complication, medical 
morbidity, ≥ 1 com-
plication) reported (R). 
No classification (M, R). No classification (M, R).  
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Table S5: Adverse event reporting  (continued) 
 
First 
Author 
Condition/ 
Population 
Definition and occurrence 
of intraoperative adverse 
event 
Definition and 
occurrence of 
postoperative adverse 
event 
Classification of intra-
operative adverse event 
Classification of 
postoperative adverse 
event 
Comments 
Mathur34* 
 
Major 
abdominal 
surgery 
No definition (M). No 
reporting (R). 
Definition of infectious 
complications occurring 
within 28 days (clinical 
sepsis (³2 of: tempera-
ture >38·5°C, heart rate > 
100 beats/min, arterial 
partial pressure of carbon 
dioxide <32 mm Hg or 
respiratory rate >20/min, 
white cell count >12×109/l 
or >10% immature forms) 
or temperature >38°C for 
24 h and no alternative 
source for the fever, and 
antibiotics were 
commenced). Drink-
associated side effects 
recorded (M). Percentage 
of patients with 
postoperative infectious 
complications reported. 
Drink-associated side-
effects reported (R). 
No classification (M, R). No classification (M, R).  
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Table S5: Adverse event reporting  (continued) 
 
First 
Author 
Condition/ 
Population 
Definition and occurrence 
of intraoperative adverse 
event 
Definition and 
occurrence of 
postoperative adverse 
event 
Classification of intra-
operative adverse event 
Classification of 
postoperative adverse 
event 
Comments 
Degiuli35* 
 
Gastric cancer No definition (M). No 
reporting (R).  
No definition, indication 
that procedure-related 
morbidity and mortality 
were recorded (M). Total 
morbidity and 30d 
mortality rates reported as 
well as numbers of post-
operative non-surgical 
and surgical (pancreatic 
leakage, peritoneal 
haemorrhage, bleeding 
from anastomosis,  
duodenal leakage, colonic 
perforation, abdominal 
abscess, intestinal 
ischaemia, acute 
pancreatitis, gastric 
atonia) complications 
reported (R). 
No classification (M, R). No classification in 
methods section (M). 
Classification in surgical 
and non-surgical, sub-
classified according to 
organ (R).  
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Table S5: Adverse event reporting  (continued) 
 
First Author Condition/ 
Population 
Definition and occurrence 
of intraoperative adverse 
event 
Definition and 
occurrence of 
postoperative adverse 
event 
Classification of intra-
operative adverse event 
Classification of 
postoperative adverse 
event 
Comments 
O’Hare 36* 
 
Foam 
sclerotherapy 
for varicose 
veins 
No definition (M). 
Numbers of patients with 
foam extravasation, 
transient visual distur-
bances within 30 min of 
treatment, allergic re-action 
to the bandages manifested 
as red and itchy skin, and 
sensation of a swollen 
throat for 6h after treatment 
reported (R). 
No definition, examples 
given: Indication that 
patients were followed for 
possible complications 
such as deep vein 
thrombosis or new reflux 
and that pain, residual 
phlebitis (novel grading 
system) and skin staining 
as well as any other 
possible complications of 
treatment were recorded 
(M). Numbers of patients 
with staining or bruising, 
bulges due to blood in the 
treated vein addressed by 
aspiration, phlebitis, skin 
discoloration, ulcer and 
new deep venous reflux 
reported. No deep vein 
thrombosis (R).  
No classification (M, R).  No classification (M, R).  
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Table S5: Adverse event reporting  (continued) 
 
First 
Author 
Condition/ 
Population 
Definition and occurrence 
of intraoperative adverse 
event 
Definition and 
occurrence of 
postoperative adverse 
event 
Classification of intra-
operative adverse event 
Classification of 
postoperative adverse 
event 
Comments 
Jiang37* 
 
Gastro-
intestinal 
cancer surgery 
No definition (M, R) Definition of infectious 
complications with 
reference (US Centers for 
Disease Control and 
Prevention) and of SIRS 
(criteria of the American 
College of Chest 
Physicians/Society of 
Critical Care Medicine 
consensus conference 
definition of 1992). 
Indication that safety of 
nutritional support was 
recorded (M). Numbers 
for infectious compli-
cations (wound, respi-
ratory tract, urological, 
skin infections and 
bacteraemia) and SIRS 
as well as of polyhidrosis 
and facial blush reported. 
Indication that there were 
no serious adverse events 
(R). 
No definition (M, R). No classification (M, R). Intervention started 
postoperatively 
  
182 
 
 
   
 
Table S5: Adverse event reporting  (continued) 
 
First 
Author 
Condition/ 
Population 
Definition and occurrence 
of intraoperative adverse 
event 
Definition and 
occurrence of 
postoperative adverse 
event 
Classification of intra-
operative adverse event 
Classification of 
postoperative adverse 
event 
Comments 
She-
pherd38* 
 
Varicose veins No definition (M). Report of 
hypotension secondary to 
general anaesthesia (R). 
No definition. Indication 
that any complications at 
1 and 6 weeks were 
recorded (M). Numbers of 
patients with complica-
tions reported as major 
(pulmonary embolus, 
lymphatic leak) versus 
minor (wound infection, 
haematoma, 
thrombophlebitis, 
saphenous nerve par-
aesthesia, skin staining, 
nausea, hypotension 
secondary to general 
anaesthesia, pain) (R). 
No classification (M, R). No pre-specified 
classification in methods 
section (M). In results, 
division in minor and major 
(R).  
In summary 
statistics, 
postoperative 
complications 
considered as 
classified according 
to severity. 
Steffen 39* Thyroid 
surgery 
No definition (M). 
No report (R) 
Definition according to 
referenced paper (M). 
Haemorrhage on 
postoperative day 1 with 
reoperation reported. 
Indication that there were 
no other adverse events 
or side-effects (R). 
No classification (M, R). No classification (M, R).  
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Table S5: Adverse event reporting  (continued) 
 
First Author Condition/ 
Population 
Definition and occurrence 
of intraoperative adverse 
event 
Definition and 
occurrence of 
postoperative adverse 
event 
Classification of intra-
operative adverse event 
Classification of 
postoperative adverse 
event 
Comments 
Braga40* 
 
Elective left 
colonic 
resection 
No definition. Indication 
how the volume of 
operative blood loss was 
calculated and in which 
cases perioperative 
transfusion of blood 
products was undertaken 
(M). No explicit reporting, 
only mean operative blood 
loss and number of 
transfused patients 
reported and number of 
patients with conversion 
due to bleeding reported 
(R).  
Yes, a distinct list of 
postoperative compli-
cations was defined 
according to previous 
literature. Indication that 
microbiological 
analysis/culture was used 
to confirm infectious 
complications and that 
follow-up was carried out 
for 30 days after 
discharge (M). Number of 
patients with a list of 
complications within 30d 
given as well as long-term 
morbidity including 
numbers with incisional 
hernia, intestinal 
obstruction, abdominal 
abscess, urinary 
dysfunction, peristomal 
abscess, anastomotic 
stricture including 
numbers of late readmi-
ssion/reoperation (R). 
No classification (M, R). No classification (M), 
classification according to 
organ and timepoint (R). 
For summary 
statistic regarded 
as classified 
according to organ 
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Table S5: Adverse event reporting  (continued) 
 
First Author Condition/ 
Population 
Definition and occurrence 
of intraoperative adverse 
event 
Definition and 
occurrence of 
postoperative adverse 
event 
Classification of intra-
operative adverse event 
Classification of 
postoperative adverse 
event 
Comments 
Carli41* 
 
Colorectal 
surgery 
No definition (M). Not 
reported (R).  
Definitions given with 
classification (M).  
Numbers of patients with 
no, grade 1, 2 and ³3 
complications reported 
(R).  
No classification (M, R). Classification according to 
severity.  
 
Hendry 42* 
 
Liver resection Definition according to 
literature reference (M). 
Reporting pooled with 
postoperative complications 
(30d morbidity and 
mortality) (R).  
Definition according to 
literature reference (M). 
Reporting pooled with 
intraoperative compli-
cations (30d morbidity 
and mortality). Numbers 
of patients with 
reoperation for haemo-
rrhage, readmission for 
intraabdominal collec-tion, 
severe constipation, bile 
leak and pneumonia and 
of deaths from myocardial 
infarction reported (R). 
Classification according to 
type (cardiorespiratory, 
surgical, infectious). 
Classification according to 
type (cardiorespiratory, 
surgical, infectious). 
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Table S5: Adverse event reporting  (continued) 
 
First 
Author 
Condition/ 
Population 
Definition and occurrence 
of intraoperative adverse 
event 
Definition and 
occurrence of 
postoperative adverse 
event 
Classification of intra-
operative adverse event 
Classification of 
postoperative adverse 
event 
Comments 
Bevis44* 
 
Open 
abdominal 
aortic 
aneurysm 
surgery 
No definition (M). No 
reporting (R). 
No definition. Indication 
that postoperative 
complication rates were 
recorded (M). Number of 
perioperative deaths 
(unrelated to inter-
vention) reported, reasons 
indicated (cardiac 
complication, intra-
abdominal bleeding within 
24h after surgery) and 
numbers of wound 
infections, small bowel 
obstruction requiring 
relaparotomy, conser-
vatively treated mesh 
seroma and incisional 
hernia (R). 
No classification (M, R).  No classification (M, R).  
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Table S5: Adverse event reporting  (continued) 
 
First 
Author 
Condition/ 
Population 
Definition and occurrence 
of intraoperative adverse 
event 
Definition and 
occurrence of 
postoperative adverse 
event 
Classification of intra-
operative adverse event 
Classification of 
postoperative adverse 
event 
Comments 
Reid46* 
 
Closure of 
ileostomy 
wounds 
No definition (M). Indication 
that there were no 
intraoperative 
complications (R). 
Surgical site infection (ssi) 
was defined according to 
the Centers for Disease 
Control (CDC) providing a 
reference paper (M). 
Indication that there were 
no anastomotic 
complications. Indication 
that postoperative 
complications were similar 
in both groups. Numbers 
with ssi, superficial wound 
dehiscence, drainage, 
intravenous/oral anti-
biotics and community 
nurse visits reported. 
Indication that there were 
no ssi-related 
reoperations and no 
readmissions (R). 
No classification (M, R). Surgical site infection 
classified as superficial or 
deep or organ/space 
infection. Other 
complications not classified 
(M, R). 
For summary 
statistics 
complications 
regarded as 
classified. 
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Table S5: Adverse event reporting  (continued) 
 
First Author Condition/ 
Population 
Definition and occurrence 
of intraoperative adverse 
event 
Definition and 
occurrence of 
postoperative adverse 
event 
Classification of intra-
operative adverse event 
Classification of 
postoperative adverse 
event 
Comments 
Nthumba 
47* 
 
Rub for 
surgical hand 
preparation in 
rural hospital in 
Kenya 
No definition (M). 
No reporting (R). 
Surgical site infection was 
defined referring to the 
Centers for Disease 
Control and Prevention 
(CDC) providing a refe-
rence paper. Tolerability 
and side-effects of skin 
preparation (M). Numbers 
with super-ficial, deep, 
organ/space infection 
reported, no skin 
reactions (R). 
No classification (M, R) Surgical site infection 
classified as superficial or 
deep or organ/space 
infection (M, R). 
For summary 
statistics 
complications 
regarded as 
classified. 
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Table S5: Adverse event reporting  (continued) 
 
First Author Condition/ 
Population 
Definition and occurrence 
of intraoperative adverse 
event 
Definition and 
occurrence of 
postoperative adverse 
event 
Classification of intra-
operative adverse event 
Classification of 
postoperative adverse 
event 
Comments 
Jayne49* 
and 49*add1 
 
Colorectal 
cancer 
No definition. Indication that 
complications during 
surgery were recorded (M). 
Numbers provided for 
clinically significant 
haemorrhage, cardiac/ 
pulmonary insufficiency, 
bowel/ureteric/vessel/ 
bladder injury (R). 
No definition (M). 
Indication that 
complications were 
recorded at 30d and 3 
months (M). At 30d, 
numbers provided for 
wound/chest infection, 
anastomotic dehiscence, 
deep vein thrombosis. At 
3 months, numbers 
provided for major and 
minor with indication that 
most frequently intestinal 
obstruction and wound 
infection occurred. In-
hospital mortality 
mentioned (R).  
No classification (M, R). Classification in major and 
minor (R). 
49*add1considered for 
this information 
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Table S5: Adverse event reporting  (continued) 
 
First Author Condition/ 
Population 
Definition and occurrence 
of intraoperative adverse 
event 
Definition and 
occurrence of 
postoperative adverse 
event 
Classification of intra-
operative adverse event 
Classification of 
postoperative adverse 
event 
Comments 
Chal-
mers50* 
 
Polytetra-
fluoroethylene 
arterial 
anastomoses 
No exact definition of 
intraoperative 
complications. Persisting 
bleeding at the 
anastomosis requiring 
adjunctive haemostatic 
measures as determined by 
the surgeon defined as 
eligibility criterion. Blee-
ding at the anastomosis at 
4, 7 and 10min defined as 
efficacy criterion (M). 
Achievement of haemo-
stasis reported, no intra-
operative complications 
except from number of 
patients fulfilling inclusion 
criteria reported (R). 
AE defined and classi-fied 
according to the Medical 
Dictionary for Regulatory 
Activities (MedDRAÒ) 
codes. Indication that AE 
potentially related to 
bleeding were recorded at 
5 weeks (M). Number of 
patients with AE (nausea, 
anaemia, cardiac failure, 
hypotension, constipation, 
graft infection, graft 
occlusion/ thrombosis, 
peripheral oedema, 
urinary tract infection) and 
complications potentially 
related to bleeding 
(anaemia/low haemo-
globin/low haematocrit, 
haematoma, bleeding, 
increased sanguinous 
drainage, seroma and 
bruising) reported (R). 
No classification (M, R). Medical Dictionary for 
Regulatory Activities 
(MedDRAÒ) codes, System 
Organ Class being the 
highest level of the 
hierarchical terminology, 
distinguishing by 
anatomical or physiological 
system, etiology, or 
purpose (M, R). 
 
In summary 
statistics, 
intraoperative 
complications 
considered as 
defined, taking the 
eligibility criterion 
as definition.  
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Table S52: Adverse event reporting  (continued) 
 
First 
Author 
Condition/ 
Population 
Definition and occurrence 
of intraoperative adverse 
event 
Definition and 
occurrence of 
postoperative adverse 
event 
Classification of intra-
operative adverse event 
Classification of 
postoperative adverse 
event 
Comments 
Watana-
be51* 
 
Colonic 
cancer 
resection 
No definition (M). Median 
operative blood loss 
indicated and notion that no 
problems with the stapling 
device occurred and that 
the frequency of spillage of 
bowel content during 
surgery did not differ 
between groups (R). 
Definition of surgical site 
infections (ssi) with 
reference. Indication that 
daily records of 
postoperative course 
were obtained, and 
infectious complications 
were recorded for up to 
30 days after surgery. 
Numbers of patients with 
complications (ssi or 
paralytic ileus) reported 
(R). 
No classification (M, R) Classification of surgical 
site infections according to 
severity in superficial 
incisional, deep incisional 
and organ/space (M, R).  
For summary 
statistics 
complications 
regarded as 
classified. 
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Appendix Table S6: Classification of postoperative complications(Dindo, Demartines, & Clavien 
2004)  
 
Grade Definition 
Grade I Any deviation from the normal postoperative course without the need for 
pharmacological treatment or surgical, endoscopic, and radiological 
interventions.  
Allowed therapeutic regimens are: drugs as antiemetics, antipyretics, 
analgetics, diuretics, electrolytes, and physiotherapy. This grade also 
includes wound infections opened at the bedside 
Grade II Requiring pharmacological treatment with drugs other than such allowed 
for grade I complications. Blood transfusions and total parenteral nutrition 
are also included 
Grade III Requiring surgical, endoscopic or radiological intervention 
- Grade IIIa - Intervention not under general anesthesia 
- Grade IIIb - Intervention under general anesthesia 
Grade IV Life-threatening complication (including CNS1 complications)2 requiring 
IC3/ICU4 management 
- Grade IVa    - Single organ dysfunction (including dialysis) 
- Grade IVb    - Multiorgan dysfunction 
Grade V Death of a patient 
Suffix “d” If the patient suffers from a complication at the time of discharge, the suffix 
“d” (for “disability”) is added to the respective grade of complication. This 
label indicates the need for a follow-up to fully evaluate the complication. 
 
  
1 CNS= Central nervous system 
2 Brain hemorrhage, ischemic stroke, subarrachnoidal bleeding, but excluding transient ischemic attacks. 
3 IC= Intermediate care 
4 ICU= Intensive care unit 
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Appendix Table S7: Definition of Surgical Site Infection (SSI)(Mangram, Horan, Pearson, Silver, & 
Jarvis 1999b)  
Type Definition 
Superficial 
Incisional SSI 
 
Infection occurs within 30 days after the operation and infection involves 
only skin or subcutaneous tissue of the incision and at least one of the 
following: 
1. Purulent drainage, with or without laboratory confirmation, from the 
superficial incision. 
2. Organisms isolated from an aseptically obtained culture of fluid or tissue 
from the superficial incision. 
3. At least one of the following signs or symptoms of infection: pain or 
tenderness, localized swelling, redness, or heat and superficial incision is 
deliberately opened by surgeon, unless incision is culture-negative. 
4. Diagnosis of superficial incisional SSI by the surgeon or attending 
physician.  
 
Do not report the following conditions as SSI: 
1. Stitch abscess (minimal inflammation and discharge confined to the 
points of suture penetration). 
2. Infection of an episiotomy or newborn circumcision site. 
3. Infected burn wound. 
4. Incisional SSI that extends into the fascial and muscle layers (see deep 
incisional SSI). 
 
Note: Specific criteria are used for identifying infected episiotomy and 
circumcision sites and burn wounds. 
Deep incisional 
SSI 
 
Infection occurs within 30 days after the operation if no implant1 is left in 
place or within 1 year if implant is in place and the infection appears to be 
related to the operation and infection involves deep soft tissues (e.g., 
fascial and muscle layers) of the incision and at least one of the following: 
1. Purulent drainage from the deep incision but not from the organ/space 
component of the surgical site. 
2. A deep incision spontaneously dehisces or is deliberately opened by a 
surgeon when the patient has at least one of the following signs or 
symptoms: fever (>38ºC), localized pain, or tenderness, unless site is 
culture-negative. 
3. An abscess or other evidence of infection involving the deep incision is 
found on direct examination, during reoperation, or by histopathologic or 
radiologic examination. 
4. Diagnosis of a deep incisional SSI by a surgeon or attending physician. 
 
 
1 National Nosocomial Infection Surveillance definition: a nonhuman-derived implantable foreign body (e.g., prosthetic heart 
valve, nonhuman vascular graft, mechanical heart, or hip prosthesis) that is permanently placed in a patient during surgery. 
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Appendix Table S7: Definition of Surgical Site Infection (continued) 
Type Definition 
Deep incisional 
SSI (continued) 
 
Notes: 
1. Report infection that involves both superficial and deep incision sites as 
deep incisional SSI. 
2. Report an organ/space SSI that drains through the incision as a deep 
incisional SSI. 
Organ/space SSI 
 
Infection occurs within 30 days after the operation if no implant1 is left in 
place or within 1 year if implant is in place and the infection appears to be 
related to the operation and infection involves any part of the anatomy 
(e.g., organs or spaces), other than the incision, which was opened or 
manipulated during an operation and at least one of the following: 
1. Purulent drainage from a drain that is placed through a stab wound1 into 
the organ/space. 
2. Organisms isolated from an aseptically obtained culture of fluid or tissue 
in the organ/space. 
3. An abscess or other evidence of infection involving the organ/space that 
is found on direct examination, during reoperation, or by histopathologic or 
radiologic examination. 
4. Diagnosis of an organ/space SSI by a surgeon or attending physician. 
 
  
1 If the area around a stab wound becomes infected, it is not an SSI. It is considered a skin or soft tissue infection, depending 
on its depth. 
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Appendix Text (including illustrations) S1: Questions and summary results 
round 1, questions round 2 
 
1. Overall usefulness of a classification of intraoperative complications 
Question round 1  
How do you rate the overall usefulness of a classification of intraoperative 
complications (1=not useful at all, 9=very useful)? 
 
Summary results 
The experts seemed to be in favour of a classification (which is as well supported 
by the tick box answers), although they thought that it is a challenge to find a 
uniform system. One expert suggested the use of CTCAE (Common Terminology 
Criteria for Adverse Events)(U.S.Department of Health and Human Services 
2014), which could be well-applicable to postoperative complications, however 
might lead to an upgrading of events when used for intraoperative complications, 
since many of these will be resolved surgically and thus graded III or higher. We 
are well aware that most importantly complications should be avoided and that 
confounding factors associated to the patient and the surgeon should be taken into 
account.  
We think that a classification system for intraoperative complications will allow for 
standardized reporting of intraoperative events and deviations from the ideal 
intraoperative course. This is important in the following context:  
· Standardization of reporting of evaluations of new surgical techniques and 
devices 
· Standardization of reporting in educational and training settings 
· Capture of intraoperative events with increased risk of postoperative 
complications for a critical incidents reporting system 
· Enhanced patient handover quality after surgery concerning anticipated 
problems.  
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2. Definition of intraoperative complications of intraoperative complications 
 
2.1. Distinction 
Questions round 1  
Please rate on a scale between 1 and 9 the appropriateness of including the 
following items in a definition of intraoperative complication (1=not appropriate at 
all, 9= completely appropriate). 
Sequelae: A definition of intraoperative complications needs to distinguish 
complications from sequelae, i.e. effects inherent to the surgery (such as the 
inability to walk after an amputation of a leg) 
Nocure: A definition of intraoperative complications needs to distinguish 
complications from failures of cure (such as residual tumor after surgery) 
Disease: A definition of intraoperative complications needs to distinguish 
complications from events related to the underlying disease (such as bleeding 
from a ruptured abdominal aortic aneurysm) 
Indication: A definition of intraoperative complications should NOT refer to errors in 
indication (such as wrong-side surgery) 
 
 
Summary results sequelae 
Most experts highly agreed with this distinction (tick box answers), however 
suggested a more precise description to distinguish effects inherent to the “index 
surgery” as initially planned for the respective pathology (e.g. aimed life-saving leg 
amputation) versus the same intervention to treat a complication (“consecutive 
surgery” e.g. leg amputation after an infected femoro-popliteal graft). 
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Additionally, it was pointed out that not every intraoperative complication leads to a 
long-term disability, to which we entirely agree. The developed system is however 
intended to capture both immediate and long-term consequences. 
The differentiation between an effect inherent to the intervention and a suboptimal 
result, e.g. in trauma surgery, may not be clear cut, especially with differences in 
surgeons’ expertise. We suggest considering those effects as sequelae which are 
evident (i.e. lack of joint function after arthrodesis) or which are inherent given 
optimal treatment according to current guidelines.  
We are aware that after leg amputation a patient is still able to walk with crutches 
or a prosthesis, yet think that this example is intuitively illustrative. 
 
Question round 2 
Based on these answers, we kindly ask you to rate the following updated definition 
(1= not at all appropriate, 9 = completely appropriate):  
A definition of intraoperative complications needs to distinguish complications from 
sequelae, i.e. effects inherent to current best practice surgery (such as the inability 
to walk after amputation of a leg). It should refer to the index surgery and not to 
potential follow-up surgeries to treat a complication. 
 
Summary results nocure 
Again, most experts seemed to agree with this distinction (tick box answers, see 
above), but pointed out the importance of expertise in the field.  
We agree with the experts that a failure of planning a complex intervention should 
be accounted for, however we think this should be rather accounted for as 
misjudgement in indication than as intraoperative event (although this may actually 
become evident only intraoperatively). 
If a patient is judged as inoperable due to an advanced tumor stage, we would not 
apply the classification, since he/she has not been operated on. Therefore, we 
cannot compare failure of cure rates between more or less “aggressive” surgeons. 
Question round 2 
Based on these answers, we kindly ask you to rate the following updated definition 
(1= not at all appropriate, 9 = completely appropriate):  
A definition of intraoperative complications needs to distinguish complications from 
failures of cure (such as residual tumor after surgery), under the condition the 
indication for surgery and the interventions conform to current guidelines.  
 
Summary results disease  
Experts seemed to agree that this distinction should be made (tick box answers, 
see above). Again, failures in indication were pointed out to be relevant as well, to 
which we entirely agree. As mentioned above, we suggest rather accounting for 
these instances as misjudgement in indication than as intraoperative event. 
Additionally, it was suggested to refer to optimal treatment, since some of these 
events potentially could have been prevented given optimal treatment. 
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Question round 2 
Based on these answers, we kindly ask you to rate the following updated definition 
(1= not at all appropriate, 9 = completely appropriate):  
A definition of intraoperative complications needs to distinguish complications from 
events related to the underlying disease (such as bleeding from a ruptured 
abdominal aortic aneurysm or intraoperative sepsis due to a purulent peritonitis 
associated to a perforated appendicitis), under the condition the indication for 
surgery and the interventions conform to current guidelines.  
 
Summary results indication 
Here, the expert opinions were contradictory. While some experts felt that 
indication belongs to the surgical procedure itself and thus wrong-site surgery is 
an intraoperative complication, others felt that errors in indication do not belong to 
the intraoperative phase. Moreover, it was suggested to distinguish between errors 
such as wrong site surgery and other errors in indication. We are well aware that 
indication is a crucial step of surgery; we propose however to limit this 
classification to the “gesture” of surgery itself and to describe errors in indication 
separately and not as intraoperative complications.   
 
Question round 2 
Based on these answers, we kindly ask you to rate the following updated definition 
(1= not at all appropriate, 9 = completely appropriate):  
A definition of intraoperative complications should NOT refer to wrong-side or 
wrong-patient surgery and NOT to errors in indication (such as inappropriate 
indication for surgery according to current guidelines). 
 
2.2. Wording 
 
Questions round 1 
Please rate on a scale between 1 and 9 the appropriateness of including the 
following items in a definition of intraoperative complication (1=not appropriate at 
all, 9= completely appropriate). 
Deviation from ideal intraop. course: A definition of intraoperative complications 
may be formulated as ‘any deviation from the ideal intraoperative course’ 
Complication: The definition (and classification) should contain the word 
‘complication’ (see as well next two questions) 
Unforeseen event: The definition (and classification) should contain the word 
‘unforeseen event’ instead of ‘complication’ 
Deviation from ideal course: The definition (and classification) should contain the 
word ‘deviation from the ideal course’ instead of ‘complication’ 
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Summary deviation from ideal intraoperative course  
Although quite some of the experts felt that this definition was completely 
appropriate, many disagreed. The rationale was that it may be difficult to define 
what is ideal and that not every deviation from the ideal course is a complication, 
for instance in case of an unexpected anatomical difficulty found upon surgery. 
Moreover, some minor deviations such as a thread rupture upon knot tying that is 
corrected may be a deviation, but without any consequence. Else an intervention 
taking longer than planned may not actually be a complication, if not patient-
relevant (disregarding cost). We agree with the issue that many complications may 
not be patient-relevant, but propose to keep the definition as such, however to 
grade these events differently according to their consequences and severity. 
Additionally, it was suggested to limit the definition to factors that are avoidable 
such as avoidable bleeding.  
 
Summary complication:  
The word complication was more uniformly accepted, since it is less subject to 
interpretation. It was however suggested to add defined qualifiers.  
 
Summary unforeseen event  
Regarding the tick box answers, this terminology was rather not accepted, 
although some felt unforeseen event and complication rather to be synonyms, 
whereas others disagreed on that issue. It was pointed out that such a definition 
would as well include instances not necessarily related to the operative procedure, 
such as on table myocardial infarction. As a matter of fact, many definitions for 
postoperative complications include both surgical and medical complications; 
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therefore this principle could apply as well to intraoperative complications. 
Additionally, it was pointed out that such a definition would be the most neutral 
encouraging surgeons to record it, while the term complication would be avoided, 
since it might be associated with legal problems. It was also pointed out that many 
complications are predictable and included in the informed consent process, 
although they are definitively unwanted.  
 
Summary deviation from the ideal course  
Regarding the tick box answers, reviewing this question after considering different 
other options seems not to be in favour of this wording. Once more, it was pointed 
out that such a deviation may be well due to the underlying disease and not to the 
operation itself, while others felt that this could be a definition or description of or 
for “complication”. Additionally, it was pointed out that not every undesired event is 
actually preventable.  
 
Question round 2 
Based on these answers, we kindly ask you to rate the following updated definition 
(1= not at all appropriate, 9 = completely appropriate):  
A definition of intraoperative complications may be formulated as ‘any preventable 
deviation from the ideal intraoperative course’ 
 
2.3. Time period 
 
Questions round 1 
Please rate on a scale between 1 and 9 the appropriateness of including the 
following items in a definition of intraoperative complication (1=not appropriate at 
all, 9= completely appropriate). 
 
Surgery: A definition of intraoperative complications should include the following 
time period: Surgery only (i.e. between skin incision and skin closure) (see as well 
next two questions) 
Induction of anesthesia and surgery: A definition of intraoperative complications 
should include the following time period: Induction of anesthesia and surgery 
Induction, surgery, termination: A definition of intraoperative complications should 
include the following time period: Induction of anesthesia, surgery and termination 
of anesthesia (defined as end of continuous presence of a member of the 
anesthesiology team (for example transfer to the recovery room or transfer to the 
ICU) 
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Summary surgery 
Here, the results were conflicting, some strongly suggested to include the period 
between skin incision and closure only (however including anesthesia-related 
complications during this period), whereas others focussed on the team 
performance including anesthesia. Others preferred to decide individually, i.e. if 
the focus was to compare two surgical techniques, not to include anesthesia, as 
opposed to when special anesthesia techniques were investigated.  
Some commented that positioning on the table belongs to surgery, while others 
disagreed. It was as well pointed out that some intraoperative complications may 
become evident only postoperatively and in that case the follow-up should even be 
longer (this was discussed in a separate question).  
Summary induction of anesthesia and surgery  
When specifically asked, if induction should be included, most disagreed (tick box 
answers), which was well reflected by the free text comments. Some suggested 
calling these perioperative complications, whereas others would call them 
anesthesia-related complications. Here again, it was stressed that complications 
that become evident only later, but have their origin in the surgical procedure, 
should be included, such as an intraabdominal abscess secondary to 
inappropriate intraoperative handling of a bowel injury.   
Summary induction, surgery, termination 
Again, both the tick box answers as well as the comments suggested quite 
contradictory views. While some strongly advocated limiting the period to the time 
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between skin incision and closure (e.g. not to include a tubus-related, central line 
or arrhythmia problem upon induction), others thought it to be mandatory to 
overview the whole process of surgical treatment including both induction and 
anesthesia (which the former then would rather call perioperative or periprocedural 
complication than intraoperative complication). It was pointed out that if induction 
was included, termination consequently should also be included.  
Summary time period overall 
It was recognized that the issue is controversial and each definition has advantages 
and disadvantages, most frequently it was suggested to distinguish between 
intraoperative complications (regardless when they become manifest) and 
perioperative complications (the latter including induction and termination). As major 
drawback it was pointed out that including induction and termination would render 
such a classification more complex and potentially less useful to surgeons.  
 
Questions round 2 
Based on these answers, we kindly ask you to rate the following updated definition 
(1= not at all appropriate, 9 = completely appropriate):  
A definition of intraoperative complications should include the following time period 
of event occurrence (disregarding time point of event manifestation): Surgery only 
(i.e. between skin incision and skin closure) and should be distinguished from 
perioperative complications including anesthesia induction and termination.  
 
It additionally seems important to clarify, what sort of complications should be 
captured, i.e. both “surgical” and “medical” (as it is the case in the Clavien-Dindo 
complication classification (Dindo, Demartines, & Clavien 2004)) or only “surgical”. 
In our opinion, making a distinction between surgical and medical is not always 
obvious; therefore it seems more practical to include both. If for instance a patient 
shows signs of cardiac ischemia during abdominal surgery, this could be due to an 
underlying coronary disease or this could be in the context of severe bleeding 
during surgery or both. Similarly, intraoperative death would be recorded regardless 
the origin.  
Therefore, please rate the following question (1= not at all appropriate, 9 = 
completely appropriate): 
A definition of intraoperative complications should include any event occurring 
during surgery, regardless whether it is related to the surgical gesture itself or not.  
 
3. Classification of intraoperative complications 
3.1. Type 
 
Questions round 1 
Severity: A classification of intraoperative complications should be undertaken 
according to severity (see as well the next question) 
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Organ: A classification of intraoperative complications should be undertaken 
according to the injured organ regardless of severity 
Consequence: If a classification of intraoperative complications is undertaken 
according to severity, shall the classification be undertaken according to the 
resulting treatment (similar to the classification of postoperative complications 
according to Clavien-Dindo (Dindo, Demartines, & Clavien 2004))? 
 
 
Summary severity  
Here, the tick box answers were in favour of a classification according to severity. 
It was pointed out that the severity should take into account the potential resulting 
morbidity, since for instance a millimetric injury to the duodenum could be much 
more dangerous than to the ileum or colon.  
One expert suggested having two surgeons classify events. We believe that this is 
a very important point, although sometimes there are not two surgeons available, 
but for instance one surgeon and one student or junior resident or sometimes the 
assistant may not be the same throughout the intervention. Moreover, in strongly 
hierarchical settings it might be difficult to find consensus. In an ideal setting, for 
instance in a clinical research setting, one could have two blinded raters who 
independently carry out the classification, whereas in every day practice, this 
might be more difficult.  
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Question round 2 
Based on these answers, we kindly ask you to rate the following:  
(1= not at all appropriate, 9 = completely appropriate):  
A classification of intraoperative complications should be undertaken by two 
independent surgeons.  
Summary organ  
The experts were not in favour of a classification according to the injured organ, as 
supported as well by the free text options favouring a patient-outcome centred 
approach with optimal generalizability.  
 
Summary consequence  
Whereas the tick box answers seemed rather in favour of a classification 
according to the resulting treatment, because the degree of invasiveness seems to 
go along with the degree of severity, it was advocated to consider as well the 
patient outcomes such as sequelae and quality of life. Additionally, it was 
suggested to distinguish between minor versus major complications as well as 
between complications with transient versus permanent consequences.  
 
Question round 2 
Based on these answers, we kindly ask you to rate the following updated definition 
(1= not at all appropriate, 9 = completely appropriate):  
A classification of intraoperative complications should consider the severity of the 
complication and take into account both the necessary treatment and permanent 
“sequelae” (i.e. disability) resulting from the complication.  
3.2. Grades 
Question round 1 
How many grades should a classification of intraoperative complications according 
to severity include (see also the next question)? 
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Summary grades 
The tick-box answers were in favour of 4 or 5 degrees, although we were well 
aware that it was difficult to decide on this issue at that point in time. Some 
suggested to keep it as simple as possible, while others felt that less than four 
would not be enough differentiated. It was suggested to align the number with the 
one in the postoperative complication scoring. Additionally, it was referred to the 
CTCAE (U.S.Department of Health and Human Services 2014), which foresee five 
degrees of severity, however allow for some not to be applicable depending on the 
type of adverse event.  
Question round 1 
Should sub-classifications be allowed in a classification of intraoperative 
complications according to severity? 
 
Summary subgrades:  
The inclusion of sub-classifications was rather preferred, however only if adding 
important information and if not rendering the classification too complex. 
 
3.3. Time 
 
Questions round 1 
Directly after surgery: Should it be possible to definitively fill in a classification of 
intraoperative complications directly after surgery, i.e. only intraoperative, but not 
postoperative outcomes are considered (see also next 3 questions)? 
Short-term: Should information collected during the short-term postoperative 
course (up to 30 days postoperatively) be accounted for in the classification of 
intraoperative complications? 
Example: Should intraoperative complications (e.g. thermic small bowel injury with 
perforation or foreign body left in place) that are not recognized intraoperatively, 
but only postoperatively, be taken into account in the classification of 
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intraoperative complications (consequently the classification may not be 
definitively filled in immediately postoperatively)? 
Mid-term: Should information collected during the mid-term postoperative course 
(up to 6 months postoperatively) be accounted for in the classification of 
intraoperative complications? 
Example: Should permanent organ dysfunction (e.g. brain, kidney) resulting from 
severe hypotension due to intraoperative bleeding be accounted for in the 
classification of intraoperative complications? Should hoarseness after 
thyroidectomy be followed up to distinguish transient from permanent recurrent 
nerve injury? Consequently, the classification may not be definitively filled in 
immediately postoperatively. 
Long-term: Should information collected during the long-term postoperative course 
(>6 months postoperatively) be accounted for in the classification of intraoperative 
complications? 
Example: Should permanent organ dysfunction (e.g. liver) resulting from common 
bile duct dissection be accounted for in the classification of intraoperative 
complications? Consequently the classification may not be definitively filled in 
immediately postoperatively. 
 
 
Summary directly after surgery  
The tick box answers reflect the free-text answers suggesting that some 
intraoperative complications are recognized only later. It was suggested to fill in 
the classification immediately after surgery and thus including it in the report of the 
intervention, however leaving an option to “correct” the classification, in case a 
complication during surgery becomes evident later. It was however also warned 
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that an extension of the time-period considered may lead to a confusion with 
classification systems for postoperative complications, such as the Clavien-Dindo 
system (Dindo, Demartines, & Clavien 2004).  
 
Summary short term 
The tick box answers seemed rather in favour of an inclusion of the short-term 
period, whereas the free-text answers again pointed out the advantages and 
disadvantages of the two approaches. Whereas it would be more accurate to 
include an option of “updating” the classification later (in analogy to the TNM 
system), feasibility might be hampered and thus complications becoming evident 
later could be handled with a classification of postoperative complications. It was 
pointed out that if a classification at a later point in time shall be allowed, initial 
classification should in any case take place as well to avoid a potential recall bias. 
Moreover, it was suggested to take into account that a differentiation between 
intraoperative complication becoming evident only later and a postoperative 
complication independent from the initial surgery might sometimes be very 
challenging, not always allowing causal inference.  
 
Summary mid-term 
Here, experts seemed to be slightly more in favour of not including such a long 
follow-up period. One expert pointed out to end at 3 months instead of 6 months, 
whereas others felt that more than 30 days is not realistic. It was again argued that 
causal inference is not clear, for instance hoarseness after thyroid surgery may be 
due to oedema or an injury. Moreover, permanent disability could be captured with 
a classification for postoperative complications. On the other hand, it was stressed 
that some complications becoming evident only postoperatively may be very 
clearly attributed to the initial surgery (e.g. foreign body left in place) and thus 
should be captured with the classification of intraoperative complications. 
 
Summary long-term 
Here, again experts rather felt that this might be too long, whereas others felt that 
functional long-term results are important. It was referred to the APGAR score as 
example of a score that may be immediately filled in regardless long-term 
outcome, although it is not strictly comparable, because all the information 
relevant to fill in the APGAR score is immediately available and does not become 
apparent only days thereafter, but we agree that the score does not take into 
account long-term outcomes, even though it may be associated with them.  
 
Comment and questions round 1 
In order to address the issue of different follow-up times, we proposed to include a 
prefix indicating the follow-up time: iCLASSIC for filling in the classification 
immediately after surgery and accounting for the intraoperative course only versus 
pCLASSIC for filling in the classification accounting for the postoperative course. 
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To include the exact time-point of assessment, one could imagine replacing the i 
and p by the time-point, e.g. 0CLASSIC for immediately after surgery, 
30dCLASSIC for 30 days, and 6mCLASSIC for 6 months after surgery. Repeated 
measurements could be taken into account per patient. 
i/pCLASSIC: Should the classification allow for differentiation of the timepoint of 
assessment of intraoperative complications by a prefix distinguishing between 
iCLASSIC for immediately after surgery and pCLASSIC accounting for the 
postoperative course (see as well the next question)? 
timeCLASSIC: Should such a prefix include more precise information about the 
duration of follow-up, e.g. 30dCLASSIC for a follow-up up to 30 days 
postoperatively? 
 
Summary i/pCLASSIC  
Experts were rather in favour for such a distinction, although comments pointed 
out again the difficult distinction between pCLASSIC and any system of 
classification of postoperative complications (with the only difference being the 
cause, which anyhow sometimes would be difficult to evaluate). Moreover, it was 
doubted that classifications evaluated at different time-points allow for 
comparisons. Clearly, in our opinion, if we allow for immediate and later 
classification, everyone should fill in the iCLASSIC and pCLASSIC would be an 
add-on.  
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Summary timeCLASSIC 
Here, quite some felt that this is inappropriate, as reflected by additional 
comments, since it is too complex, not everyone might choose the same time-point 
hampering comparison and it would end-up in different grades over time. One 
expert suggested taking into account only the highest grade to correct over time.  
Question round 1 
For which follow-up periods should intraoperative complications be assessed 
(several options possible)? 
 
 
 
Summary 
Whereas the tick box answers suggested the inclusion of the time of surgery and 
the 30d follow-up, the free-text answers were more in favour of only including the 
intraoperative time-period, for the reasons mentioned above. It was additionally 
suggested that this may not be generalized, since every surgical branch might be 
different. 
Question round 2 
Based on these answers, we kindly ask you to rate the following updated definition 
(1= not at all appropriate, 9 = completely appropriate):  
Should it be possible to definitively fill in a classification of intraoperative 
complications directly after surgery, whereas complications apparent only after 
surgery are handled with a classification system for postoperative complications? 
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3.4. Classification 
 
Proposed classification and question round 1 
The following questions refer to the initially proposed classification of 
intraoperative complications below: 
 
Table: Proposed Classification of intraoperative complications (CLASSIC) 
Please note that the classification could be denoted with a prefix indicating the 
time-point of assessment. Examples indicated mostly refer to abdominal surgery; 
however, the classification is intended to be used in any surgical discipline. 
IC=intermediate care; ICU=intensive care unit. 
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Grade Definition Examples 
Grade I Any deviation from the ideal 
intraoperative course 
· Without the need for any 
additional treatment or 
intervention  
· Bleeding: Self-limiting bleeding at trocar 
site 
· Injury: Electrocautery injury to parietal 
peritoneum 
· Non-surgical: self-limiting arrhythmia 
Grade II Any deviation from the ideal 
intraoperative course 
· Requiring pharmacological 
treatment, plasma volume 
expansion, coagulation 
products or blood transfusion 
· Not life-threatening and not 
leading to permanent 
disability  
Note: Routine medications and 
infusions to maintain anaesthesia 
are not considered as treatment. 
Blood transfusions for 
preoperative anaemia are not 
considered as treatment 
· Bleeding: Plasma volume expansion for 
transient abundant venous bleeding from 
presacral venous plexus at rectal surgery 
· Non-surgical: Antiarrhythmic treatment 
 
Grade III Any deviation from the ideal 
intraoperative course  
· With the need for an 
additional surgical/endoscopic 
intervention  
· Not life-threatening and not 
leading to permanent 
disability 
 
· Grade IIIa With organ preservation and low 
risk of long-term disability 
· Bleeding: Redo-vascular anastomosis for 
bleeding 
· Injury: Suture of iatrogenic bladder injury 
at rectum resection 
· Injury: Direct closure with suture of 
iatrogenic small bowel injury 
· Injury: Chest tube insertion for accidental 
iatrogenic pneumothorax 
· Grade IIIb With loss of organ or part of organ 
and low risk of long-term disability 
· Bleeding: Splenectomy for bleeding 
complication at left hemicolectomy  
· Injury: Short segmental resection of small 
bowel for iatrogenic injury 
· Injury: Cholecystectomy for incidental 
gallbladder injury  
 
Grade IV Any deviation from the ideal 
intraoperative course  
· With the need for an 
additional intervention 
· Life-threatening (requiring 
IC/ICU management) and/or 
leading to permanent 
disability or with a high risk of 
permanent disability 
 
· Bleeding: Hypovolemic shock due to 
laceration of the caval vein at right 
adrenalectomy  
· Injury: Roux-en-y reconstruction for major 
bile duct injury  
· Injury: Accidental transection of femoral 
nerve 
· Injury: Bilateral transection of recurrent 
laryngeal nerve 
· Non-surgical: anaphylactic shock from 
routine antimicrobial prophylaxis 
Grade V Death of a patient · Bleeding: Death from hypovolemic shock 
· Non-surgical: Death from myocardial 
infarction 
211 
 
   
 
Classification overall: OVERALL, how appropriate is the proposed classification of 
intraoperative complications (see as well next five questions)? 
Class I: How appropriate is the proposed CLASS I type of intraoperative 
complications? 
Class II: How appropriate is the proposed CLASS II type of intraoperative 
complications? 
Class III: How appropriate is the proposed CLASS III type of intraoperative 
complications? 
Class IV: How appropriate is the proposed CLASS IV type of intraoperative 
complications? 
Class V: How appropriate is the proposed CLASS V type of intraoperative 
complications? 
 
 
Summary classification overall  
Concerning the tick box answers, the experts were rather in favour of the 
proposed classification and the grades, although to a lower extent of grade I and 
II.  
In general, the classification was criticised for being too complicated, whereas the 
contrary was as well the case, one expert pointing out that it was too broad for 
instance compared to the CTCAE(U.S.Department of Health and Human Services 
2014).  
Again, the wording ‘any deviation from the ideal intraoperative course’ was felt to 
be inappropriate, since ideal or normal is difficult to define and since some 
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deviations are not preventable and not considered as complication. In contrast, 
they are important, such as a deviation due to an unexpected anatomical situation. 
As mentioned above, this could be handled by adding any ‘preventable’ deviation 
from the ideal course, ‘given optimal treatment according to current guidelines’. 
It was pointed out that in some specialties such as cardiac surgery, grade I-II 
complications are very frequent, for instance bleeding due to preoperative 
administration of anti-platelet drugs; that in major liver surgery for instance 
bleeding is difficult to define, since it may be part of a routine course and a 
definition over transfusion requirement would not seem to be appropriate in such a 
case. In neurosurgery, a single non-life-threatening, but persistent deficit should 
be taken into account with the classification.  
Some felt the classification to be too similar to the Clavien-Dindo classification for 
postoperative complications (Dindo, Demartines, & Clavien 2004) and it was 
therefore suggested to use the Clavien-Dindo Classification for intraoperative 
complications as well. It was as well suggested to test practicability in a 
retrospective cohort, as foreseen. The use of the Clavien-Dindo classification for 
intraoperative complications would again have the disadvantage of “upgrading” 
complications requiring a surgical intervention, since intraoperatively an additional 
surgical gesture would more deliberately be carried out as compared to after 
completion of the surgery. 
 
Summary class I  
This and the following questions refer to “grade”, although it was misleadingly 
called “class”. It was pointed out by the experts that class I complications are 
irrelevant to the patients’ health and that they happen so often that most likely they 
will not be listed anyhow. Conversely, it was proposed to include subcategories for 
grade I. It was as well suggested to introduce a grade 0 for no complication. In our 
opinion, a grade I might still be interesting in research settings, although we agree 
that in daily practice such complications most likely would not be mentioned. For 
analysis, grades 0 and 1 could be taken together anyhow.   
 
Summary class II  
It was questioned whether a bleeding managed with plasma volume expansion is 
less severe than a suture of a iatrogenic small bowel injury and that a surgically 
managed bleeding was not listed to belong to grade II. Additionally, it was 
mentioned that plasma volume expansion is difficult to define. Moreover, it was 
suggested to include a measure of preoperative patient morbidity, since indication 
for interventions such as blood transfusions depend on comorbidity.  
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Summary class III:  
It was pointed out to be unclear whether a conversion to open procedures is 
regarded as additional surgical intervention. Additionally, low versus high risk of 
long-term disability was criticised for a lack in definition. 
 
Summary class IV:  
Experts seemed to feel the grading somewhat arbitrary or in other words that it is 
difficult to decide whether a bile duct injury is “worse” than a massive bleeding with 
massive blood transfusions. The definition of an additional intervention seemed 
not clear, i.e. is revision surgery included in this definition? The requirement for an 
additional intervention seemed to be estimated as rather a lower grade than grade 
IV. 
Summary class V  
While some felt that at least death was a clear definition, it was pointed out that 
the definition was lacking which time period should be included. This was handled 
previously in the questions referring to which time interval should be included. 
Questions round 2 
Based on these answers, we updated the classification as follows:  
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Table: Proposed updated Classification of intraoperative complications (CLASSIC) 
Grade Definition 
Grade 0 No preventable1 deviation from the ideal intraoperative 
course, under the condition the indication for surgery and 
the interventions conform to current guidelines.  
Grade I Any preventable deviation from the ideal intraoperative 
course, under the condition the indication for surgery and 
the interventions conform to current guidelines. 
· Without the need for any additional treatment or 
intervention  
Grade II Any preventable deviation from the ideal intraoperative 
course, under the condition the indication for surgery and 
the interventions conform to current guidelines. 
· With the need for any additional treatment or intervention 
· Not life-threatening and not leading to permanent disability  
Grade III Any preventable deviation from the ideal intraoperative 
course, under the condition the indication for surgery and 
the interventions conform to current guidelines. 
· With the need for any additional treatment or intervention 
· Life-threatening and/or leading to permanent disability 
Grade IV Any preventable deviation from the ideal intraoperative 
course, under the condition the indication for surgery and 
the interventions conform to current guidelines. 
· With death of the patient 
 
 
We kindly ask you to rate the updated classification as presented in this table (1= 
not at all appropriate, 9 = completely appropriate).  
Should complications needed to be dichotomised for further analysis (which we 
not necessarily advocate), we propose to summarize grades I-II together as “minor 
complications” versus grades III-IV as “major complications” (1= not at all 
appropriate, 9 = completely appropriate):  
 
 
 
 
 
1 an unpreventable deviation could be for instance a deviation due to an unexpected anatomical situation 
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Appendix Text (including illustrations) S2: Results round 2 
1. Definition of intraoperative complications 
 
1.1. Distinction  
 
Questions round 2 
Based on these answers of round 1, we kindly ask you to rate the following 
updated definition (1= not at all appropriate, 9 = completely appropriate): 
Sequelae: A definition of intraoperative complications needs to distinguish 
complications from sequelae, i.e. effects inherent to current best practice surgery 
(such as the inability to walk after amputation of a leg). It should refer to the index 
surgery and not to potential follow-up surgeries to treat a complication. 
Failure to cure: A definition of intraoperative complications needs to distinguish 
complications from failures of cure (such as residual tumor after surgery), under 
the condition the indication for surgery and the interventions conform to current 
guidelines.  
Disease: A definition of intraoperative complications needs to distinguish 
complications from events related to the underlying disease (such as bleeding 
from a ruptured abdominal aortic aneurysm or intraoperative sepsis due to a 
purulent peritonitis associated to a perforated appendicitis), under the condition 
the indication for surgery and the interventions conform to current guidelines. 
Indication error: A definition of intraoperative complications should NOT refer to 
wrong-side or wrong-patient surgery and NOT to errors in indication (such as 
inappropriate indication for surgery according to current guidelines) 
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Summary sequelae 
Experts seemed largely to agree with this definition (tick box answers). One expert 
again pointed out that sequelae could be the result of poor surgical practice. We 
entirely agree, but think that the addendum ‘best practice’ should rule out such 
cases. Another expert pointed out that the sentence about index surgery was 
unclear.  
 
Update 
We thus update the definition as follows:  
A definition of intraoperative complications needs to distinguish complications from 
sequelae, i.e. effects inherent to current best practice surgery (such as the inability 
to walk after amputation of a leg). It should refer to complications occurring during 
the index surgery and not to those occurring during potential follow-up surgeries to 
treat a complication. 
 
Summary nocure 
Again, the tick box answers suggested that the reviewers agreed with this 
distinction. The importance of adequate staging was pointed out and is already 
accounted for in the provided definition. We agree that failure to cure is an 
important predictive parameter for long-term outcome. It was additionally 
suggested to slightly shorten the definition (replace ‘under the condition’ by 
‘provided’). It was highlighted that ‘cure’ does not broadly apply to all interventions 
and that it could be replaced by ‘intended or proposed aim of surgery’, as for 
instance in aesthetic surgery. We agree with the expert that cure is less broadly 
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applicable, feel however that if we distinguish failures of reaching the intended or 
proposed aim of surgery from intraoperative complications, many complications 
would not be captured, since recorded as failure of reaching the aim instead of as 
complication. It additionally was stressed that guidelines are not always 
appropriate or available and thus it was suggested to write ‘under the condition the 
indication for surgery was properly planned and indicated’. Again, we agree that 
there are not always established high-level evidence guidelines. However when 
using ‘properly’, a definition should be provided, which may not be clear-cut. 
Additionally, the question was highlighted on how to handle failures of adherence 
to the indicated plan or guidelines. In our opinion, this may not be uniformly 
answered. Failure of adherence to guidelines may be at the level of indication and 
is outlined below or can occur during surgery and manifest as intraoperative 
complication, which then is captured as such.  
 
Update 
We thus update the definition as follows: 
A definition of intraoperative complications needs to distinguish complications from 
failures of cure (such as residual tumor after surgery), provided the indication for 
surgery and the interventions conform to current guidelines.  
 
Summary disease  
Experts seemed to agree on this point (tick box). Besides the same shortening as 
mentioned above, there were no more comments.  
 
Update 
We thus update the definition as follows: 
A definition of intraoperative complications needs to distinguish complications from 
events related to the underlying disease (such as bleeding from a ruptured 
abdominal aortic aneurysm or intraoperative sepsis due to a purulent peritonitis 
associated to a perforated appendicitis), provided the indication for surgery and 
the interventions conform to current guidelines.  
Summary indication 
Here, similar to the first round, the tick box answers suggested that some experts 
rather regarded errors in indication as intraoperative complications. These 
contradictory answers were as well reflected by the comments. On one hand, it 
was pointed out that indication is taking place before surgery and for practical 
reasons, such a classification should account only for the time from skin incision to 
closure. Conversely, the operation was as well considered as part of a whole 
system highlighting that the systems’ behaviour dictates the outcome. Additionally, 
it was pointed out that errors in indication may lead to intraoperative complications, 
such as in the case of an inadvertent vessel injury while attempting to remove a 
non-resectable tumour. However, an intervention could be carried out without any 
intraoperative ‘technical’ complications, but for instance on the wrong side. So we 
rather see error in indication as a risk factor for intraoperative complications, which 
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then may or may not occur. We agree with one expert that wrong side surgery is 
not the same as error in indication, since the indication could be entirely 
appropriate, had the intervention been carried out on the proper side. It is evident 
that the controversy on how to handle these errors in indication, side or patient 
may not be resolved. We propose however to handle such errors separately in 
order to enhance practicability. Moreover, there are interventions that – if carried 
out on the wrong patient - are neither life-threatening nor leading to permanent 
disability, so they will be graded low, whereas intuitively it seems to be a very 
serious complication, if you carry out a surgery on the wrong patient.   
 
Update 
We thus update the definition as follows: 
A definition of intraoperative complications should NOT refer to wrong-site or 
wrong-patient surgery and NOT to errors in indication (such as inappropriate 
indication for surgery according to current guidelines). Wrong-site, wrong-patient 
surgery and errors in indication should be reported separately. 
 
1.2. Wording 
Questions round 2 
Preventable deviation from ideal course: A definition of intraoperative 
complications may be formulated as “any preventable deviation from the ideal 
intraoperative course” 
Skin incision to closure: A definition of intraoperative complications should include 
the following time period of event occurrence (disregarding time-point of event 
manifestation): Surgery only (i.e. between skin incision and skin closure) and 
should be distinguished from perioperative complications including anesthesia 
induction and termination.  
Any event: A definition of intraoperative complications should include any event 
occurring during surgery, regardless whether it is related to the surgical gesture 
itself.  
Two raters: A classification of intraoperative complications should be undertaken 
by two independent surgeons.  
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Summary preventable deviation from ideal course 
Given the tick-box answers, experts seemed more to agree, although in this case 
there were quite some which were rather neutral or disagreeing. The word 
preventable was added after the first round, because experts suggested that not 
every deviation from the ideal course is a complication, for instance in case of an 
unexpected anatomical difficulty found upon surgery. It was however argued in this 
round that even given unexpected anatomical difficulties, there could be an ideal 
course (which may be different from the originally planned ideal course) and that 
deviations from the course would be an intraoperative complication. Additionally, it 
was argued that preventable is highly dependent on individual (subjective) 
judgment and that it is not always clear-cut to assess whether a deviation was 
preventable or not, as for instance an enterotomy during extensive adhesiolysis. It 
was as well argued that some intraoperative events are not actually preventable, 
such as fat embolism when reaming a bone or cement embolism in cemented hip 
arthroplasty, but still should be recorded as serious complications. It was 
additionally pointed out that ‘ideal’ implies a non-real world situation and 
suggested rather to use ‘deviation from the planned/expected/correct course’. With 
‘planned’ we are facing again the problem that sometimes plans need to be 
changed due to unexpected events, such as anatomical difficulties. If ‘deviation 
from the expected course’ is used, it may be attempted to list some relevant 
deviations as expected and not capture them anymore as such.  
One expert pointed out to use the OCHRA system for definitions of error. OCHRA 
stands for Observational Clinical Human Reliability Assessment.(Tang et al. 2004) 
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n the cited work, human error was defined according to the Bellagio Conference 
on Human error as  “ . . . something that has been done which was: (i) not 
intended by the actor, (ii) not desired by a set of rules or an external observer, or 
(iii) that led the task or system outside acceptable limits”.(Senders W 2014) The 
authors considered “any action or omission that resulted in a negative 
consequence or increased the time of the surgical procedure by necessitating a 
corrective action, that fell outside of the “acceptable limits” and was, therefore, 
registered as a consequential error.” The authors defined inconsequential error as 
“action or omission that increased the likelihood of negative consequence and 
under slightly different circumstances could have had a consequential 
effect”.(Tang, Hanna, Joice, & Cuschieri 2004)  
We suggest not including the concept of ‘intention’ in the definition, i.e. omitting 
‘not intended’. Complications may result from intended actions resulting from 
misinterpretation of a situation. Similarly, desired seems to be linked to some sort 
of intention. We agree entirely on the point that such a deviation may be 
consequential or inconsequential, which is however covered by the grading (i.e. 
inconsequential is similar to ‘no need for additional action’.  
Update 
We thus update the definition as follows: 
A definition of intraoperative complications may be formulated as “any deviation 
from the ideal intraoperative course” 
 
Summary skin incision to closure 
Experts seemed largely to agree on this point (tick box answers). It was however 
pointed out that this definition would then not cover any bowel injury manifest only 
some days later. Based on the discussion of round 1, we felt that in many cases it 
is difficult to establish such a causal relationship, although in some it is obvious 
(i.e. foreign body left back). However in the majority of cases, it will be difficult to 
definitively advocate a causal relationship. In the rare event that causal 
relationship between a surgical intervention and a complication becoming evident 
only some days after surgery (e.g. surgical instrument left in place), we suggest 
capturing this event with the postoperative complication tool and additionally 
transparently reporting the specific event as such.   
It was additionally pointed out that anaesthetic complications should not be 
considered separately and the example of an anaphylactic response occurring 
during surgery based on an antibiotic given before surgery should be captured. 
We entirely agree on this point and such an event would be captured as long as 
occurring during surgery. One expert asked how to handle mispositioning 
complications, for instance compartment syndrome or nerve injury. We propose to 
capture these events as perioperative events, similar to events occurring during 
induction of anaesthesia prior skin incision.  
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Update 
We thus update the definition as follows: 
A definition of intraoperative complications should include the following time period 
of event occurrence (disregarding time-point of event manifestation): Surgery only 
(i.e. between skin incision and skin closure) and should be distinguished from 
perioperative complications occurring between the beginning of anesthesia 
induction and patient positioning (whichever is first) and skin incision and between 
skin closure and anaesthesia termination. 
 
Summary any event  
Here, most of the experts seemed to be in favour of including any event (tick box 
answers). One expert argued that this approach is in accordance with the patient’s 
view not to distinguish between the surgeon and any other reason during surgery.  
 
Update  
We thus maintain the definition unchanged: 
A definition of intraoperative complications should include any event occurring 
during surgery, regardless whether it is related to the surgical gesture itself.  
 
Summary number of raters  
In this regard, there was no uniform opinion at all. As a matter of fact, most of the 
tick box answers were chosen at about the same frequency.  
The comments revealed a number of arguments for and against a rating by two 
independent surgeons. Quite some experts were in favour of the idea, stressing 
that this would be the optimal way to proceed, felt however that it was impractical. 
It was pointed out that an easy and pragmatic classification should not need to 
implicate two surgeons; especially not once it has been validated. Additionally, it 
was highlighted that with such a prerequisite, some events might not be captured 
because of a lack of a second independent assessor. In any case, a second 
surgeon having taken part in the surgery would not really be independent. So it 
was rather proposed to seek an agreement of all surgeons present during the 
surgery with the option to include a suffix if not in agreement. One expert 
suggested opting for an agreement between 2 members of the operating team, not 
necessarily 2 surgeons. Similarly, one expert pointed out the option of including 
the scrub-nurse. It was additionally mentioned that there is a risk of underreporting 
in surgeon-led non-training services. Finally, one expert pointed out that in future 
“litigation-happy societies” anyhow all procedures would be videotaped solving the 
problem of independent review.  
Update 
We thus update the definition as follows: 
Any report on intraoperative complications should state how many raters were 
classifying the events and whether they were involved in the procedure. If they 
were involved in the procedure, it should be stated in which role and if not, 
whether the classification was based on records or on videorecordings of the 
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intervention. In case of multiple raters, it should additionally be reported how a 
consensus was reached.  
 
2. Classification of intraoperative complications 
Questions round 2 
We kindly ask you to rate the following (1= not at all appropriate, 9 = completely 
appropriate) 
Graded according to severity: A classification of intraoperative complications 
should consider the severity of the complication and take into account both the 
necessary treatment and permanent sequelae resulting from the complication. 
Immediately after surgery: Should it be possible to definitively fill in a classification 
of intraoperative complications directly after surgery, whereas complications 
apparent only after surgery are handled with a classification system for 
postoperative complications? 
Classification overall: We kindly ask you to rate the updated classification as 
presented in the table below.  
Minor/major complications: Should complications needed to be dichotomised for 
further analysis (which we not necessarily advocate), we propose to summarize 
grades I-II together as “minor complications” versus grades III-IV as “major 
complications”. 
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Table : Proposed updated Classification of intraoperative complications (CLASSIC) 
Grade Definition 
Grade 0 No preventable1 deviation from the ideal intraoperative course, 
under the condition the indication for surgery and the 
interventions conform to current guidelines.  
Grade I Any preventable deviation from the ideal intraoperative course, 
under the condition the indication for surgery and the 
interventions conform to current guidelines. 
· Without the need for any additional treatment or 
intervention  
Grade II Any preventable deviation from the ideal intraoperative course, 
under the condition the indication for surgery and the 
interventions conform to current guidelines. 
· With the need for any additional treatment or intervention 
· Not life-threatening and not leading to permanent disability  
Grade III Any preventable deviation from the ideal intraoperative course, 
under the condition the indication for surgery and the 
interventions conform to current guidelines. 
· With the need for any additional treatment or intervention 
· Life-threatening and/or leading to permanent disability 
Grade IV Any preventable deviation from the ideal intraoperative course, 
under the condition the indication for surgery and the 
interventions conform to current guidelines. 
· With death of the patient 
 
 
1 an unpreventable deviation could be for instance a deviation due to an unexpected anatomical situation 
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Summary graded according to severity 
Here, experts mostly agreed with the definition (tick box answers), although some 
felt that wording was quite complex and that the interplay with any classification of 
postoperative complications should be clarified.   
 
Update 
We thus update the definition as follows:  
A classification of intraoperative complications should consider the severity of the 
complication. The severity is graded taking into account whether an additional 
treatment is resulting from the complication and whether it is life-threatening 
and/or leading to permanent disability.  
 
Summary immediately after surgery 
Experts largely support the proposition of grading directly after surgery (tick box 
answers), because more practical and for a clear distinction from any 
postoperative classification system. However, one expert preferred keeping a 
30day-evaluation.  
 
Update 
We thus maintain the definition unchanged:  
It should be possible to definitively fill in a classification of intraoperative 
complications directly after surgery, whereas complications apparent only after 
surgery are handled with a classification system for postoperative complications. 
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Summary Classification overall  
The tick box answers showed that the experts mostly were in favour of the 
presented classification. Similar to the comments on the definition of intraoperative 
complications, many experts felt that the word ‘preventable’, which was added due 
to suggestions of the first round, was inappropriate (see above) and should be 
deleted. It was pointed out that ‘preventable’ is difficult to define and that many 
surgeons would claim many errors as not preventable. Some events are not 
preventable, even in very experienced hands, so the only way to prevent them is 
not to carry out the intervention at all. The example given by one expert was dural 
tear in decompression spine surgery requiring an additional intervention (suture). 
Another example given by another expert was that cimented hip hemiarthroplasty 
in frail patients is associated with a certain mortality rate, which is not really 
preventable. If we kept ‘preventable’ in the definition, such a death would not be 
captured.     
Some experts still felt the grading system to be too complicated, whereas others 
would like to add more subgroups such as for grade III, because they felt this 
group might then unify complications with different consequences. In the example 
given, small bowel injury, splenectomy and bile duct injury were graded as III, 
whereas in our opinion, for instance a small bowel injury not qualifies in all 
instances to be graded as III. Additionally, it was pointed out that a bleeding 
without requiring blood substitution might not be captured as grade I. However, a 
bleeding not requiring blood substitution, but additional volume (e.g. cristalloids), 
would still be captured.    
One expert criticised the classification for being an adaption of the Clavien-Dindo 
classification (Dindo, Demartines, & Clavien 2004) and thus not original and the 
fact that it seems to require the observer to await the outcome (such as death) not 
allowing immediate classification. We intended however to capture with the 
classification only deaths during the time of surgery, whereas deaths thereafter 
would be captured with the classification of postoperative complications, 
regardless the aetiology of death (since it might not be obvious to establish a 
causal relationship between a postoperative event and the index surgery). The 
experts suggested rather classifying complications not based on the actual 
outcome, but based on the probability of the outcome. This would allow for 
immediate classification and accounting for the fact that some severe 
complications remaining ‘silent’ might then erroneously be graded as I, although a 
relatively small complication might lead to severe consequences in exceptional 
circumstances.   
We actually discussed the issue in our group before launching the Delphi process 
and initially foresaw including a term ‘potentially’ to account for the fact that we are 
unable to await the outcome for practical reasons. The consequence would then 
be to adapt the wording into ‘life-threatening/potentially life-threatening and/or 
leading/potentially leading to permanent disability’. The drawback of such a 
wording then however is that ‘potentially’ allows for quite some range of 
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interpretation and thus hampering again uniform reporting. This is the reason why 
we dropped again this option.  
 
Update 
We thus update the grading omitting ‘preventable’ as follows: 
 
Proposed updated Classification of intraoperative complications (CLASSIC), not 
allowing for potential consequences 
Grade Definition  
Prerequisite: the indication for surgery and the 
interventions conform to current guidelines 
Grade 0 No deviation from the ideal intraoperative course  
Grade I Any deviation from the ideal intraoperative course 
· Without the need for any additional treatment or 
intervention  
Grade II Any deviation from the ideal intraoperative course 
· With the need for any additional treatment or 
intervention 
· Not life-threatening and not leading to permanent 
disability  
Grade III Any deviation from the ideal intraoperative course 
· With the need for any additional treatment or 
intervention 
· Life-threatening and/or leading to permanent 
disability 
Grade IV Any deviation from the ideal intraoperative course 
· With death of the patient 
 
 
Summary minor/major complications  
The tick box answers were not conclusive, although more experts found the 
suggestion appropriate. While one expert preferred dichotomia, others felt 0-IV 
categories to be more appropriate and not too complex to memorize. While it was 
suggested first addressing the pilot study before deciding on this issue, it was also 
criticised that grade II complications should not be regarded as minor.   
 
Update 
We thus update the definition as follows:  
We propose not to dichotomise the grading for further analysis. If it shall still be 
used for investigating minor versus major complications, both results from the 
original classification and the contracted classification should be reported 
providing a clear definition for the cut-off. 
 
Summary comments overall 
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The initiative to undertake this study was well received and it was proposed to 
validate the classification within a multicentre and international setting (if possible 
including the involved experts again).   
 
 
3. Summary overall 
 
3.1. Definition of intraoperative complications 
 
3.1.1. Distinction 
A definition of intraoperative complications  
· Needs to distinguish complications from sequelae, i.e. effects inherent to 
current best practice surgery (such as the inability to walk after amputation of 
a leg).  
· Refers to complications occurring during the index surgery and not to those 
occurring during potential follow-up surgeries to treat a complication. 
· Needs to distinguish complications from failures of cure (such as residual 
tumor after surgery), provided the indication for surgery and the interventions 
conform to current guidelines 
· Needs to distinguish complications from events related to the underlying 
disease (such as bleeding from a ruptured abdominal aortic aneurysm or 
intraoperative sepsis due to a purulent peritonitis associated to a perforated 
appendicitis), provided the indication for surgery and the interventions conform 
to current guidelines. 
· Does NOT refer to wrong-site or wrong-patient surgery and NOT to errors in 
indication (such as inappropriate indication for surgery according to current 
guidelines). Wrong-site, wrong-patient surgery and errors in indication should 
be reported separately. 
3.1.2. Wording 
 
An intraoperative complication  
 
· Is defined as “any deviation from the ideal intraoperative course” 
· Includes the following time period of event occurrence (disregarding time-point 
of event manifestation): Surgery only (i.e. between skin incision and skin 
closure) and should be distinguished from perioperative complications 
occurring between the beginning of anesthesia induction and patient 
positioning (whichever is first) and skin incision and between skin closure and 
anesthesia termination. 
· Includes any event occurring during surgery, regardless whether it is related to 
the surgical gesture itself or not.  
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Any report on intraoperative complications should state how many raters were 
classifying the events and whether they were involved in the procedure. If they were 
involved in the procedure, it should be stated in which role and if not, whether the 
classification was based on records or on videotapings of the intervention. In case of 
multiple raters it should additionally be reported how a consensus was reached. 
 
 
3.2. Classification of intraoperative complications 
 
A classification of intraoperative complications  
 
· Considers the severity of the complication.  
· Concerns deviations from the ideal intraoperative course, provided the 
indication for surgery and the interventions conform to current guidelines. 
· Takes into account,  
§ whether a complication occurs (no [grade 0] versus yes)  
§ whether an additional treatment is resulting from the 
complication (no [grade I] versus yes) 
§ whether it is life-threatening and/or leading to permanent 
disability (no [grade II] versus yes [grade III]).  
§ whether it is resulting in death of the patient [grade IV]) 
· Is definitively filled in directly after surgery, whereas complications apparent 
only later after surgery are handled with a classification system for 
postoperative complications. 
 
We propose not to dichotomise the grading for further analysis. If it shall still be used 
for investigating minor versus major complications, both results from the original 
classification and the contracted classification should be reported providing a clear 
definition for the cut-off. 
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Appendix Table S8: Patient characteristics of the pilot study (n=60) 
 
Characteristic Category Value 
Median (IQR1) age in years 69 (54, 77) 
Gender, n (%) Male 39 (65%) 
Female 21 (35%) 
ASA2 classification, n (%) 1 5 (8%) 
 2 32 (53%) 
 3 20 (33%) 
 4 3 (5%) 
 5 0 (0%) 
Admission type, n (%) Elective 43 (72%) 
 Emergency 17 (28%) 
Diagnosis, n (%) Benign thyroid disease  7(12%) 
 Thyroid cancer 2 (3%) 
 Primary hyperparathyreoidism 1 (2%) 
 Inguinal hernia 
- unilateral 
- bilateral 
 
5 (8%) 
3 (5%) 
 Unilateral femoral hernia 
- without incarceration 
- with incarceration 
 
1 (2%) 
1 (2%) 
 Symptomatic cholecystolithiasis 3 (5%) 
 Acute cholecystitis 5 (8%) 
 Cholangitis/cholangiosepsis 2 (3%) 
 Colorectal cancer 9 (15%) 
 Colorectal metastasis 1 (2%) 
 Volvulus of sigmoid colon 1 (2%) 
 Diverticulitis 
- free perforation 
- perforation in mesentery 
- vesicoenteric fistula 
 
1 (2%) 
2 (3%) 
1 (2%) 
 Hepatocellulary carcinoma 2 (3%) 
 Liver metastasis 3 (5%) 
 Pancreatic cancer 4 (7%) 
 Intraductal papillary mucinous neoplasm 1 (2%) 
 Esophageal cancer 5 (8%) 
 
 
  
1 IQR=Interquartile range 
2 ASA= American Society of Anesthesiologists 
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Appendix Table S9: Procedure characteristics of the pilot study (n=60) 
 
Characteristic Complexity1 of surgery(Dindo, Demartines, & Clavien 2004;Klotz, Candinas, Platz, Horvath, Dindo, Schlumpf, & 
Largiader 1996) 
Type A 
n=20 
Type B 
n=20 
Type C 
n=20 
Type of surgical 
intervention, n (%) 
4 (7%) Hemithyreoidectomy 
1 (2%) Hemithyreoidectomy with 
parathyreoidectomy 
1 (2%) Open cholecystectomy 
1 (2%) Open cholecystectomy & 
cholangiography 
1 (2%) Right hemihepatectomy 
1 (2%) Left hemihepatectomy 
3 (5%) Total thyreoidectomy 
1 (2%) Total thyreoidectomy with 
neck dissection 
8 (13%) Laparoscopic cholecystectomy 2 (3%) Open bisegmentectomy/atypical 
liver resection 
1 (2%) Laparoscopic bisegmentectomy/ 
atypical liver resection 
1 (2%) Parathyreoidectomy 1 (2%) Open right hemicolectomy 
2 (3%) Laparoscopic right hemicolectomy 
1 (2%) Laparoscopic left pancreatectomy 
4 (7%) Lichtenstein unilateral 
1 (2%) Lichtenstein bilateral 
1 (2%) Open left hemicolectomy 
0 (0%) Laparoscopic left hemicolectomy 
4 (7%) Pyloruspreserving pancreatectomy 
(Traverso-Longmire) 
1 (2%) McVay repair 
1 (2%) McVay repair with small 
bowel resection  
4 (7%) Open sigmoidectomy 
1 (2%) Laparoscopic sigmoidectomy 
2 (3%) Transhiatal esophagus resection 
1 (2%) TEP2 unilateral  
2 (3%) TEP bilateral  
1 (2%) Hartmann’s procedure 1 (2%) Open abdominothoracal esophagus 
resection 
2 (3%) Laparoscopic abdominothoracal 
esophagus resection 
  1 (2%) Total mesorectal excision 
  1 (2%) Open rectosigmoid resection 
3 (5%) Laparoscopic rectosigmoid resection 
Wound class(Mangram, 
Horan, Pearson, Silver, & 
Jarvis 1999a) 
  Clean 
  Clean-contaminated 
  Contaminated 
  Dirty-infected 
 
 
19 (95%) 
1 (5%) 
0 (0%) 
0 (0%) 
 
 
0 (0%) 
10 (50%) 
8 (40%) 
2 (10%) 
 
 
0 (0%) 
18 (90%) 
1 (5%) 
1 (5%) 
 
1 Complexity A=low, B=intermediate, C=high 
2 TEP=Total extraperitoneal repair 
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Appendix Table S9: Procedure characteristics (continued) 
Characteristic Complexity1 of surgery(Dindo, Demartines, & Clavien 2004;Klotz, Candinas, Platz, Horvath, Dindo, Schlumpf, & 
Largiader 1996) 
Type A 
n=20 
Type B 
n=20 
Type C 
n=20 
Surgeon experience, n (%) 
  Resident 
  Junior consultant 
  Senior consultant 
 
14 (24%) 
23 (38%) 
23 (38%) 
 
7 (35%) 
9 (45%) 
4 (20%) 
 
7 (35%) 
7 (35%) 
6 (30%) 
Assistant experience, n (%) 
  Resident 
 Junior consultant 
  Senior consultant 
 
6 (30%) 
11 (55%) 
3 (15%) 
 
5 (25%) 
12 (60%) 
3 (15%) 
 
1 (5%) 
8 (40%) 
11 (55%) 
Median (IQR2) duration of 
surgery in minutes 
93 (75, 125)  133 (70, 195) 253 (183, 320) 
 
 
 
 
  
1 Complexity A=low, B=intermediate, C=high 
2 IQR=Interquartile range 
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Appendix Table S10: Outcomes of the pilot study (n=60) 
 
Characteristic Category All 
n=60 
Complexity1 of surgery(Dindo, 
Demartines, & Clavien 2004;Klotz, 
Candinas, Platz, Horvath, Dindo, 
Schlumpf, & Largiader 1996) 
Type A 
n=20 
Type B 
n=20 
Type C 
n=20 
Median (IQR2) 
length of hospital 
stay in days 
 8 (3, 15) 3 (2,3) 8 (7,15) 14 (9,31) 
Intraoperative 
complications, n 
(%) 
0 41 (68%) 17 (85%) 13 (65%) 11 (55%) 
1 2 (3%) 0 (0%) 1 (5%) 1 (5%) 
2 16 (27%) 2 (10%) 6 (30%) 8 (40%) 
3 1 (2%) 1 (5%) 0 (0%) 0 (0%) 
4 0 (0%) 0 (0%) 0 (0%) 0 (0%) 
Postoperative 
complications, n 
(%)(Dindo, 
Demartines, & 
Clavien 2004) 
0 33 (55%) 15 (75%) 12 (60%) 6 (30%) 
1 7 (12%) 0 (0%) 3 (15%) 4 (20%) 
2 8 (13%) 2 (10%) 1 (5%) 5 (25%) 
3a 2 (3%) 0 (0%) 0 (0%) 2 (10%) 
3b 5 (8%) 2 (10%) 1 (5%) 2 (10%) 
4a 0 (0%) 0 (0%) 0 (0%) 0 (0%) 
4b 1 (2%) 0 (0%) 1 (5%) 0 (0%) 
53 4 (7%) 1 (5%) 2 (10%) 1 (5%) 
 
 
 
 
1 Complexity A=low, B=intermediate, C=high 
2 IQR=Interquartile range 
3 Related to patient factors (comorbidities) and/or severe illness 
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